FedInvent™ Patents

Patent Details for Tuesday, October 06, 2015 

This page was updated on Monday, March 27, 2023 at 04:22 AM GMT

Department of Health and Human Services (HHS) 

US 09149024 Huang et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Deafness and Other Communication Disorders (NIDCD)
APPLICANT(S) Mingqian Huang (Winchester, Massachusetts);  Albena Kantardzhieva (Cambridge, Massachusetts);  Zheng-Yi Chen (Somerville, Massachusetts)
ASSIGNEE(S) Massachusetts Eye and Ear Infirmary (Boston, Massachusetts)
INVENTOR(S) Mingqian Huang (Winchester, Massachusetts);  Albena Kantardzhieva (Cambridge, Massachusetts);  Zheng-Yi Chen (Somerville, Massachusetts)
ABSTRACT Described are methods and compositions for increasing islet-1 (Isl1) activity (e.g., biological activity) and or expression (e.g., transcription and/or translation) in a biological cell and or in a subject.
FILED Tuesday, June 22, 2010
APPL NO 13/380143
ART UNIT 1633 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Animal Husbandry; Care of Birds, Fishes, Insects; Fishing; Rearing or Breeding Animals, Not Otherwise Provided For; New Breeds of Animals
A01K 67/0275 (20130101) Original (OR) Class
A01K 2227/105 (20130101)
A01K 2267/03 (20130101)
A01K 2267/0393 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6883 (20130101)
C12Q 2600/106 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5023 (20130101)
G01N 33/6872 (20130101)
G01N 2800/14 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149200 Arora et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) NORTHWESTERN UNIVERSITY (Evanston, Illinois)
ASSIGNEE(S) Northwestern University (Evanston, Illinois)
INVENTOR(S) Rishi Arora (Chicago, Illinois);  Jason Ng (Evanston, Illinois)
ABSTRACT A method of targeting fibrosis or autonomic nerve tissue for ablation in a subject is provided. The method includes performing at least one EGM analysis of a plurality of recorded atrial EGMs for a tissue in a region suspected of having fibrosis or autonomic nerve tissue. With regard to targeting fibrosis for ablation, the method includes determining one or more correlations of at least one AF EGM characteristic to a region having fibrosis from the plurality of recorded atrial EGMs for the tissue and determining whether the tissue contains dense fibrosis that would preclude effective ablation of the analysis region of the tissue. With regard to targeting autonomic nerve for ablation, the method includes determining whether one or more significant changes in EGM characteristics with autonomic blockade exist that would indicate the need to perform ablation of the analysis region of the tissue.
FILED Wednesday, May 08, 2013
APPL NO 13/890112
ART UNIT 3762 — Refrigeration, Vaporization, Ventilation, and Combustion
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0044 (20130101)
A61B 5/046 (20130101) Original (OR) Class
A61B 5/0422 (20130101)
A61B 5/04012 (20130101)
A61B 5/4887 (20130101)
A61B 5/4893 (20130101)
A61B 18/00 (20130101)
A61B 18/14 (20130101)
A61B 2018/00351 (20130101)
A61B 2018/00434 (20130101)
A61B 2018/00577 (20130101)
A61B 2018/00839 (20130101)
A61B 2562/046 (20130101)

Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 1/395 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149204 Ehman et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) Richard L. Ehman (Rochester, Minnesota);  Jun Chen (Rochester, Minnesota);  Phillip J. Rossman (Rochester, Minnesota)
ASSIGNEE(S) MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (Rochester, Minnesota)
INVENTOR(S) Richard L. Ehman (Rochester, Minnesota);  Jun Chen (Rochester, Minnesota);  Phillip J. Rossman (Rochester, Minnesota)
ABSTRACT A flexible passive acoustic driver for use in an acoustic driver system which applies an oscillating stress to a subject undergoing a magnetic resonance elastography (MRE) examination which includes receiving acoustic pressure waves from an active driver through a tube and imparts pressure waves to a subject of an imaging procedure. In one configuration, the passive driver includes a flexible bag that forms the walls of an acoustic cavity, and a structure filling material located inside the acoustic cavity provides support for the flexible bag. The flexible bag conforms to the shape of the subject and may be held in place by an elastic band. The passive driver can have an integrated or detachable non-active push-on compartment which is rigid or semi-flexible to improve the human-driver mechanical coupling and the driver energy efficiency of converting acoustic pressure to mechanical vibration applied to a subject.
FILED Monday, April 23, 2012
APPL NO 13/453681
ART UNIT 3777 — Refrigeration, Vaporization, Ventilation, and Combustion
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0051 (20130101)
A61B 5/055 (20130101) Original (OR) Class
A61B 8/485 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149205 Hancu et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) General Electric Company (Schenectady, New York)
ASSIGNEE(S) General Electric Company (Niskayuna, New York)
INVENTOR(S) Ileana Hancu (Clifton Park, New York);  Kenneth William Rohling (Schenectady, New York);  Luca Marinelli (Schenectady, New York);  Eric William Fiveland (Niskayuna, New York);  Seung-Kyun Lee (Cohoes, New York);  Keith J. Park (Clifton Park, New York)
ABSTRACT The present disclosure relates to a receive coil assembly for use in magnetic resonance imaging of breast tissue. In certain embodiments the assembly comprises separable parts: a configurable mechanical support and a flexible receive coil array. The adjustability and separability of the receive coil array relative to the mechanical support allows the receive coil array to substantially conform to the breasts of the patient during imaging.
FILED Thursday, March 28, 2013
APPL NO 13/852723
ART UNIT 3737 — Refrigeration, Vaporization, Ventilation, and Combustion
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0555 (20130101) Original (OR) Class
A61B 5/708 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149224 Newman et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
National Aeronautics and Space Administration (NASA)
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computer and Network Systems (CNS)
APPLICANT(S) Dava J. Newman (Cambridge, Massachusetts);  Ashley M. Wessendorf (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Dava J. Newman (Cambridge, Massachusetts);  Ashley M. Wessendorf (Cambridge, Massachusetts)
ABSTRACT Described herein are systems and techniques for a motion capture system and a three-dimensional (3D) tracking system used to record body position and/or movements/motions and using the data to measure skin strain (a strain field) all along the body while a joint is in motion (dynamic) as well as in a fixed position (static). The data and technique can be used to quantify strains, calculate 3D contours, and derive patterns believed to reveal skin's properties during natural motions.
FILED Monday, October 17, 2011
APPL NO 13/274992
ART UNIT 3736 — Sheet Container Making, Package Making, Receptacles, Shoes, Apparel, and Tool Driving or Impacting
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0064 (20130101)
A61B 5/0077 (20130101)
A61B 5/442 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149229 Tarler
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Matthew David Tarler (Westlake, Ohio)
ASSIGNEE(S) Great Lakes NeuroTechnologies Inc. (Cleveland, Ohio)
INVENTOR(S) Matthew David Tarler (Westlake, Ohio)
ABSTRACT The present invention is related, in general, to a wireless electrode patch and/or a wireless system for measuring the physiological condition of a subject, more particularly to an electrode patch for ECG monitoring, and a method of sensing, analyzing and/or transmitting or relaying a physiological signal. The wireless system and/or wireless electrode patch of the present invention is preferably lightweight and compact. The wireless electrode patch preferably additionally provides a low-power system for extended battery life and use. The wireless electrode patch and/or wireless system still further preferably allows for good and reliable measurement of physiological signals from the subject. The wireless electrode patch is still preferably simple enough to apply as a single patch, but versatile enough to be reconfigured as more than one patch.
FILED Tuesday, February 27, 2007
APPL NO 11/711365
ART UNIT 3762 — Refrigeration, Vaporization, Ventilation, and Combustion
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0006 (20130101)
A61B 5/6833 (20130101) Original (OR) Class

Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 1/05 (20130101)
A61N 1/08 (20130101)

Transmission of Digital Information, e.g Telegraphic Communication
H04L 67/125 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149424 Mehal et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) Wajahat Mehal (Guilford, Connecticut);  Avlin Imaeda (Guilford, Connecticut)
ASSIGNEE(S) YALE UNIVERSITY (New Haven, Connecticut)
INVENTOR(S) Wajahat Mehal (Guilford, Connecticut);  Avlin Imaeda (Guilford, Connecticut)
ABSTRACT The present invention relates to the discovery that acetylsalicylic acid (ASA or aspirin), salicylic acid (SA) and related salicylate esters and their pharmaceutically acceptable salts, when coadministered in effective amounts with a drug or other bioactive agent which typically (in the absence of the salicylate compound) produces significant hepatotoxicity as a secondary indication, will substantially reduce or even eliminate such hepatotoxicity. Favorable therapeutic intervention results from the use of the present invention having the effect of reducing hepatotoxicity associated with the administration of certain drugs and other bioactive agents and in certain instances of allowing the administration of higher doses of a compound which, without the coadministration, would produce hepatotoxicity which limits or even negates the therapeutic value of the compound.
FILED Monday, October 20, 2008
APPL NO 12/734153
ART UNIT 1627 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/02 (20130101)
A61K 9/0014 (20130101)
A61K 9/0019 (20130101) Original (OR) Class
A61K 9/0031 (20130101)
A61K 9/0046 (20130101)
A61K 9/0048 (20130101)
A61K 9/0073 (20130101)
A61K 31/60 (20130101)
A61K 31/60 (20130101)
A61K 31/198 (20130101)
A61K 31/198 (20130101)
A61K 45/06 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149432 Irvine et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Darrell J. Irvine (Arlington, Massachusetts);  Jaehyun Moon (Ann Arbor, Michigan)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Darrell J. Irvine (Arlington, Massachusetts);  Jaehyun Moon (Ann Arbor, Michigan)
ABSTRACT The invention provides delivery systems comprised of stabilized multilamellar vesicles, as well as compositions, methods of synthesis, and methods of use thereof. The stabilized multilamellar vesicles comprise terminal-cysteine-bearing antigens or cysteine-modified antigens, at their surface and/or internally.
FILED Sunday, February 19, 2012
APPL NO 13/400076
ART UNIT 1617 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/1273 (20130101) Original (OR) Class
A61K 39/00 (20130101)
A61K 39/015 (20130101)
A61K 39/21 (20130101)
A61K 39/39 (20130101)
A61K 47/48815 (20130101)
A61K 2039/575 (20130101)
A61K 2039/55511 (20130101)
A61K 2039/55555 (20130101)
A61K 2039/55572 (20130101)

Peptides
C07K 14/005 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/88 (20130101)
C12N 2740/15034 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149440 Turos et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) Edward Turos (Wesley Chapel, Florida);  Jeung-Yeop Shim (Tampa, Florida)
ASSIGNEE(S) UNIVERSITY OF SOUTH FLORIDA (Tampa, Florida)
INVENTOR(S) Edward Turos (Wesley Chapel, Florida);  Jeung-Yeop Shim (Tampa, Florida)
ABSTRACT This invention relates to polymeric nanoparticles useful for drug delivery with target molecules bonded to the surface of the particles and having sizes of up to 1000 nm, preferably 1 nm to 400 nm, more preferably 1 nm to 200 nm, that are dispersed homogeneously in aqueous solution. The target drug/target substance is covalently bonded to the novel polymeric nanoparticles to secure them from outer intervention in vivo or cell culture in vitro until they are exposed at the target site within the cell. This invention also relates to microemulsion polymerization techniques useful for preparing the novel nanoparticles.
FILED Thursday, September 02, 2004
APPL NO 10/570461
ART UNIT 1615 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/5138 (20130101) Original (OR) Class
A61K 9/5192 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149444 Barres et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
National Institute on Drug Abuse (NIDA)
APPLICANT(S) Ben A. Barres (Palo Alto, California);  Beth A. Stevens (Palo Alto, California)
ASSIGNEE(S) The Board of Trustees of the Leland Stanford Junior University (Stanford, California)
INVENTOR(S) Ben A. Barres (Palo Alto, California);  Beth A. Stevens (Palo Alto, California)
ABSTRACT C1q is shown to be expressed in neurons, where it acts as a signal for synapse elimination. Methods are provided for protecting or treating an individual suffering from adverse effects of synapse loss. These findings have broad implications for a variety of clinical conditions, including Alzheimer's disease.
FILED Wednesday, December 14, 2011
APPL NO 13/326180
ART UNIT 1676 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/00 (20130101) Original (OR) Class
A61K 31/727 (20130101)
A61K 31/727 (20130101)
A61K 45/06 (20130101)
A61K 48/00 (20130101)
A61K 2300/00 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/564 (20130101)
G01N 33/5058 (20130101)
G01N 33/6872 (20130101)
G01N 33/6896 (20130101)
G01N 2333/4716 (20130101)
G01N 2500/04 (20130101)
G01N 2800/28 (20130101)
G01N 2800/2821 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149445 Liu et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Sean Liu (North Brunswick, New Jersey);  Joshua D. Rabinowitz (Princeton, New Jersey);  Thomas Shenk (Princeton, New Jersey)
ASSIGNEE(S) THE TRUSTEES OF PRINCETON UNIVERSITY (Princeton, New Jersey)
INVENTOR(S) Sean Liu (North Brunswick, New Jersey);  Joshua D. Rabinowitz (Princeton, New Jersey);  Thomas Shenk (Princeton, New Jersey)
ABSTRACT A method of treating or preventing a viral infection in a mammal by administering a compound or pharmaceutically acceptable derivative thereof that inhibits a phosphatidic acid synthesis enzyme.
FILED Tuesday, July 27, 2010
APPL NO 13/387452
ART UNIT 1627 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/38 (20130101)
A61K 31/045 (20130101) Original (OR) Class
A61K 31/381 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149446 Palczewski et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S) Krzysztof Palczewski (Bellevue, Washington);  Shalesh Kaushal (Gainesville, Florida);  Vladimir Kuksa (Seattle, Washington);  Syed M. Noorwez (Gainesville, Florida)
ASSIGNEE(S) UNIVERSITY OF WASHINGTON (Seattle, Washington);  REGENTS OF THE UNIVERSITY OF MINNESOTA (Minneapolis, Minnesota)
INVENTOR(S) Krzysztof Palczewski (Bellevue, Washington);  Shalesh Kaushal (Gainesville, Florida);  Vladimir Kuksa (Seattle, Washington);  Syed M. Noorwez (Gainesville, Florida)
ABSTRACT Methods and compositions for stabilizing opsin protein, such as a Pro23His mutant opsin protein, in a vertebrate visual system, by administration of opsin-binding synthetic retinoids, are provided. The mutant opsin protein binds to the synthetic retinoid, which stabilizes the mutant opsin protein and/or ameliorates the effects of the mutant opsin protein on the vertebrate visual system.
FILED Wednesday, August 24, 2011
APPL NO 13/217128
ART UNIT 1621 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/07 (20130101) Original (OR) Class
A61K 31/11 (20130101)
A61K 31/382 (20130101)
A61K 31/435 (20130101)
A61K 31/695 (20130101)
A61K 38/1709 (20130101)

Technical Subjects Covered by Former USPC Cross-reference Art Collections [XRACs] and Digests
Y10S 514/912 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149450 Andrews et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) Regents of the University of Minnesota (Minneapolis, Minnesota)
ASSIGNEE(S) Regents of the University of Minnesota (Minneapolis, Minnesota)
INVENTOR(S) Matthew T. Andrews (Duluth, Minnesota);  Lester R. Drewes (Duluth, Minnesota);  Greg Beilman (Richfield, Minnesota)
ABSTRACT The invention provides for ischemia/reperfusion protection compositions having one or more ketone bodies and melatonin. The invention also provides for methods of using such compositions to reduce or prevent ischemia/reperfusion injury due to blood loss, stroke or cardiopulmonary arrest or surgery.
FILED Thursday, April 24, 2014
APPL NO 14/260377
ART UNIT 1653 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0019 (20130101)
A61K 31/12 (20130101)
A61K 31/12 (20130101)
A61K 31/19 (20130101) Original (OR) Class
A61K 31/404 (20130101)
A61K 31/4045 (20130101)
A61K 31/4045 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149463 Einav et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) Shirit Einav (Stanford, California);  Jeffrey S. Glenn (Palo Alto, California);  Wenjin Yang (Foster City, California);  Hadas Dvory-Sobol (Mountain View, California);  Ingrid C. Choong (Palo Alto, California);  Robert McDowell (San Francisco, California)
ASSIGNEE(S) The Board of Trustees of the Leland Standford Junior University (Palo Alto, California)
INVENTOR(S) Shirit Einav (Stanford, California);  Jeffrey S. Glenn (Palo Alto, California);  Wenjin Yang (Foster City, California);  Hadas Dvory-Sobol (Mountain View, California);  Ingrid C. Choong (Palo Alto, California);  Robert McDowell (San Francisco, California)
ABSTRACT Briefly described, embodiments of this disclosure include compounds (e.g., such as Formula II, Formula II-a, and specific compounds shown in Table 1), pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of inhibiting HCV replication in a host, methods of inhibiting the binding of NS4B polypeptide to the 3′UTR of HCV negative strand RNA in a host, methods of treating liver fibrosis in a host, and the like.
FILED Wednesday, March 18, 2009
APPL NO 12/383071
ART UNIT 1628 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/416 (20130101) Original (OR) Class
A61K 31/454 (20130101)
A61K 31/4439 (20130101)
A61K 31/7056 (20130101)
A61K 31/7056 (20130101)
A61K 38/212 (20130101)
A61K 38/212 (20130101)
A61K 45/06 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)

Heterocyclic Compounds
C07D 231/56 (20130101)
C07D 401/06 (20130101)
C07D 401/12 (20130101)

Peptides
C07K 14/005 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 2770/24122 (20130101)
C12N 2770/24222 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 2333/186 (20130101)
G01N 2500/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149485 Pan et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) The University of Chicago (Chicago, Illinois)
ASSIGNEE(S) The University of Chicago (Chicago, Illinois)
INVENTOR(S) Deng Pan (Chicago, Illinois);  Masha Kocherginsky (Chicago, Illinois);  Suzanne D. Conzen (Park Ridge, Illinois)
ABSTRACT Embodiments of the invention are directed to methods of determining the prognosis of a breast cancer patient by evaluating the activity of the glucocorticoid receptor in tumor cells. Other embodiment include methods of treating breast cancer cells, particularly, chemo-resistant cells, with a glucocorticoid receptor antagonist and an anticancer agent or compound.
FILED Tuesday, February 04, 2014
APPL NO 14/172051
ART UNIT 1628 — Organic Chemistry
CURRENT CPC
Containers Specially Adapted for Medical or Pharmaceutical Purposes; Devices or Methods Specially Adapted for Bringing Pharmaceutical Products into Particular Physical or Administering Forms; Devices for Administering Food or Medicines Orally; Baby Comforters; Devices for Receiving Spittle
A61J 1/00 (20130101)

Preparations for Medical, Dental, or Toilet Purposes
A61K 31/58 (20130101)
A61K 31/282 (20130101)
A61K 31/337 (20130101)
A61K 31/357 (20130101)
A61K 31/567 (20130101) Original (OR) Class
A61K 31/575 (20130101)
A61K 31/575 (20130101)
A61K 31/4745 (20130101)
A61K 31/7068 (20130101)
A61K 33/24 (20130101)
A61K 39/3955 (20130101)
A61K 45/06 (20130101)
A61K 2300/00 (20130101)

Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 5/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149489 Priebe et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Waldeman Priebe (Houston, Texas);  Charles Conrad (Spring, Texas);  Timothy Madden (Sugar Land, Texas);  Izabela Fokt (Houston, Texas);  Slawomir Szymanski (Spring, Texas);  Leposava Antonovic (Houston, Texas)
ASSIGNEE(S) Board of Regents, University of Texas System (Austin, Texas)
INVENTOR(S) Waldeman Priebe (Houston, Texas);  Charles Conrad (Spring, Texas);  Timothy Madden (Sugar Land, Texas);  Izabela Fokt (Houston, Texas);  Slawomir Szymanski (Spring, Texas);  Leposava Antonovic (Houston, Texas)
ABSTRACT Provided herein are methods of treating brain tumors by administering a therapeutically effective amount of a compound of the Formulas I or II to a patient in need thereof.
FILED Monday, March 02, 2009
APPL NO 12/920104
ART UNIT 1673 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/70 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149492 Chang et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) Trustees of Dartmouth College (Hanover, New Hampshire)
ASSIGNEE(S) Trustees of Dartmouth College (Hanover, New Hampshire)
INVENTOR(S) Ta-Yuan Chang (Etna, New Hampshire);  Catherine C. Y. Chang (Etna, New Hampshire);  Yohei Shibuya (West Lebanon, New Hampshire);  Elena Bryleva (Lebanon, New Hampshire);  Stephanie Murphy (West Lebanon, New Hampshire);  Maximillian A. Rogers (White River Junction, Vermont)
ABSTRACT The present invention features methods for stimulating clearance of amyloid beta in microglia, decreasing cognitive decline associated with amyloid pathology, and treating Alzheimer's disease by selectively inhibiting the expression or activity of Acyl-CoA:Cholesterol Acyltransferase 1, but not Acyl-CoA:Cholesterol Acyltransferase 2.
FILED Wednesday, September 11, 2013
APPL NO 14/023952
ART UNIT 1674 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/00 (20130101)
A61K 9/5184 (20130101)
A61K 31/00 (20130101)
A61K 31/44 (20130101)
A61K 31/55 (20130101)
A61K 31/70 (20130101)
A61K 31/167 (20130101)
A61K 31/255 (20130101)
A61K 31/395 (20130101)
A61K 31/415 (20130101)
A61K 31/496 (20130101)
A61K 31/713 (20130101) Original (OR) Class
A61K 31/7105 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/1137 (20130101)
C12N 2310/14 (20130101)
C12N 2310/141 (20130101)

Enzymes
C12Y 203/01009 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149503 Roden et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Richard B. S. Roden (Baltimore, Maryland);  Reinhard Kirnbauer (Vienna, Austria);  Christina Schellenbacher (Vienna, Austria)
ASSIGNEE(S) The Johns Hopkins University (Baltimore, Maryland)
INVENTOR(S) Richard B. S. Roden (Baltimore, Maryland);  Reinhard Kirnbauer (Vienna, Austria);  Christina Schellenbacher (Vienna, Austria)
ABSTRACT This invention relates, e.g., to a virus-like particle (VLP) composition assembled from a chimeric polypeptide comprising a papilloma virus (e.g., human papillomavirus, or HPV) L1 major capsid protein, into which is inserted a surface-displayed peptide comprising a neutralizing epitope of a papillomavirus L2 protein. Vaccine compositions comprising the VLP are described, as well as methods for inducing an immune response (e.g., vaccinating) a subject against papilloma virus, using the VLP, and kits comprising the VLP, for carrying out a method of the invention.
FILED Monday, April 12, 2010
APPL NO 13/263563
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/16 (20130101) Original (OR) Class
A61K 39/12 (20130101)

Peptides
C07K 14/005 (20130101)
C07K 2319/40 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 7/00 (20130101)
C12N 2710/20023 (20130101)
C12N 2710/20034 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149516 Livingston et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (New York, New York)
ASSIGNEE(S) SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (New York, New York)
INVENTOR(S) Philip O. Livingston (New York, New York);  Govindaswami Ragupathi (New York, New York);  Samuel J. Danishefsky (Englewood, New Jersey)
ABSTRACT This invention provides a polyvalent vaccine comprising at least two conjugated antigens selected from a group containing glycolipid antigen, polysaccharide antigen, mucin antigen, glycosylated mucin antigen and an appropriate adjuvant. This invention also provides a multivalent vaccine comprising at least two of the following: glycosylated MUC-1-32mer, Globo H, GM2, Ley, Tn(c), sTN(c), and TF(c). This invention provides the vaccine above, wherein the adjuvant is saponin-based adjuvant. This invention provides a method for inducing immune response in a subject comprising administering an effective amount of the vaccine above to the subject. Finally, this invention provides a method for treating cancer in a subject comprising administering an appropriate amount of the vaccine above to the subject.
FILED Friday, July 26, 2013
APPL NO 13/951795
ART UNIT 1643 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/0011 (20130101) Original (OR) Class
A61K 2039/627 (20130101)
A61K 2039/6081 (20130101)
A61K 2039/55577 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149517 Roden et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Richard Roden (Severna Park, Maryland);  Subhashini Jagu (Baltimore, Maryland)
ASSIGNEE(S) The Johns Hopkins University (Baltimore, Maryland)
INVENTOR(S) Richard Roden (Severna Park, Maryland);  Subhashini Jagu (Baltimore, Maryland)
ABSTRACT Embodiments of the invention are directed to methods and compositions of multitype HPV polypeptides.
FILED Monday, November 03, 2008
APPL NO 12/740815
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/12 (20130101) Original (OR) Class
A61K 39/42 (20130101)
A61K 2039/58 (20130101)
A61K 2039/70 (20130101)
A61K 2039/645 (20130101)
A61K 2039/55505 (20130101)
A61K 2039/55561 (20130101)
A61K 2039/55566 (20130101)
A61K 2039/55577 (20130101)

Peptides
C07K 14/005 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 7/00 (20130101)
C12N 2710/20022 (20130101)
C12N 2710/20034 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149519 Landau et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Nathaniel R. Landau (New York, New York);  Nicole Sunseri (New York, New York);  Thomas D. Norton (New York, New York)
ASSIGNEE(S) New York University (New York, New York)
INVENTOR(S) Nathaniel R. Landau (New York, New York);  Nicole Sunseri (New York, New York);  Thomas D. Norton (New York, New York)
ABSTRACT The compositions and methods described herein relate to lentiviral vectors that can be used to generate virions/viruses that exhibit enhanced infectivity with respect to monocyte-derived macrophages (MDM) and dendritic cells (MDDC). Such compositions and methods further relate to production of virions/viruses that can be used as components of vaccines that effectively stimulate innate immune responses. In a particular embodiment, compositions and methods described herein relate to production of virions/viruses that can be used as components of human immunodeficiency-1 (HIV-1) vaccines administered to stimulate innate immune responses to HIV-1.
FILED Thursday, January 17, 2013
APPL NO 13/743877
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/12 (20130101)
A61K 39/21 (20130101) Original (OR) Class
A61K 2039/5256 (20130101)
A61K 2039/5258 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 7/00 (20130101)
C12N 15/86 (20130101)
C12N 2740/16034 (20130101)
C12N 2740/16041 (20130101)
C12N 2740/16045 (20130101)
C12N 2740/16052 (20130101)
C12N 2740/16134 (20130101)
C12N 2740/16234 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149537 Wang et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
APPLICANT(S) Dong Wang (Omaha, Nebraska);  Matthew Kelso (Papillion, Nebraska)
ASSIGNEE(S) BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (Lincoln, Nebraska)
INVENTOR(S) Dong Wang (Omaha, Nebraska);  Matthew Kelso (Papillion, Nebraska)
ABSTRACT Compositions and methods for the inhibition and/or prevention of traumatic brain injury and the symptoms associated with it are provided.
FILED Friday, November 04, 2011
APPL NO 13/880829
ART UNIT 1618 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 45/06 (20130101)
A61K 47/48 (20130101)
A61K 47/48007 (20130101)
A61K 47/48023 (20130101)
A61K 47/48169 (20130101)
A61K 47/48176 (20130101) Original (OR) Class
A61K 47/48192 (20130101)
A61K 49/00 (20130101)
A61K 49/0008 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149544 Morgan et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Thomas T. Morgan (Pepperell, Massachusetts);  Brian M. Barth (Elizabethtown, Pennsylvania);  James H. Adair (State College, Pennsylvania);  Rahul Sharma (Baton Rouge, Louisiana);  Mark Kester (Harrisburg, Pennsylvania);  Sriram S. Shanmugavelandy (Hershey, Pennsylvania);  Jill P. Smith (Camp Hill, Pennsylvania);  Erhan I. Altinoglu (Boston, Massachusetts);  Gail L. Matters (Hummelstown, Pennsylvania);  James M. Kaiser (Harrisburg, Pennsylvania);  Christopher McGovern (Harrisburg, Pennsylvania)
ASSIGNEE(S) THE PENN STATE RESEARCH FOUNDATION (State College, Pennsylvania)
INVENTOR(S) Thomas T. Morgan (Pepperell, Massachusetts);  Brian M. Barth (Elizabethtown, Pennsylvania);  James H. Adair (State College, Pennsylvania);  Rahul Sharma (Baton Rouge, Louisiana);  Mark Kester (Harrisburg, Pennsylvania);  Sriram S. Shanmugavelandy (Hershey, Pennsylvania);  Jill P. Smith (Camp Hill, Pennsylvania);  Erhan I. Altinoglu (Boston, Massachusetts);  Gail L. Matters (Hummelstown, Pennsylvania);  James M. Kaiser (Harrisburg, Pennsylvania);  Christopher McGovern (Harrisburg, Pennsylvania)
ABSTRACT Non-aggregating resorbable calcium phosphosilicate nanoparticles (CPNPs) are bioconjugated to targeting molecules that are specific for particular cells. The CPNPs are stable particles at normal physiological pH. Chemotherapy and imaging agents may be integrally formed with the CPNPs so that they are compartmentalized within the CPNPs. In this manner, the agents are protected from interaction with the environment at normal physiological pH. However, once the CPNPs have been taken up, at intracellular pH, the CPNPs dissolve releasing the agent. Thus, chemotherapeutic or imaging agents are delivered to specific cells and permit the treatment and/or imaging of those cells. Use of the bioconjugated CPNPs both limits the amount of systemic exposure to the agent and delivers a higher concentration of the agent to the cell. The methods and principals of bioconjugating CPNPs are taught by examples of bioconjugation of targeting molecules for breast cancer, pancreatic cancer, and leukemia.
FILED Monday, November 08, 2010
APPL NO 12/941719
ART UNIT 1618 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 41/0057 (20130101)
A61K 47/48861 (20130101)
A61K 49/0034 (20130101)
A61K 49/0043 (20130101)
A61K 49/0093 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149555 Smith
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) FXS Ventures, LLC (Salem, New Hampshire)
ASSIGNEE(S) FXS Ventures, LLC (Salem, New Hampshire)
INVENTOR(S) Francis X. Smith (Salem, New Hampshire)
ABSTRACT The present invention relates to a lens care solution having 0.001 to about 5 weight percent of a low molecular weight amine of the general formula:
where R1, R2, R3 and R4 are —H or low molecular weight radicals, and R5 is a low molecular weight radical, or salt thereof; an effective amount of a tonicity agent; and the balance water.
FILED Thursday, April 25, 2013
APPL NO 13/870094
ART UNIT 1621 — Organic Chemistry
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 33/12 (20130101)
A01N 37/44 (20130101)
A01N 43/38 (20130101)
A01N 43/50 (20130101)
A01N 47/44 (20130101)

Purses; Luggage; Hand Carried Bags
A45C 11/005 (20130101)

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 2/18 (20130101)
A61L 12/12 (20130101) Original (OR) Class
A61L 12/086 (20130101)
A61L 12/143 (20130101)

Coating Compositions, e.g Paints, Varnishes or Lacquers; Filling Pastes; Chemical Paint or Ink Removers; Inks; Correcting Fluids; Woodstains; Pastes or Solids for Colouring or Printing; Use of Materials Therefor
C09D 5/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149666 Fletcher et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) Paul L. Fletcher (Greenville, North Carolina);  Maryann D. Fletcher (Greenville, North Carolina);  Brian M. Martin (Rockville, Maryland)
ASSIGNEE(S) East Carolina University (Greenville, North Carolina);  National Institutes of Health (Rockville, Maryland)
INVENTOR(S) Paul L. Fletcher (Greenville, North Carolina);  Maryann D. Fletcher (Greenville, North Carolina);  Brian M. Martin (Rockville, Maryland)
ABSTRACT The present invention relates to metalloprotease enzymes isolated from scorpion venom, their nucleic acid and amino acid sequences, and methods of use thereof in the treatment of various diseases, disorders and cosmetic conditions.
FILED Tuesday, August 17, 2010
APPL NO 13/390674
ART UNIT 1652 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 8/64 (20130101)
A61K 8/66 (20130101)
A61K 8/606 (20130101)
A61K 38/00 (20130101)
A61K 38/48 (20130101)
A61K 38/4886 (20130101)

Specific Use of Cosmetics or Similar Toilet Preparations
A61Q 19/08 (20130101) Original (OR) Class

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/6402 (20130101)
C12N 9/6416 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149805 Kartalov et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) UNIVERSITY OF SOUTHERN CALIFORNIA (Los Angeles, California);  APIC CORPORATION (Culver City, California);  CALIFORNIA INSTITUTE OF TECHNOLOGY (Pasadena, California)
ASSIGNEE(S) UNIVERSITY OF SOUTHERN CALIFORNIA (Los Angeles, California);  APIC CORPORATION (Culver City, California);  CALIFORNIA INSTITUTE OF TECHNOLOGY (Pasadena, California)
INVENTOR(S) Emil P. Kartalov (Pasadena, California);  Axel Scherer (Woodstock, Vermont);  Koichi Sayano (Montebello, California)
ABSTRACT A microfluidic fluid separator for separating target components of a fluid by filtration is described. Methods for separating target components of a fluid by filtration and methods for processing blood on a large scale with the microfluidic fluid separator are provided.
FILED Friday, June 07, 2013
APPL NO 13/913321
ART UNIT 1798 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 1/3472 (20130101)
A61M 1/3496 (20130101)
A61M 1/3633 (20130101)

Chemical or Physical Laboratory Apparatus for General Use
B01L 3/502753 (20130101) Original (OR) Class
B01L 2300/087 (20130101)
B01L 2300/0645 (20130101)
B01L 2300/0681 (20130101)
B01L 2300/0816 (20130101)
B01L 2300/0864 (20130101)
B01L 2400/0424 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 436/25125 (20150115)
Y10T 436/25375 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150516 Ritter et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Tobias Ritter (Cambridge, Massachusetts);  Pingping Tang (Quincy, Massachusetts)
ASSIGNEE(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
INVENTOR(S) Tobias Ritter (Cambridge, Massachusetts);  Pingping Tang (Quincy, Massachusetts)
ABSTRACT Methods for fluorinating organic compounds are described herein.
FILED Wednesday, April 11, 2012
APPL NO 13/444676
ART UNIT 1626 — Organic Chemistry
CURRENT CPC
General Methods of Organic Chemistry; Apparatus Therefor
C07B 39/00 (20130101)
C07B 2200/05 (20130101)

Acyclic or Carbocyclic Compounds
C07C 17/16 (20130101)
C07C 17/16 (20130101)
C07C 17/16 (20130101)
C07C 25/13 (20130101)
C07C 25/18 (20130101)
C07C 41/22 (20130101)
C07C 41/22 (20130101)
C07C 43/225 (20130101)
C07C 45/63 (20130101)
C07C 45/63 (20130101)
C07C 49/697 (20130101)
C07C 67/307 (20130101)
C07C 67/307 (20130101)
C07C 67/307 (20130101)
C07C 69/76 (20130101)
C07C 69/734 (20130101)
C07C 201/12 (20130101)
C07C 201/12 (20130101)
C07C 205/12 (20130101)
C07C 209/74 (20130101)
C07C 209/74 (20130101)
C07C 211/52 (20130101)

Heterocyclic Compounds
C07D 233/10 (20130101)
C07D 233/28 (20130101) Original (OR) Class

Steroids
C07J 1/0059 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150521 Karsenty et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) Gerard Karsenty (New York, New York);  Grzegorz Sumara (New York, New York);  Olga Sumara (New York, New York)
ASSIGNEE(S) The Trustees of Columbia University in the City of New York (New York, New York)
INVENTOR(S) Gerard Karsenty (New York, New York);  Grzegorz Sumara (New York, New York);  Olga Sumara (New York, New York)
ABSTRACT The present invention provides methods and therapeutic agents for lowering serum or plasma serotonin levels in a patient in order to prevent or treat diabetes. In preferred embodiments, the patient is known to have, or to be at risk for, diabetes and the agents are TPH1 inhibitors.
FILED Thursday, January 31, 2013
APPL NO 14/375722
ART UNIT 1622 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/505 (20130101)
A61K 31/505 (20130101)
A61K 31/513 (20130101)
A61K 45/06 (20130101)
A61K 2300/00 (20130101)

Heterocyclic Compounds
C07D 239/47 (20130101) Original (OR) Class

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/26 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/942 (20130101)
G01N 2333/90245 (20130101)
G01N 2800/042 (20130101)
G01N 2800/52 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150534 Silverman et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Northwestern University (Evanston, Illinois);  Albert Einstein College of Medicine of Yeshiva University (Bronx, New York)
ASSIGNEE(S) Northwestern University (Evanston, Illinois);  Albert Einstein College of Medicine of Yeshiva University (Bronx, New York)
INVENTOR(S) Richard B. Silverman (Winnetka, Illinois);  Mizuki Watanabe (Kyoto, Japan);  Soosung Kang (Wilmette, Illinois);  Thomas S. Leyh (Katonah, New York)
ABSTRACT Fluorinated prodrug compounds as can be used for selective streptococcal mevalonate pathway inhibition.
FILED Thursday, February 28, 2013
APPL NO 13/780929
ART UNIT 1622 — Organic Chemistry
CURRENT CPC
Acyclic or Carbocyclic Compounds
C07C 69/675 (20130101)
C07C 235/06 (20130101)

Heterocyclic Compounds
C07D 309/30 (20130101)
C07D 319/06 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150558 Kem et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Mental Health (NIMH)
APPLICANT(S) University of Florida Research Foundation (Gainesville, Florida)
ASSIGNEE(S) University of Florida Research Foundation, Inc. (Gainesville, Florida)
INVENTOR(S) William R. Kem (Gainesville, Florida);  Ferenc Soti (Gainesville, Florida);  Hong Xing (Gainesville, Florida)
ABSTRACT The invention relates to the design and synthesis of novel anabaseine-based compounds, which are useful in treating or preventing a wide variety of conditions, including nervous system diseases or disorders, such as, schizophrenia, Alzheimer's disease, Parkinson's disease, drug dependence, and substance addiction, and compositions, kits, and methods thereof. The invention also provides novel anabaseine-based compounds, compositions, kits, and methods thereof for treating or preventing non-nerve system diseases or disorders (such as, inflammation and cancer) in a subject identified in need thereof. Certain enantiomeric compounds of the invention exhibited enhanced selectivity toward α7 nAChRs relative to alpha4beta2 nAChRs. Other enantiomeric compounds of the invention exhibited enhanced selectivity for alpha4beta2 nAChRs relative to α7 nAChRs.
FILED Tuesday, December 11, 2012
APPL NO 14/364499
ART UNIT 1625 — Organic Chemistry
CURRENT CPC
Heterocyclic Compounds
C07D 401/04 (20130101)
C07D 401/14 (20130101)
C07D 405/14 (20130101)
C07D 409/14 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150559 Cleary et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Michael L. Cleary (Eugene, Oregon);  Christina Matheny (San Francisco, California)
ASSIGNEE(S) The Board of Trustees of the Leland Stanford Junior University (Stanford, California)
INVENTOR(S) Michael L. Cleary (Eugene, Oregon);  Christina Matheny (San Francisco, California)
ABSTRACT Disclosed herein are anti-proliferative compounds which find use in inhibiting the growth of cancer cells. Also provided herein are methods for using these compounds for inhibiting growth of cancer cells. Also provided herein are methods for using these compounds for treating a subject for hyperproliferative conditions, including without limitation the treatment of hematopoietic cancers.
FILED Tuesday, May 15, 2012
APPL NO 14/117571
ART UNIT 1625 — Organic Chemistry
CURRENT CPC
Heterocyclic Compounds
C07D 263/32 (20130101)
C07D 413/12 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150581 Carroll et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
APPLICANT(S) RESEARCH TRIANGLE INSTITUTE (Research Triangle Park, North Carolina);  THE REGENTS OF THE UNIVERSITY OF MICHIGAN (Ann Arbor, Michigan);  VIRGINIA COMMONWEALTH UNIVERSITY (Richmond, Virginia)
ASSIGNEE(S) RESEARCH TRIANGLE INSTITUTE (Research Triangle Park, North Carolina);  THE REGENTS OF THE UNIVERSITY OF MICHIGAN (Ann Arbor, Michigan);  VIRGINIA COMMONWEALTH UNIVERSITY (Richmond, Virginia)
INVENTOR(S) Frank Ivy Carroll (Durham, North Carolina);  Pauline Wanjiku Ondachi (Raleigh, North Carolina);  Hernan A. Navarro (Chapel Hill, North Carolina);  M. Imad Damaj (Richmond, Virginia);  James H. Woods (Ann Arbor, Michigan);  Emily M. Jutkiewicz (Ann Arbor, Michigan)
ABSTRACT Compounds and compositions for promoting smoking cessation or decreasing tobacco use or nicotine addiction are provided. The compounds are 2′-fluoro-3′-(substituted phenyl) deschloroepibatidine analogs. The compounds have been found to modulate neuronal nicotine acetylcholine receptors and are useful in methods for the treatment of conditions or disorders influenced by the modulation of neuronal nicotinic acetylcholine receptors.
FILED Wednesday, December 26, 2012
APPL NO 14/368111
ART UNIT 1625 — Organic Chemistry
CURRENT CPC
Heterocyclic Compounds
C07D 487/08 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150582 Runyon et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Mental Health (NIMH)
APPLICANT(S) RESEARCH TRIANGLE INSTITUTE (Research Triangle Park, North Carolina)
ASSIGNEE(S) RESEARCH TRIANGLE INSTITUTE (Research Triangle Park, North Carolina)
INVENTOR(S) Scott Runyon (Hillsborough, North Carolina);  Yanan Zhang (Apex, North Carolina);  Carla Hassler (Durham, North Carolina);  Brian Gilmour (Mebane, North Carolina)
ABSTRACT Neuropeptide S receptor antagonists are provided that bind in functional assays to neuropeptide S receptors; methods are provided for use of these antagonists in treatment of conditions or disease states that are ameliorated by blocking of the neuropeptide S receptor, including substance abuse and substance abuse relapse; and for use of neuropeptide S receptor antagonists in the manufacture of therapeutics and pro-drugs for therapeutics useful in disease states and conditions sensitive to binding of the neuropeptide S receptor.
FILED Thursday, December 06, 2012
APPL NO 14/363079
ART UNIT 1625 — Organic Chemistry
CURRENT CPC
Heterocyclic Compounds
C07D 491/04 (20130101)
C07D 491/10 (20130101)
C07D 491/048 (20130101) Original (OR) Class
C07D 491/107 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150604 Cheng
FUNDED BY
Department of Defense (DOD)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) University of South Florida (Tampa, Florida)
ASSIGNEE(S) University of South Florida (Tampa, Florida)
INVENTOR(S) Jin Q. Cheng (Tampa, Florida)
ABSTRACT The inventors have determined, contrary to the prior art and experience, how to successfully use triciribine to treat esophogeal adenocarcinoma by one or a combination of (i) administering triciribine only to patients which according to a diagnostic test described below, exhibit enhanced sensitivity to the drug; (ii) use of a described dosage level that minimizes the toxicity of the drug but yet still exhibits efficacy; or (iii) use of a described dosage regimen that minimizes the toxicity of the drug.
FILED Monday, June 03, 2013
APPL NO 13/908821
ART UNIT 1672 — Printing/Measuring and Testing
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/70 (20130101)
A61K 31/7042 (20130101)
A61K 31/7052 (20130101)

Sugars; Derivatives Thereof; Nucleosides; Nucleotides; Nucleic Acids
C07H 19/23 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150613 Harding et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Mental Health (NIMH)
APPLICANT(S) Joseph W. Harding (Pullman, Washington);  John W. Wright (Pullman, Washington);  Caroline C. Benoist (Nashville, Tennessee);  Leen H. Kawas (Pullman, Washington);  Gary A. Wayman (Pullman, Washington)
ASSIGNEE(S) Washington State University (Pullman, Washington)
INVENTOR(S) Joseph W. Harding (Pullman, Washington);  John W. Wright (Pullman, Washington);  Caroline C. Benoist (Nashville, Tennessee);  Leen H. Kawas (Pullman, Washington);  Gary A. Wayman (Pullman, Washington)
ABSTRACT Small molecule, peptidic hepatocyte growth factors mimics, which act as both mimetics and antagonists, have been generated. These molecules have been shown or predicted to have therapeutic potential for numerous pathologies including dementia, neurodegenerative disease, diabetes and metabolic syndrome, cancer, and defective wound healing.
FILED Monday, April 02, 2012
APPL NO 14/009459
ART UNIT 1675 — Printing/Measuring and Testing
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)
A61K 38/06 (20130101)
A61K 38/07 (20130101)
A61K 45/06 (20130101)

Peptides
C07K 5/02 (20130101) Original (OR) Class
C07K 5/021 (20130101)
C07K 5/0808 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150614 Szeto et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) Hazel H. Szeto (New York, New York);  Shaoyl Liu (Palisades Park, New Jersey);  Sunghee Cho (Scarsdale, New York)
ASSIGNEE(S) CORNELL RESEARCH FOUNDATION, INC. (Ithaca, New York)
INVENTOR(S) Hazel H. Szeto (New York, New York);  Shaoyl Liu (Palisades Park, New Jersey);  Sunghee Cho (Scarsdale, New York)
ABSTRACT The invention provides a method for treating one or more complications of diabetes in a mammal. The method comprises administering to a mammal in need thereof an effective amount of an aromatic-cationic peptide having at least one net positive charge; a minimum of four amino acids; a maximum of about twenty amino acids; a relationship between the minimum number of net positive charges (pm) and the total number of amino acid residues (r) wherein 3 pm is the largest number that is less than or equal to r+1; and a relationship between the minimum number of aromatic groups (a) and the total number of net positive charges (pt) wherein 2a is the largest number that is less than or equal to pt+1, except that when a is 1, pt may also be 1.
FILED Friday, November 08, 2013
APPL NO 14/075686
ART UNIT 1675 — Printing/Measuring and Testing
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/03 (20130101)
A61K 38/06 (20130101)
A61K 38/08 (20130101)

Peptides
C07K 5/101 (20130101) Original (OR) Class
C07K 5/1008 (20130101)
C07K 5/1016 (20130101)
C07K 5/1019 (20130101)
C07K 5/1024 (20130101)
C07K 14/705 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150616 McCoy et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute on Deafness and Other Communication Disorders (NIDCD)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) 13 Therapeutics, Inc. (Portland, Oregon)
ASSIGNEE(S) 13THERAPEUTICS, INC. (Portland, Oregon)
INVENTOR(S) Sharon L. McCoy (Portland, Oregon);  Steven H. Hefeneider (Portland, Oregon)
ABSTRACT Peptides for the treatment of inflammation, and therapeutic uses and methods of using the same are disclosed. Peptides including a transducing sequence are effective for inhibiting cytokine activity and TNF-α secretion through interaction with toll-like receptors. Experiments are described illustrating the efficacy of the compounds in treating otitis media.
FILED Tuesday, January 29, 2013
APPL NO 13/753106
ART UNIT 1676 — Printing/Measuring and Testing
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)

Peptides
C07K 7/06 (20130101)
C07K 7/08 (20130101) Original (OR) Class
C07K 14/005 (20130101)
C07K 14/07 (20130101)
C07K 14/47 (20130101)
C07K 2319/10 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 2710/24122 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150617 McCoy et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute on Deafness and Other Communication Disorders (NIDCD)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) 13 Therapeutics, Inc. (Portland, Oregon)
ASSIGNEE(S) 13THERAPEUTICS, INC. (Portland, Oregon)
INVENTOR(S) Sharon L. McCoy (Portland, Oregon);  Steven H. Hefeneider (Portland, Oregon)
ABSTRACT Peptides for the treatment of inflammation, and therapeutic uses and methods of using the same are disclosed. Peptides including a transducing sequence are effective for inhibiting cytokine activity and TNF-α secretion through interaction with toll-like receptors. Experiments are described illustrating the efficacy of the compounds in treating otitis media
FILED Tuesday, January 29, 2013
APPL NO 13/753141
ART UNIT 1676 — Printing/Measuring and Testing
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)

Peptides
C07K 7/06 (20130101)
C07K 7/08 (20130101) Original (OR) Class
C07K 14/005 (20130101)
C07K 14/07 (20130101)
C07K 14/47 (20130101)
C07K 2319/10 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 2710/24122 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150626 Liu et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) David R. Liu (Lexington, Massachusetts);  Kevin John Phillips (Somerville, Massachusetts);  Michael S. Lawrence (Atkinson, New Hampshire)
ASSIGNEE(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
INVENTOR(S) David R. Liu (Lexington, Massachusetts);  Kevin John Phillips (Somerville, Massachusetts);  Michael S. Lawrence (Atkinson, New Hampshire)
ABSTRACT Aggregation is a major cause of the misbehavior of proteins. A system for modifying a protein to create a more stable variant is provided. The method involves identifying non-conserved hydrophobic amino acid residues on the surface of a protein, suitable for mutating to more hydrophilic residues (e.g., charged amino acids). Any number of residues on the surface may be changed to create a variant that is more soluble, resistant to aggregation, has a greater ability to re-fold, and/or is more stable under a variety of conditions. The invention also provides GFP, streptavidin, and GST variants with an increased theoretical net charge created by the inventive technology. Kits are also provided for carrying out such modifications on any protein of interest.
FILED Friday, June 01, 2007
APPL NO 12/303047
ART UNIT 1631 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Peptides
C07K 14/43595 (20130101) Original (OR) Class

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/93 (20130101)

Enzymes
C12Y 603/02003 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150635 Suciu-Foca et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) Nicole Suciu-Foca (New York, New York);  Luigi Scotto (Stamford, Connecticut);  Seunghee Kim-Schulze (Tenafly, New Jersey);  George Vlad (Forest Hills, New York);  Raffaello Cortesini (New York, New York)
ASSIGNEE(S) THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (New York, New York)
INVENTOR(S) Nicole Suciu-Foca (New York, New York);  Luigi Scotto (Stamford, Connecticut);  Seunghee Kim-Schulze (Tenafly, New Jersey);  George Vlad (Forest Hills, New York);  Raffaello Cortesini (New York, New York)
ABSTRACT This invention provides a first polypeptide comprising all or a portion of the extracellular domain of ILT3, wherein the polypeptide is water-soluble and does not comprise the Fc portion of an immunoglobulin. This invention also provides a second polypeptide comprising (i) all or a portion of the extracellular domain of ILT3 operable affixed to (ii) the Fc portion of an immunoglobulin, wherein the Fc portion of the immunoglobulin comprises a function-enhancing mutation, and wherein the polypeptide is water-soluble. This invention further provides a third polypeptide comprising (i) all or a portion of the extracellular domain of ILT3 operable affixed to (ii) a transmembrane domain. This invention further provides related nucleic acids, expression vectors, host vector systems, compositions, and articles of manufacture and therapeutic and prophylactic methods using the polypeptides of the invention.
FILED Thursday, May 24, 2012
APPL NO 13/480421
ART UNIT 1644 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Peptides
C07K 14/70503 (20130101) Original (OR) Class
C07K 2319/30 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150636 Campbell
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Kerry S. Campbell (Wyncote, Pennsylvania)
ASSIGNEE(S) Fox Chase Cancer Center (Philadelphia, Pennsylvania)
INVENTOR(S) Kerry S. Campbell (Wyncote, Pennsylvania)
ABSTRACT The invention provides a natural killer cell, NK-92, modified to express an Fc receptor on the surface of the cell, such as CD16 (FcγRIII-A), or other Fcγ or Fc receptors. The modified NK-92 cell can be further modified to concurrently express an associated accessory signaling protein, such as FcεRI-γ, TCR-ζ, or to concurrently express interleukin-2 (IL-2) or other cytokines. Additional methods are disclosed for various assays, assessments, and therapeutic treatments with the modified NK-92 cells.
FILED Tuesday, September 22, 2009
APPL NO 12/564255
ART UNIT 1644 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 2035/124 (20130101)

Peptides
C07K 14/70535 (20130101) Original (OR) Class
C07K 16/28 (20130101)
C07K 16/32 (20130101)
C07K 16/283 (20130101)
C07K 2317/24 (20130101)
C07K 2317/31 (20130101)
C07K 2317/732 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0646 (20130101)
C12N 2501/23 (20130101)
C12N 2503/00 (20130101)
C12N 2503/02 (20130101)
C12N 2510/00 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5011 (20130101)
G01N 33/5047 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150644 Dimitrov et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) Dimiter S. Dimitrov (Frederick, Maryland);  Zhongyu Zhu (Frederick, Maryland);  Qi Zhao (Frederick, Maryland)
ASSIGNEE(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, District of Columbia)
INVENTOR(S) Dimiter S. Dimitrov (Frederick, Maryland);  Zhongyu Zhu (Frederick, Maryland);  Qi Zhao (Frederick, Maryland)
ABSTRACT Disclosed herein are human monoclonal antibodies that specifically bind both IGF-I and IGF-II with picomolar affinity and potently inhibit the IGF-IR signal transduction function. These antibodies are active in both an IgG and a scFv format. Bispecific forms of these antibodies are also disclosed. Nucleic acids encoding these antibodies, vectors including these nucleic acids, and host cells transformed with these vectors are also disclosed herein. Also disclosed are pharmaceutical compositions including these antibodies. Methods are provided for treating a subject with cancer and for inhibiting phosphorylation of the insulin-like growth factor-I receptor. Methods are also provided for diagnosing cancer.
FILED Wednesday, April 11, 2012
APPL NO 14/111507
ART UNIT 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 2039/505 (20130101)

Peptides
C07K 16/22 (20130101) Original (OR) Class
C07K 2317/21 (20130101)
C07K 2317/31 (20130101)
C07K 2317/76 (20130101)
C07K 2317/92 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/74 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150666 Bowen
FUNDED BY
Department of Commerce (DOC)
National Institute of Standards and Technology (NIST)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Dental and Craniofacial Research (NIDCR)
U.S. Public Health Service (USPHS)
APPLICANT(S) Rafael L. Bowen (Gaithersburg, Maryland)
ASSIGNEE(S) ADA Foundation (Chicago, Illinois)
INVENTOR(S) Rafael L. Bowen (Gaithersburg, Maryland)
ABSTRACT Disclosed are compositions that comprise vinylarylalkylene ethers of cyclodextrins optionally containing ether-linked adhesion-promoting groups, in combination with copolymerizable monomer or monomers. The copolymerizable monomer or monomers may include vinylarylalkylene ethers of oligohydroxy compounds (for example, sorbitol divinylbenzyl ether and others). The composition further may include stabilizers (for example, 1,3,5-trimethyl-2,4,6-tris(3,5-di-(tert)-butyl-4-hydroxybenzyl)benzene and others), and polymerization initiators (for example, phenylbis[2,4,6-trimethylbenzoyl]phosphine oxide and others) and reinforcing materials (for example, imogolite). Methods of preparing the compositions as well as the components of compositions and methods for their use in dental and other applications are also disclosed.
FILED Tuesday, January 27, 2009
APPL NO 12/360421
ART UNIT 1762 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 6/08 (20130101)

Polysaccharides; Derivatives Thereof
C08B 11/18 (20130101)
C08B 37/0009 (20130101)
C08B 37/0012 (20130101) Original (OR) Class

Macromolecular Compounds Obtained by Reactions Only Involving Carbon-to-carbon Unsaturated Bonds
C08F 224/00 (20130101)

Compositions of Macromolecular Compounds
C08L 5/16 (20130101)

Adhesives; Non-mechanical Aspects of Adhesive Processes in General; Adhesive Processes Not Provided for Elsewhere; Use of Materials as Adhesives
C09J 4/00 (20130101)
C09J 101/30 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150830 Tilly et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Aging (NIA)
National Research Service Award (NRSA)
APPLICANT(S) Jonathan L. Tilly (Windham, New Hampshire);  Dori C. Woods (Weymouth, Massachusetts)
ASSIGNEE(S) The General Hospital Corporation (Boston, Massachusetts)
INVENTOR(S) Jonathan L. Tilly (Windham, New Hampshire);  Dori C. Woods (Weymouth, Massachusetts)
ABSTRACT Oogonial stem cell (OSC)-derived compositions, such as nuclear free cytoplasm or isolated mitochondria, and uses of OSC-derived compositions in autologous fertility-enhancing procedures are described.
FILED Friday, September 07, 2012
APPL NO 13/606914
ART UNIT 1632 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0609 (20130101) Original (OR) Class
C12N 5/0611 (20130101)
C12N 2501/11 (20130101)
C12N 2501/13 (20130101)
C12N 2501/115 (20130101)
C12N 2501/235 (20130101)
C12N 2502/13 (20130101)
C12N 2517/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150839 Slade et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) ARCADIA BIOSCIENCES, INC. (Davis, California)
ASSIGNEE(S) Arcadia Biosciences, Inc. (Davis, California)
INVENTOR(S) Ann J. Slade (Bellevue, Washington);  Dayna L. Loeffler (Seattle, Washington);  Aaron M. Holm (Shoreline, Washington);  Jessica C. Mullenberg (Lynnwood, Washington)
ABSTRACT A series of independent human-induced non-transgenic mutations found at one or more of the SBEII genes of wheat; wheat plants having these mutations in one or more of their SBEII genes; and a method of creating and finding similar and/or additional mutations of SBEII by screening pooled and/or individual wheat plants. The seeds and flour from the wheat plants of the present invention exhibit an increase in amylose and resistant starch without having the inclusion of foreign nucleic acids in their genomes. Additionally, the wheat plants of the present invention exhibit altered SBEII activity without having the inclusion of foreign nucleic acids in their genomes.
FILED Tuesday, October 02, 2012
APPL NO 13/633588
ART UNIT 1662 — Plants
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/107 (20130101) Original (OR) Class
C12N 15/8245 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150849 Liu et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) Chang Liu (San Diego, California);  Meng-Lin Tsao (Merced, California);  Vaughn Smider (San Diego, California);  Peter G. Schultz (La Jolla, California)
ASSIGNEE(S) The Scripps Research Institute (La Jolla, California)
INVENTOR(S) Chang Liu (San Diego, California);  Meng-Lin Tsao (Merced, California);  Vaughn Smider (San Diego, California);  Peter G. Schultz (La Jolla, California)
ABSTRACT The invention provides methods and compositions for screening polypeptide libraries that include variants comprising unnatural amino acids. In addition, the invention provides vector packaging systems and methods for packaging a nucleic acid in a vector. Compositions of vectors produced by the methods and systems are also provided.
FILED Friday, October 31, 2008
APPL NO 12/290673
ART UNIT 1639 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/67 (20130101)
C12N 15/1037 (20130101) Original (OR) Class
C12N 15/1058 (20130101)

Combinatorial Chemistry; Libraries, e.g Chemical Libraries
C40B 40/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150859 Croce et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Thomas Jefferson University (Philadelphia, Pennsylvania)
ASSIGNEE(S) Thomas Jefferson University (Philadelphia, Pennsylvania)
INVENTOR(S) Carlo M. Croce (Columbus, Ohio);  Chang-Gong Liu (Pearland, Texas);  George A. Calin (Pearland, Texas);  Cinzia Sevignani (Philadelphia, Pennsylvania)
ABSTRACT MicroRNA genes are highly associated with chromosomal features involved in the etiology of different cancers. The perturbations in the genomic structure or chromosomal architecture of a cell caused by these cancer-associated chromosomal features can affect the expression of the miR gene(s) located in close proximity to that chromosomal feature. Evaluation of miR gene expression can therefore be used to indicate the presence of a cancer-causing chromosomal lesion in a subject. As the change in miR gene expression level caused by a cancer-associated chromosomal feature may also contribute to cancerigenesis, a given cancer can be treated by restoring the level of miR gene expression to normal. microRNA expression profiling can be used to diagnose cancer and predict whether a particular cancer is associated with an adverse prognosis. The identification of specific mutations associated with genomic regions that harbor miR genes in CLL patients provides a means for diagnosing CLL and possibly other cancers.
FILED Monday, May 19, 2014
APPL NO 14/281756
ART UNIT 1674 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/713 (20130101)
A61K 31/7088 (20130101)
A61K 45/06 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/113 (20130101) Original (OR) Class

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101)
C12Q 2600/106 (20130101)
C12Q 2600/158 (20130101)
C12Q 2600/178 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150860 Kwiatkowski, Jr. et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) Thomas J. Kwiatkowski, Jr. (Cambridge, Massachusetts);  Robert H. Brown, Jr. (Needham, Massachusetts)
ASSIGNEE(S) The General Hospital Corporation (Boston, Massachusetts)
INVENTOR(S) Thomas J. Kwiatkowski, Jr. (Cambridge, Massachusetts);  Robert H. Brown, Jr. (Needham, Massachusetts)
ABSTRACT The invention provides novel FUS/TLS nucleic acids and proteins that comprise one or more genetic markers (for example, single nucleotide polymorphisms) and methods of use thereof including methods relating to the diagnosis of ALS or other related motor neuron disease by virtue of the presence of the mutant FUS/TLS sequence(s).
FILED Tuesday, July 21, 2009
APPL NO 13/055482
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/1135 (20130101) Original (OR) Class
C12N 2310/14 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6883 (20130101)
C12Q 2600/136 (20130101)
C12Q 2600/156 (20130101)
C12Q 2600/158 (20130101)
C12Q 2600/172 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/6896 (20130101)
G01N 2800/28 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150863 Tolentino et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S) The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania)
ASSIGNEE(S) THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (Philadelphia, Pennsylvania)
INVENTOR(S) Michael J. Tolentino (Winter Haven, Florida);  Samuel Jotham Reich (Miami Beach, Florida)
ABSTRACT RNA interference using small interfering RNAs which are specific for the vascular endothelial growth factor (VEGF) gene and the VEGF receptor genes Flt-1 and Flk-1/KDR inhibit expression of these genes. Diseases which involve angiogenesis stimulated by overexpression of VEGF, such as diabetic retinopathy, age related macular degeneration and many types of cancer, can be treated by administering the small interfering RNAs.
FILED Friday, December 19, 2014
APPL NO 14/577156
ART UNIT 1674 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)
A61K 45/06 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/11 (20130101)
C12N 15/86 (20130101)
C12N 15/88 (20130101)
C12N 15/1136 (20130101) Original (OR) Class
C12N 15/1138 (20130101)
C12N 2310/14 (20130101)
C12N 2310/53 (20130101)
C12N 2310/111 (20130101)
C12N 2310/531 (20130101)
C12N 2320/51 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150865 Bubeck Wardenburg
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Research Resources (NCRR)
APPLICANT(S) Juliane Bubeck Wardenburg (Frankfort, Illinois)
ASSIGNEE(S) The University of Chicago (Chicago, Illinois)
INVENTOR(S) Juliane Bubeck Wardenburg (Frankfort, Illinois)
ABSTRACT Certain embodiments are directed to compositions and methods of inhibiting pathogenic bacterial infection involving ADAMIO comprising administering an effective amount of a metalloprotease inhibitor to a patient. Certain embodiments are directed to method of inhibiting Staphylococcal infection comprising administering an effective amount of a metalloprotease inhibitor to a patient. Other embodiments concern methods of inhibiting infection by a bacteria from the genus Clostridium, Streptococcus, Listeria, Bacillus, or Arcanobacterium.
FILED Wednesday, November 09, 2011
APPL NO 13/884502
ART UNIT 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/00 (20130101)
A61K 31/165 (20130101)
A61K 38/07 (20130101)
A61K 38/08 (20130101)
A61K 38/17 (20130101)
A61K 39/085 (20130101)

Peptides
C07K 16/40 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/1137 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150882 Kay et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Mark A. Kay (Los Altos, California);  Dirk Grimm (Palo Alto, California)
ASSIGNEE(S) The Board of Trustees of the Leland Stanford Junior University (Stanford, California)
INVENTOR(S) Mark A. Kay (Los Altos, California);  Dirk Grimm (Palo Alto, California)
ABSTRACT The teachings herein are generally directed to a method of enhancing the genetic stability of parvovirus vectors. The stability of conventional ss or dsAAV vector constructs can be enhanced, for example, to obtain a concurrent increase in vector titer and purity, as well as an improvement in vector safety, due at least in part to the elimination of stuffer DNA from the AAV vector. The method is broadly applicable to all gene transfer/therapy applications, such as those requiring delivery of foreign DNA containing recombinant gene expression cassettes. Such foreign DNA can range, for example, from about 0.2 up to about 5.2 kb in length. The enhanced vector constructs are highly flexible, user-friendly, and can be easily modified (via routine DNA cloning) and utilized (via standard AAV vector technology) by anyone skilled in the art.
FILED Wednesday, January 31, 2007
APPL NO 11/701279
ART UNIT 1636 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 48/005 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/86 (20130101) Original (OR) Class
C12N 2750/14143 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150897 Kowalczykowski et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Stephen Kowalczykowski (Davis, California);  Ryan Jensen (Davis, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Stephen Kowalczykowski (Davis, California);  Ryan Jensen (Davis, California)
ABSTRACT The present invention provides a new method for recombinantly expressing a protein of interest, such as the human BRCA2 protein, BLM protein, CtIP protein, or EXOI protein, by expressing the protein in the form of a fusion protein comprising two maltose-binding protein (MBP) or glutathione-S-transferase (GST) tags. The expression cassette useful for this method and the fusion protein produced by this method are also described.
FILED Friday, August 05, 2011
APPL NO 13/814713
ART UNIT 1656 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Peptides
C07K 2319/23 (20130101)
C07K 2319/24 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/62 (20130101)

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 21/00 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150903 Reed
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Guy L. Reed (Memphis, Tennessee)
ASSIGNEE(S) TRANSLATIONAL SCIENCES INC. (Memphis, Tennessee)
INVENTOR(S) Guy L. Reed (Memphis, Tennessee)
ABSTRACT Methods for increasing plasmin activity in a patient in need thereof are provided, comprising administering to the patient a therapeutic amount of an agent which binds to α2-antiplasmin at a binding site to increase conversion of cc2-antiplasmin from an inhibitor to a plasmin substrate, thereby increasing plasmin activity in the patient. Also provided are methods for the identification of compounds or molecules that increase plasmin activity, comprising determining whether the compound or molecule binds to a binding site on α2-antiplasmin which increases the conversion of α2-antiplasmin from an inhibitor to a plasmin substrate, wherein the compound or molecule is not an antibody, thereby identifying a compound or molecule which increases plasmin activity. Further provided are pharmaceutical compositions and methods of use thereof for the treatment of myocardial infarction, thrombosis, ischemic stroke, and pulmonary embolism.
FILED Friday, April 25, 2008
APPL NO 12/597311
ART UNIT 1676 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/56 (20130101) Original (OR) Class

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/86 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150915 Esfandyarpour et al.
FUNDED BY
Department of Health and Human Services (HHS)
Department of the Treasury (TREASURY)
Internal Revenue Service (IRS)
APPLICANT(S) Genapsys, Inc. (Redwood City, California)
ASSIGNEE(S) GENAPSYS, INC. (Redwood City, California)
INVENTOR(S) Hesaam Esfandyarpour (Redwood City, California);  Mark Oldham (Emerald Hills, California)
ABSTRACT A method comprises magnetically holding a bead carrying biological material (e.g., nucleic acid, which may be in the form of DNA fragments or amplified DNA) in a specific location of a substrate, and applying an electric field local to the bead to isolate the biological material or products or byproducts of reactions of the biological material. For example, the bead is isolated from other beads having associated biological material. The electric field in various embodiments concentrates reagents for an amplification or sequencing reaction, and/or concentrates and isolates detectable reaction by-products. For example, by isolating nucleic acids around individual beads, the electric field can allow for clonal amplification, as an alternative to emulsion PCR. In other embodiments, the electric field isolates a nanosensor proximate to the bead, to facilitate detection of at least one of local pH change, local conductivity change, local charge concentration change and local heat. The beads may be trapped in the form of an array of localized magnetic field regions.
FILED Tuesday, January 13, 2015
APPL NO 14/596111
ART UNIT 1639 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6869 (20130101) Original (OR) Class

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 27/4145 (20130101)
G01N 27/4146 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 29/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150924 Shaw et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Robin Shaw (San Francisco, California);  Ting-Ting Hong (San Mateo, California);  James Smyth (San Francisco, California)
ABSTRACT The present disclosure provides methods involving use of BIN1 expression levels, in heart tissue, in evaluating the risk of a poor outcome in a patient diagnosed with congestive heart failure. The methods finds use in evaluating patients who are heart transplant candidates as well as in assessing therapy options and efficacy of treatment in congestive heart failure patients.
FILED Monday, February 10, 2014
APPL NO 14/176985
ART UNIT 1678 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Peptides
C07K 14/4716 (20130101)
C07K 14/4747 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6883 (20130101) Original (OR) Class

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/6893 (20130101)
G01N 2333/4703 (20130101)
G01N 2800/56 (20130101)
G01N 2800/325 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150925 Stanford
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Janet L. Stanford (Seattle, Washington)
ASSIGNEE(S) FRED HUTCHINSON CANCER RESEARCH CENTER (Seattle, Washington)
INVENTOR(S) Janet L. Stanford (Seattle, Washington)
ABSTRACT Provided are SNP panels and methods that employ SNP panels for predicting prostate cancer-specific mortality in a human patient. Exemplary SNP panels presented herein comprise one or more of the SNPs designated rs1137100, rs228697, rs2839685, rs1799814, rs627839, rs5993891, rs635261, rs11710277, rs11205, rs2494750, rs4608577, rs4645959, rs1799964, rs25487, rs2308327, rs915927, rs2070874, rs1029153, rs12467911, rs10778534, rs523349, and rs4583514 and are exemplified by SNP panels comprising variant alleles in one or more of the SNPs designated rs1137100, rs2070874, rs10778534, rs627839, and rs5993891.
FILED Tuesday, November 23, 2010
APPL NO 12/953261
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150926 Kebebew et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) Electron Kebebew (Rockville, Maryland);  Erin Patterson (Kensington, Maryland)
ASSIGNEE(S) The United States of America, as Represented by the Secretary, Department of Health and Human Services (Washington, District of Columbia)
INVENTOR(S) Electron Kebebew (Rockville, Maryland);  Erin Patterson (Kensington, Maryland)
ABSTRACT Disclosed herein are methods of diagnosing and treating a malignant adrenocortical tumor, including adrenocortical carcinoma. In some examples, methods of diagnosing a malignant adrenocortical tumor include detecting expression of at least one microRNA (miR) gene product, such as miR-100, miR-125b, miR-195, miR-483-3p, miR-483-5p and IGF2 mRNA in a sample obtained from the subject with an adrenocortical tumor and comparing expression of at least one of these miR gene products and IGF2 mRNA in the sample obtained from the subject to a control. Altered expression of at least one of the miR gene products and IGF2 mRNA, such as a decrease in miR-100, miR-125b or miR-195 or an increase in miR-483-3p, miR-483-5p, and an increase in IGF2 mRNA, in the sample obtained from the subject compared to the control indicates a malignant adrenocortical tumor.
FILED Monday, December 06, 2010
APPL NO 12/961298
ART UNIT 1674 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/113 (20130101)
C12N 2310/113 (20130101)
C12N 2310/141 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101) Original (OR) Class
C12Q 2600/106 (20130101)
C12Q 2600/112 (20130101)
C12Q 2600/118 (20130101)
C12Q 2600/136 (20130101)
C12Q 2600/178 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150928 Krichevsky et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Anna M. Krichevsky (Brookline, Massachusetts);  Nadiya Teplyuk (Boston, Massachusetts);  Brit Mollenhauer (Kassel, Germany);  Santosh Kesari (San Diego, California)
ASSIGNEE(S) The Brigham and Women's Hospital, Inc. (Boston, Massachusetts);  The Regents of the University of California (Oakland, California)
INVENTOR(S) Anna M. Krichevsky (Brookline, Massachusetts);  Nadiya Teplyuk (Boston, Massachusetts);  Brit Mollenhauer (Kassel, Germany);  Santosh Kesari (San Diego, California)
ABSTRACT The use of specific microRNAs (miRNAs) present in CSF as biomarkers for particular brain malignancies and disease activity.
FILED Wednesday, November 16, 2011
APPL NO 13/885762
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101) Original (OR) Class
C12Q 2600/118 (20130101)
C12Q 2600/178 (20130101)

Electric Digital Data Processing
G06F 19/18 (20130101)
G06F 19/24 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150929 Xing et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Michael Mingzhao Xing (Clarksville, Maryland);  Murugan Avaniyapuram Kannan (Baltimore, Maryland)
ASSIGNEE(S) The Johns Hopkins University (Baltimore, Maryland)
INVENTOR(S) Michael Mingzhao Xing (Clarksville, Maryland);  Murugan Avaniyapuram Kannan (Baltimore, Maryland)
ABSTRACT The present invention relates to diagnostic, therapeutic and prognostic methods for thyroid cancers. In one embodiment, the present invention provides a method for treating a an anaplastic thyroid cancer (ATC) patient comprising the step of administering to the patient an effective amount of an anaplastic lymphoma kinase (ALK) inhibitor. In another embodiment, a method for diagnosing ATC in patient comprises the step of performing an assay on a biological sample from the patient to identify the presence or absence of a C3592T and/or a G3602A mutation in exon 23 of the ALK gene according to SEQ ID NO:6, wherein the presence of either of both of the mutations correlates with a diagnosis of ATC in the patient.
FILED Monday, May 07, 2012
APPL NO 14/117898
ART UNIT 1629 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/4155 (20130101)
A61K 31/4545 (20130101)
A61K 45/06 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150971 Zeng et al.
FUNDED BY
Department of Health and Human Services (HHS)
Centers for Disease Control and Prevention (CDC)
National Institute for Occupational Safety and Health (NIOSH)
APPLICANT(S) Xiangqun Zeng (Rochester Hills, Michigan);  Zhe Wang (Auburn Hills, Michigan)
ASSIGNEE(S) Oakland University (Rochester, Michigan)
INVENTOR(S) Xiangqun Zeng (Rochester Hills, Michigan);  Zhe Wang (Auburn Hills, Michigan)
ABSTRACT An aerobic method for oxidizing an alkane is disclosed herein. At least a portion of a surface of a platinum working electrode is activated at an interface between the platinum working electrode and an ionic liquid electrolyte (i.e., 1-ethyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide, 1-propyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide, 1-butyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide, 1-pentyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide, 1-hexyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide, 1-heptyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide, 1-octyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide, 1-nonyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide, and 1-decyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imidem, and combinations thereof). An interface complex is formed at the interface. An alkane gas is supplied to the interface. The alkane adsorbs at or near the interface complex. The alkane gas in the presence of oxygen is supplied to the interface. While the alkane gas in the presence of oxygen is supplied to the interface, a positive electrode potential is applied to the platinum working electrode, which causes a reactive oxygen species formed at the interface to catalyze oxidation of the adsorbed alkane to form a reaction product.
FILED Tuesday, August 28, 2012
APPL NO 13/597071
ART UNIT 1671 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Electrolytic or Electrophoretic Processes for the Production of Compounds or Non-metals; Apparatus Therefor
C25B 3/00 (20130101)
C25B 3/02 (20130101) Original (OR) Class
C25B 9/08 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09151709 O'Brien et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Christine Mary O'Brien (St. Louis, Missouri);  Sagar K. Gupta (Columbia, Missouri);  John Andrew Viator (Columbia, Missouri);  Shramik Sengupta (Columbia, Missouri);  Jeff Mosley (New Bloomfield, Missouri);  Kyle Rood (Saint Peters, Missouri)
ASSIGNEE(S) The Curators of the University of Missouri (Columbia, Missouri)
INVENTOR(S) Christine Mary O'Brien (St. Louis, Missouri);  Sagar K. Gupta (Columbia, Missouri);  John Andrew Viator (Columbia, Missouri);  Shramik Sengupta (Columbia, Missouri);  Jeff Mosley (New Bloomfield, Missouri);  Kyle Rood (Saint Peters, Missouri)
ABSTRACT A multiple flow system and method for detecting substances in a fluid is provided. More specifically, a first fluid tube containing a first fluid and a second fluid tube containing a second fluid are coupled to a common fluid tube via a connector, such that alternating discrete compartments of the first fluid and the second fluid flow through the common fluid tube. The first and second fluids are immiscible. A substance detector, having a flow chamber with an internal wall, is coupled to the common fluid tube. The alternating discrete compartments of the first and second fluids flow through the flow chamber and are analyzed by the substance detector.
FILED Thursday, September 08, 2011
APPL NO 13/228428
ART UNIT 1797 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Mixing, e.g Dissolving, Emulsifying, Dispersing
B01F 13/0071 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/05 (20130101)
G01N 21/1702 (20130101) Original (OR) Class
G01N 2021/1708 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09151758 Zetter et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) Bruce R. Zetter (Wayland, Massachusetts);  Sabarni K. Chatterjee (Gaithersburg, Maryland)
ASSIGNEE(S) Children'Medical Center Corporation (Boston, Massachusetts)
INVENTOR(S) Bruce R. Zetter (Wayland, Massachusetts);  Sabarni K. Chatterjee (Gaithersburg, Maryland)
ABSTRACT Embodiments of the invention are directed to methods for predicting the resistance of cancer to members of the taxoid family by measuring the levels of prohibitin. Methods for treating cancer and taxoid family member resistant cancers using inhibitors of prohibitin, as well as therapeutic complexes that target prohibitin are also provided.
FILED Friday, February 24, 2012
APPL NO 13/404398
ART UNIT 1642 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/94 (20130101)
G01N 33/574 (20130101) Original (OR) Class
G01N 33/6893 (20130101)
G01N 2800/44 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09151760 Weissman et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Irving L. Weissman (Stanford, California);  Alexander D. Boiko (Menlo Park, California)
ASSIGNEE(S) The Board of Trustees of the Leland Stanford Junior University (Stanford, California)
INVENTOR(S) Irving L. Weissman (Stanford, California);  Alexander D. Boiko (Menlo Park, California)
ABSTRACT A set of markers for melanoma cancer stem cells are provided. The cells can be prospectively isolated or identified from primary tumor samples, and possess the unique properties of cancer stem cells in functional assays for tumor initiation, cancer stem cell self-renewal and differentiation. In addition, cancer stem cells can be used as a predictor for disease progression. The CSC have the phenotype of being positive for expression CD271.
FILED Wednesday, September 29, 2010
APPL NO 13/498876
ART UNIT 1643 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/39558 (20130101)
A61K 47/48538 (20130101)
A61K 47/48569 (20130101)
A61K 47/48676 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0695 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5743 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09151762 Gutkind et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) J. Silvio Gutkind (Potomac, Maryland);  Vyomesh Patel (Washington, District of Columbia);  Alfredo Molinolo (Rockville, Maryland);  Timothy D. Veenstra (Jefferson, Maryland)
ASSIGNEE(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, District of Columbia)
INVENTOR(S) J. Silvio Gutkind (Potomac, Maryland);  Vyomesh Patel (Washington, District of Columbia);  Alfredo Molinolo (Rockville, Maryland);  Timothy D. Veenstra (Jefferson, Maryland)
ABSTRACT Disclosed herein is a method of detecting metastasis of a tumor in a subject, such as metastasis to a lymph node. The method includes directly determining an amount of desmoglein-3 (DSG-3) protein in a sample from the subject (such as a lymph node sample) and comparing the amount of DSG-3 protein to a control, wherein an increase in the amount of DSG-3 protein in the sample relative to the control indicates metastasis of the tumor to the lymph node. The disclosed methods further include selecting a therapy (for example, surgery, lymph node dissection, radiation therapy, chemotherapy, or a combination of two or more thereof) for the subject based on the amount of DSG-3 protein in the sample from the subject.
FILED Friday, June 11, 2010
APPL NO 13/376984
ART UNIT 1646 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Peptides
C07K 16/28 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/53 (20130101)
G01N 33/5005 (20130101)
G01N 33/5091 (20130101)
G01N 33/57407 (20130101)
G01N 33/57484 (20130101) Original (OR) Class
G01N 2333/705 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09151763 Osterfeld et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Sebastian J. Osterfeld (Mountain View, California);  Shan X. Wang (Portola Valley, California)
ASSIGNEE(S) MagArray, Inc. (Milpitas, California)
INVENTOR(S) Sebastian J. Osterfeld (Mountain View, California);  Shan X. Wang (Portola Valley, California)
ABSTRACT Provided are high-throughput detection systems. The systems include a magnetic sensor device, a magnetic field source and a reservoir plate that includes a plurality of fluid reservoirs. The magnetic sensor device includes a support with two or more elongated regions each having a magnetic sensor array disposed at a distal end. Also provided are methods in which the subject high-throughput detection systems find use.
FILED Friday, March 09, 2012
APPL NO 13/416928
ART UNIT 1798 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 2219/00317 (20130101)
B01J 2219/00655 (20130101)
B01J 2219/00662 (20130101)

Chemical or Physical Laboratory Apparatus for General Use
B01L 3/5085 (20130101)
B01L 9/523 (20130101)
B01L 2300/0829 (20130101)

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 10/00 (20130101)
B82Y 15/00 (20130101)
B82Y 30/00 (20130101)

Combinatorial Chemistry; Libraries, e.g Chemical Libraries
C40B 60/12 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 27/745 (20130101)
G01N 27/3276 (20130101)
G01N 33/587 (20130101) Original (OR) Class
G01N 35/026 (20130101)
G01N 35/0098 (20130101)

Measuring Electric Variables; Measuring Magnetic Variables
G01R 33/0094 (20130101)
G01R 33/1269 (20130101)

Technical Subjects Covered by Former USPC Cross-reference Art Collections [XRACs] and Digests
Y10S 977/92 (20130101)
Y10S 977/773 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09151813 Hu et al.
FUNDED BY
Department of Energy (DOE)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Environmental Health Sciences (NIEHS)
APPLICANT(S) Jian Zhi Hu (Richland, Washington);  Mary Y. Hu (Richland, Washington);  Mark R. Townsend (Kennewick, Washington);  Johannes A. Lercher (Ottobrunn, Germany);  Charles H. F. Peden (West Richland, Washington)
ASSIGNEE(S) BATTELLE MEMORIAL INSTITUTE (Richland, Washington)
INVENTOR(S) Jian Zhi Hu (Richland, Washington);  Mary Y. Hu (Richland, Washington);  Mark R. Townsend (Kennewick, Washington);  Johannes A. Lercher (Ottobrunn, Germany);  Charles H. F. Peden (West Richland, Washington)
ABSTRACT Re-usable ceramic magic angle spinning (MAS) NMR rotors constructed of high-mechanic strength ceramics are detailed that include a sample compartment that maintains high pressures up to at least about 200 atmospheres (atm) and high temperatures up to about least about 300° C. during operation. The rotor designs minimize pressure losses stemming from penetration over an extended period of time. The present invention makes possible a variety of in-situ high pressure, high temperature MAS NMR experiments not previously achieved in the prior art.
FILED Wednesday, August 07, 2013
APPL NO 13/961012
ART UNIT 1797 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Thread Cutting; Working of Screws, Bolt Heads, or Nuts, in Conjunction Therewith
B23G 1/02 (20130101)

Measuring Electric Variables; Measuring Magnetic Variables
G01R 3/00 (20130101)
G01R 33/305 (20130101) Original (OR) Class
G01R 33/307 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 29/49996 (20150115)
Y10T 409/300112 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09152851 Goulding et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Mental Health (NIMH)
APPLICANT(S) Evan Goulding (San Francisco, California);  A. Katrin Schenk (San Francisco, California);  Laurence Tecott (San Francisco, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Evan Goulding (San Francisco, California);  A. Katrin Schenk (San Francisco, California);  Laurence Tecott (San Francisco, California)
ABSTRACT Systems and methods for the analysis of the diverse behaviors of animal subjects in defined areas are provided, including tools for filtering and analysis of high-resolution behavioral data. These systems and methods provide an opportunity to examine behavioral patterns with levels of precision and quantization that have not been previously achieved. Methods and systems for managing and analyzing the very large and unique datasets produced by behavioral monitoring systems, including quality assessment and control, archiving, data query, data reduction, analytical procedures and visualization techniques are provided. Such detailed analyses of spontaneous behavior provide fundamental insights into the neural organization of behavior and enable detection of genetic, pharmacological and environmental influences on brain function with high sensitivity.
FILED Wednesday, January 21, 2009
APPL NO 12/863970
ART UNIT 3643 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Animal Husbandry; Care of Birds, Fishes, Insects; Fishing; Rearing or Breeding Animals, Not Otherwise Provided For; New Breeds of Animals
A01K 1/031 (20130101)
A01K 29/005 (20130101)

Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 9/00335 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09152884 Lee et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Shih-Jong J. Lee (Bellevue, Washington);  Chi-Chou Huang (Redmond, Washington)
ASSIGNEE(S) DRVision Technologies LLC (Bellevue, Washington)
INVENTOR(S) Shih-Jong J. Lee (Bellevue, Washington);  Chi-Chou Huang (Redmond, Washington)
ABSTRACT A computerized teachable pattern scoring method receives a teaching image and region pattern labels. A region segmentation is performed using the teaching image to generate regions of interest output. A feature measurement is performed using the teaching image and the regions of interest to generate region features output. A pattern score learning is performed using the region features and the region pattern labels to generate pattern score recipe output. A computerized region classification method using the region features and the pattern score recipe to generate pattern scores output. A region classification is performed using the pattern scores and region features to generate region class output.
FILED Tuesday, June 05, 2012
APPL NO 13/507115
ART UNIT 2668 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 9/0014 (20130101)
G06K 9/62 (20130101)
G06K 9/00147 (20130101)
G06K 9/6256 (20130101) Original (OR) Class
G06K 9/6272 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US RE45718 Kilgore et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) Kevin L. Kilgore (Avon Lake, Ohio);  Warren M. Grill (Chapel Hill, North Carolina);  Cameron C. McIntyre (Cleveland, Ohio);  John T. Mortimer (Chagrin Falls, Ohio)
ASSIGNEE(S) BOSTON SCIENTIFIC CORPORATION (Natick, Massachusetts)
INVENTOR(S) Kevin L. Kilgore (Avon Lake, Ohio);  Warren M. Grill (Chapel Hill, North Carolina);  Cameron C. McIntyre (Cleveland, Ohio);  John T. Mortimer (Chagrin Falls, Ohio)
ABSTRACT Systems and methods for blocking nerve impulses use an implanted electrode located on or around a nerve. A specific waveform is used that causes the nerve membrane to become incapable of transmitting an action potential. The membrane is only affected underneath the electrode, and the effect is immediately and completely reversible. The waveform has a low amplitude and can be charge balanced, with a high likelihood of being safe to the nerve for chronic conditions. It is possible to selectively block larger (motor) nerve fibers within a mixed nerve, while allowing sensory information to travel through unaffected nerve fibers.
FILED Wednesday, June 16, 2010
APPL NO 12/816802
ART UNIT 3766 — Electrical Circuits and Systems
CURRENT CPC
Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 1/3605 (20130101)
A61N 1/36071 (20130101) Original (OR) Class
A61N 1/36164 (20130101)
A61N 1/36171 (20130101)
A61N 1/36178 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US RE45725 Mugler, III et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) University of Virginia Patent Foundation (Charlottesville, Virginia)
ASSIGNEE(S) University of Virginia Patent Foundation (Charlottesville, Virginia)
INVENTOR(S) John P. Mugler, III (Charlottesville, Virginia);  James R. Brookeman (Charlottesville, Virginia)
ABSTRACT A magnetic resonance imaging “MRI” method and apparatus for lengthening the usable echo-train duration and reducing the power deposition for imaging is provided. The method explicitly considers the t1 and t2 relaxation times for the tissues of interest, and permits the desired image contrast to be incorporated into the tissue signal evolutions corresponding to the long echo train. The method provides a means to shorten image acquisition times and/or increase spatial resolution for widely-used spin-echo train magnetic resonance techniques, and enables high-field imaging within the safety guidelines established by the Food and Drug Administration for power deposition in human MRI.
FILED Monday, October 14, 2013
APPL NO 14/053190
ART UNIT 2866 — Printing/Measuring and Testing
CURRENT CPC
Measuring Electric Variables; Measuring Magnetic Variables
G01R 33/586 (20130101)
G01R 33/5615 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Defense (DOD) 

US 09149218 Heller et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) Abbott Diabetes Care Inc. (Alameda, California)
ASSIGNEE(S) Abbott Diabetes Care Inc. (Alameda, California)
INVENTOR(S) Adam Heller (Austin, Texas);  Pawel Rowinski (Piaseczno, Poland);  Benjamin J. Feldman (Oakland, California)
ABSTRACT The present invention is directed to membranes composed liquid crystals having continuous aqueous channels, such as a lyotropic liquid crystal, including a cubic phase lyotropic liquid crystal, and to electrochemical sensors equipped with such membranes. The membranes are useful in limiting the diffusion of an analyte to a working electrode in an electrochemical sensor so that the sensor does not saturate and/or remains linearly responsive over a large range of analyte concentrations. Electrochemical sensors equipped with membranes of the present invention demonstrate considerable sensitivity and stability, and a large signal-to-noise ratio, in a variety of conditions.
FILED Friday, February 28, 2014
APPL NO 14/193983
ART UNIT 3735 — Sheet Container Making, Package Making, Receptacles, Shoes, Apparel, and Tool Driving or Impacting
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/1468 (20130101) Original (OR) Class

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/006 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 29/49117 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149222 Zets et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Gary Zets (Maitland, Florida);  Bruce Mortimer (Maitland, Florida)
ASSIGNEE(S) Engineering Acoustics, Inc (Casselberry, Florida)
INVENTOR(S) Gary Zets (Maitland, Florida);  Bruce Mortimer (Maitland, Florida)
ABSTRACT A system and method for providing therapy and assessment utilizing vibrotactile feedback is disclosed. Such treatment is useful for the assessment and treatment of disequilibrium, movement and balance disorders. The system and method measures a subject's performance of predetermined tasks with respect to expected parameters using sensors such as force plates, inertial sensors, and three dimensional cameras. Predetermined motions are motions such as stand, sit-to-stand, reach, bend, functional gait, functional gait plus headshake, and other functional tasks. Vibrotactile stimulation may be applied during the subject's performance as disruptive input. Variance and rate of change of variance between measured and expected parameters is used as a tool for assessment of said subject, and is also used for providing real-time vibrotactile training to said subject. The invention is useful in the treatment of Traumatic Brain Injury (TBI), neurologic disorders causing disequilibrium and balance disorders, and the like.
FILED Friday, November 18, 2011
APPL NO 13/300428
ART UNIT 3736 — Sheet Container Making, Package Making, Receptacles, Shoes, Apparel, and Tool Driving or Impacting
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/16 (20130101) Original (OR) Class
A61B 5/1114 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149432 Irvine et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Darrell J. Irvine (Arlington, Massachusetts);  Jaehyun Moon (Ann Arbor, Michigan)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Darrell J. Irvine (Arlington, Massachusetts);  Jaehyun Moon (Ann Arbor, Michigan)
ABSTRACT The invention provides delivery systems comprised of stabilized multilamellar vesicles, as well as compositions, methods of synthesis, and methods of use thereof. The stabilized multilamellar vesicles comprise terminal-cysteine-bearing antigens or cysteine-modified antigens, at their surface and/or internally.
FILED Sunday, February 19, 2012
APPL NO 13/400076
ART UNIT 1617 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/1273 (20130101) Original (OR) Class
A61K 39/00 (20130101)
A61K 39/015 (20130101)
A61K 39/21 (20130101)
A61K 39/39 (20130101)
A61K 47/48815 (20130101)
A61K 2039/575 (20130101)
A61K 2039/55511 (20130101)
A61K 2039/55555 (20130101)
A61K 2039/55572 (20130101)

Peptides
C07K 14/005 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/88 (20130101)
C12N 2740/15034 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149450 Andrews et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) Regents of the University of Minnesota (Minneapolis, Minnesota)
ASSIGNEE(S) Regents of the University of Minnesota (Minneapolis, Minnesota)
INVENTOR(S) Matthew T. Andrews (Duluth, Minnesota);  Lester R. Drewes (Duluth, Minnesota);  Greg Beilman (Richfield, Minnesota)
ABSTRACT The invention provides for ischemia/reperfusion protection compositions having one or more ketone bodies and melatonin. The invention also provides for methods of using such compositions to reduce or prevent ischemia/reperfusion injury due to blood loss, stroke or cardiopulmonary arrest or surgery.
FILED Thursday, April 24, 2014
APPL NO 14/260377
ART UNIT 1653 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0019 (20130101)
A61K 31/12 (20130101)
A61K 31/12 (20130101)
A61K 31/19 (20130101) Original (OR) Class
A61K 31/404 (20130101)
A61K 31/4045 (20130101)
A61K 31/4045 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149473 Ecker et al.
FUNDED BY
Department of Homeland Security (DHS)
Homeland Security Advanced Research Projects Agency (HSARPA)
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
APPLICANT(S) David J. Ecker (Encinitas, California);  Mark W. Eshoo (Solana Beach, California)
ASSIGNEE(S) IBIS BIOSCIENCES, INC. (Carlsbad, California)
INVENTOR(S) David J. Ecker (Encinitas, California);  Mark W. Eshoo (Solana Beach, California)
ABSTRACT The methods disclosed herein relate to methods and compositions for amplifying nucleic acid sequences, more specifically, from nucleic acid sequences of pathogens by targeted whole genome amplification.
FILED Friday, September 14, 2007
APPL NO 12/441329
ART UNIT 1637 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/4741 (20130101) Original (OR) Class

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 19/34 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/68 (20130101)
C12Q 1/686 (20130101)
C12Q 1/686 (20130101)
C12Q 1/689 (20130101)
C12Q 1/6806 (20130101)
C12Q 1/6806 (20130101)
C12Q 1/6848 (20130101)
C12Q 1/6848 (20130101)
C12Q 2531/119 (20130101)
C12Q 2531/119 (20130101)
C12Q 2537/143 (20130101)
C12Q 2537/143 (20130101)
C12Q 2537/143 (20130101)
C12Q 2563/167 (20130101)
C12Q 2565/513 (20130101)
C12Q 2565/627 (20130101)
C12Q 2565/627 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149566 Van Dyke
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
APPLICANT(S) Mark E. Van Dyke (Winston-Salem, North Carolina)
ASSIGNEE(S) Wake Forest University Health Sciences (Winston-Salem, North Carolina)
INVENTOR(S) Mark E. Van Dyke (Winston-Salem, North Carolina)
ABSTRACT Methods are provided to produce optimal fractionations of charged keratins that have superior biomedical activity. Also provided are medical implants coated with these keratin preparations. Further provided are methods of treating blood coagulation in a patient in need thereof.
FILED Thursday, February 15, 2007
APPL NO 12/279641
ART UNIT 1656 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 15/32 (20130101)
A61L 26/0047 (20130101)
A61L 27/34 (20130101)
A61L 27/227 (20130101)
A61L 27/227 (20130101)
A61L 29/048 (20130101)
A61L 29/048 (20130101)
A61L 29/085 (20130101)
A61L 31/10 (20130101) Original (OR) Class
A61L 31/047 (20130101)
A61L 31/047 (20130101)

Compositions of Macromolecular Compounds
C08L 89/04 (20130101)
C08L 89/04 (20130101)
C08L 89/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149806 Collins
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
APPLICANT(S) Biopico Systems (Irvine, California)
ASSIGNEE(S) Biopico Systems Inc (Irvine, California)
INVENTOR(S) John Collins (Irvine, California)
ABSTRACT Microfluidic devices and methods that use cells such as cancer cells, stem cells, blood cells for preprocessing, sorting for various biodiagnostics or therapeutical applications are described. Microfluidics electrical sensing such as measurement of field potential or current and phenomena such as immiscible fluidics, inertial fluidics are used as the basis for cell and molecular processing (e.g., characterizing, sorting, isolation, processing, amplification) of different particles, chemical compositions or biospecies (e.g., different cells, cells containing different substances, different particles, different biochemical compositions, proteins, enzymes etc.). Specifically this invention discloses a few sorting schemes for stem cells, whole blood and circulating tumor cells and also extracting serum from whole blood. Further medical diagnostics technology utilizing high throughput single cell PCR is described using immiscible fluidics couple with single or multi cells trapping technology.
FILED Thursday, January 10, 2013
APPL NO 13/738968
ART UNIT 1639 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Chemical or Physical Laboratory Apparatus for General Use
B01L 3/502753 (20130101)
B01L 3/502761 (20130101) Original (OR) Class
B01L 7/52 (20130101)
B01L 2200/0652 (20130101)
B01L 2200/0668 (20130101)
B01L 2200/0673 (20130101)
B01L 2300/0832 (20130101)
B01L 2300/0861 (20130101)
B01L 2300/0864 (20130101)
B01L 2300/1822 (20130101)
B01L 2400/086 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 15/1031 (20130101)
G01N 15/1056 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149896 Batty et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
APPLICANT(S) Joseph Clair Batty (North Logan, Utah);  Blake Rusch (Hyde Park, Utah);  Scott Schick (Hyde Park, Utah)
ASSIGNEE(S) Thermal Management Technologies (North Logan, Utah)
INVENTOR(S) Joseph Clair Batty (North Logan, Utah);  Blake Rusch (Hyde Park, Utah);  Scott Schick (Hyde Park, Utah)
ABSTRACT Modular thermal truss plates carry heat in multiple directions. Framing around an array of flat heat pipes provides mechanical and thermal connections to other truss plates, and a base, such as a satellite, thereby supporting thermally active equipment. Walls sandwich banks of flat heat pipes and may bond to a honey comb, metal core conducting heat between multiple walls. Each bank of flat heat pipes passes heat best in one direction, and may be formed of corrugated copper sheets spaced apart by a metal mesh, such as an expanded metal or screen, also stamped or otherwise formed into a corrugated configuration. Joining methods (e.g., brazing, soldering, etc.) increase stiffness, pressure containment, and strength, by binding the two layers of metal sheet to one another.
FILED Thursday, July 12, 2012
APPL NO 13/507593
ART UNIT 3726 — Manufacturing Devices & Processes, Machine Tools & Hand Tools Group Art Units
CURRENT CPC
Working or Processing of Sheet Metal or Metal Tubes, Rods or Profiles Without Essentially Removing Material; Punching Metal
B21D 53/06 (20130101)
B21D 53/08 (20130101)

Metal-working Not Otherwise Provided For; Combined Operations; Universal Machine Tools
B23P 15/26 (20130101) Original (OR) Class

Heat-exchange Apparatus, Not Provided for in Another Subclass, in Which the Heat-exchange Media Do Not Come into Direct Contact
F28D 15/0275 (20130101)

Printed Circuits; Casings or Constructional Details of Electric Apparatus; Manufacture of Assemblages of Electrical Components
H05K 7/20663 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150069 Kalantari et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) Arash Kalantari (Chicago, Illinois);  Matthew Spenko (Chicago, Illinois)
ASSIGNEE(S) Illinois Institute of Technology (Chicago, Illinois)
INVENTOR(S) Arash Kalantari (Chicago, Illinois);  Matthew Spenko (Chicago, Illinois)
ABSTRACT A vehicle capable of both aerial and terrestrial locomotion. The terrestrial and aerial vehicle includes a flying device and a rolling cage connected to the flying device by at least one revolute joint. The rolling cage at least partially surrounds the flying device and is free-rolling and not separately powered.
FILED Friday, August 08, 2014
APPL NO 14/454973
ART UNIT 3644 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Toys, e.g Tops, Dolls, Hoops or Building Blocks
A63H 27/12 (20130101)
A63H 33/005 (20130101)

Vehicles for Use Both on Rail and on Road; Amphibious or Like Vehicles; Convertible Vehicles
B60F 5/02 (20130101) Original (OR) Class

Aeroplanes; Helicopters
B64C 25/36 (20130101)
B64C 37/00 (20130101)
B64C 39/024 (20130101)
B64C 39/028 (20130101)
B64C 2201/027 (20130101)
B64C 2201/042 (20130101)
B64C 2201/127 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150431 Gorun et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) Sergiu M. Gorun (Montclair, New Jersey);  Kimberly Ann Griswold (Flanders, New Jersey)
ASSIGNEE(S) The United States of America as Represented by the Secretary of the Army (Washington, District of Columbia)
INVENTOR(S) Sergiu M. Gorun (Montclair, New Jersey);  Kimberly Ann Griswold (Flanders, New Jersey)
ABSTRACT A method of purifying or sanitizing contaminated water to be potable, by exposing the water in the presence of light, to an electrically neutral metal complex of a perfluoroalkylated fluorinated phthalocyanine photosensitizer, having only external R groups with C—F bonds, preferably F64PcZn; whereby, a sufficient quantity of singlet oxygen is provided by the chemical reaction of the light and the photosensitizer to destroy the pollutants or pathogens present in the contaminated water.
FILED Thursday, November 29, 2012
APPL NO 13/688816
ART UNIT 1774 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Treatment of Water, Waste Water, Sewage, or Sludge
C02F 1/30 (20130101) Original (OR) Class
C02F 1/32 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150533 Whitlon et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) Donna S. Whitlon (Deerfield, Illinois);  Claus-Peter Richter (Skokie, Illinois)
ASSIGNEE(S) Northwestern University (Evanston, Illinois)
INVENTOR(S) Donna S. Whitlon (Deerfield, Illinois);  Claus-Peter Richter (Skokie, Illinois)
ABSTRACT Statin compositions are disclosed for stimulating neurite growth from spiral ganglion neurons in the inner ear and methods for preventing damage to or treating damage of auditory neurons and/or hair cells of the cochlea following acoustic or toxic insult.
FILED Friday, December 13, 2013
APPL NO 14/105582
ART UNIT 1625 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/40 (20130101)
A61K 31/366 (20130101)
A61K 31/405 (20130101)
A61K 31/4418 (20130101)

Heterocyclic Compounds
C07D 207/34 (20130101)
C07D 209/24 (20130101)
C07D 213/55 (20130101)
C07D 309/30 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150604 Cheng
FUNDED BY
Department of Defense (DOD)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) University of South Florida (Tampa, Florida)
ASSIGNEE(S) University of South Florida (Tampa, Florida)
INVENTOR(S) Jin Q. Cheng (Tampa, Florida)
ABSTRACT The inventors have determined, contrary to the prior art and experience, how to successfully use triciribine to treat esophogeal adenocarcinoma by one or a combination of (i) administering triciribine only to patients which according to a diagnostic test described below, exhibit enhanced sensitivity to the drug; (ii) use of a described dosage level that minimizes the toxicity of the drug but yet still exhibits efficacy; or (iii) use of a described dosage regimen that minimizes the toxicity of the drug.
FILED Monday, June 03, 2013
APPL NO 13/908821
ART UNIT 1672 — Printing/Measuring and Testing
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/70 (20130101)
A61K 31/7042 (20130101)
A61K 31/7052 (20130101)

Sugars; Derivatives Thereof; Nucleosides; Nucleotides; Nucleic Acids
C07H 19/23 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150756 Carney
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) Kenneth Carney (Rancho Cucamonga, California)
ASSIGNEE(S) HAMILTON SPACE SYSTEMS INTERNATIONAL, INC. (Windsor Locks, Connecticut)
INVENTOR(S) Kenneth Carney (Rancho Cucamonga, California)
ABSTRACT A sampling device for a substance detection instrument includes a membrane comprising a porous support having a coating thereon, the coating comprising a carborane polysiloxane or an arylene polysiloxane, the membrane having a front side configured to be placed in contact with a test sample and a back side; a sample line having an inlet proximate to the back side of the membrane and an outlet in fluid communication with a substance detector; and a source of carrier gas in fluid communication with the back side of the membrane and the sample line inlet.
FILED Wednesday, August 10, 2011
APPL NO 13/207071
ART UNIT 1798 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Macromolecular Compounds Obtained Otherwise Than by Reactions Only Involving Unsaturated Carbon-to-carbon Bonds
C08G 77/52 (20130101)

Coating Compositions, e.g Paints, Varnishes or Lacquers; Filling Pastes; Chemical Paint or Ink Removers; Inks; Correcting Fluids; Woodstains; Pastes or Solids for Colouring or Printing; Use of Materials Therefor
C09D 183/14 (20130101) Original (OR) Class

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 1/02 (20130101)
G01N 2001/028 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 428/249991 (20150401)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150897 Kowalczykowski et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Stephen Kowalczykowski (Davis, California);  Ryan Jensen (Davis, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Stephen Kowalczykowski (Davis, California);  Ryan Jensen (Davis, California)
ABSTRACT The present invention provides a new method for recombinantly expressing a protein of interest, such as the human BRCA2 protein, BLM protein, CtIP protein, or EXOI protein, by expressing the protein in the form of a fusion protein comprising two maltose-binding protein (MBP) or glutathione-S-transferase (GST) tags. The expression cassette useful for this method and the fusion protein produced by this method are also described.
FILED Friday, August 05, 2011
APPL NO 13/814713
ART UNIT 1656 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Peptides
C07K 2319/23 (20130101)
C07K 2319/24 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/62 (20130101)

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 21/00 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09151165 Donnell et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Department of the Navy (DON)
APPLICANT(S) United Technologies Corporation (Hartford, Connecticut)
ASSIGNEE(S) United Technologies Corporation (Hartford, Connecticut)
INVENTOR(S) Brandon S. Donnell (Hartford, Connecticut);  Yafet Girma (Hartford, Connecticut);  Gina C. O'Dell (Pawleys Island, South Carolina)
ABSTRACT A damper body extends between an axial first end, an opposing axial second end, a first lateral side, and an opposing second lateral side. A first pair of lugs are disposed at the first axial end and a second pair of lugs are disposed at the second axial end. In the first lug pair, a lug has an axially outermost foot which extends laterally beyond a lateral wall. The second lug pair has a lug with an axial outermost point with a foot extending laterally beyond a lateral wall. The foot on the first axial end and the foot on the second axial end are on opposed lateral sides.
FILED Monday, October 22, 2012
APPL NO 13/657190
ART UNIT 3745 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Non-positive Displacement Machines or Engines, e.g Steam Turbines
F01D 5/22 (20130101) Original (OR) Class
F01D 5/26 (20130101)
F01D 11/005 (20130101)
F01D 11/008 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09151193 Delaloye et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) Jim Delaloye (Mesa, Arizona);  Matthew Christopher (Phoenix, Arizona)
ASSIGNEE(S) HONEYWELL INTERNATIONAL INC. (Morristown, New Jersey)
INVENTOR(S) Jim Delaloye (Mesa, Arizona);  Matthew Christopher (Phoenix, Arizona)
ABSTRACT A system and method are provided for controlling an electric motor driven lubrication supply pump that is supplied with electrical power from a power bus, and that supplies lubricant to a rotating machine that is at least part of a vehicle subsystem. A determination is made that the subsystem is being started-up. Moreover, one or more lubricant parameters, power bus electrical state, and one or more lubricant load states are determined. The electrical power supplied from the power bus to the electric motor is varied, based on the one or more lubricant parameters, the power bus electrical state, and the one or more lubricant load states.
FILED Monday, July 28, 2008
APPL NO 12/181195
ART UNIT 3654 — Material and Article Handling
CURRENT CPC
Lubricating of Machines or Engines in General; Lubricating Internal Combustion Engines; Crankcase Ventilating
F01M 5/025 (20130101) Original (OR) Class
F01M 2001/0215 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09151673 Reyes et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Army Research Office (CCDC ARO)
APPLICANT(S) David Reyes (Boston, Massachusetts);  E. Robert Schildkraut (Waltham, Massachusetts);  Jinhong Kim (Brookline, Massachusetts)
ASSIGNEE(S) Block Engineering, LLC (Marlborough, Massachusetts)
INVENTOR(S) David Reyes (Boston, Massachusetts);  E. Robert Schildkraut (Waltham, Massachusetts);  Jinhong Kim (Brookline, Massachusetts)
ABSTRACT An interferometer system includes an optical bench and at least two mirror structures, being patterned from one or more layers on the optical bench and erected to extend substantially perpendicularly to the bench to define two interferometer arms to provide a Micro-Electro-Mechanical Systems (MEMS) interferometer. The MEMS interferometer is further implemented in a Fourier transform spectrometer, which includes a common housing containing the interferometer and a gas cell, possibly including a preconcentrator.
FILED Friday, November 19, 2010
APPL NO 12/950363
ART UNIT 2886 — Optics
CURRENT CPC
Measuring Length, Thickness or Similar Linear Dimensions; Measuring Angles; Measuring Areas; Measuring Irregularities of Surfaces or Contours
G01B 9/02051 (20130101)

Measurement of Intensity, Velocity, Spectral Content, Polarisation, Phase or Pulse Characteristics of Infra-Red, Visible or Ultra-violet Light; Colorimetry; Radiation Pyrometry
G01J 3/4535 (20130101) Original (OR) Class

Technical Subjects Covered by Former US Classification
Y10T 29/49002 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09151705 Di Carlo et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Space and Naval Warfare Systems Center (SPAWAR)
National Science Foundation (NSF)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
ASSIGNEE(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
INVENTOR(S) Dino Di Carlo (Los Angeles, California);  Daniel R. Gossett (Los Angeles, California);  Henry T. K. Tse (San Francisco, California);  Aram Chung (Los Angeles, California)
ABSTRACT A system for deforming and analyzing a plurality of particles carried in a sample volume includes a substrate defining an inlet, configured to receive the sample volume, and an outlet; and a fluidic pathway fluidly coupled to the inlet and the outlet. The fluidic pathway includes a delivery region configured to receive the plurality of particles from the inlet and focus the plurality of particles from a random distribution to a focused state, a deformation region defining an intersection located downstream of the delivery region and coupled to the outlet, and wherein the deformation region is configured to receive the plurality of particles from the delivery region and to transmit each particle in the plurality of particles into the intersection from a single direction, a first branch fluidly coupled to the deformation region and configured to transmit a first flow into the intersection, and a second branch fluidly coupled to the deformation region and configured to transmit a second flow, substantially opposing the first flow, into the intersection, wherein the first flow and the second flow are configured to induce extension of one or more particles in the plurality of particles.
FILED Friday, October 18, 2013
APPL NO 14/058028
ART UNIT 1797 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 15/1434 (20130101) Original (OR) Class
G01N 33/50 (20130101)
G01N 33/5091 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09151732 Santiago et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) Juan G. Santiago (Stanford, California);  Alexandre Persat (Metuchen, New Jersey);  Giancarlo Garcia (Stanford, California);  Charbel Eid (Stanford, California)
ASSIGNEE(S) THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Palo Alto, California)
INVENTOR(S) Juan G. Santiago (Stanford, California);  Alexandre Persat (Metuchen, New Jersey);  Giancarlo Garcia (Stanford, California);  Charbel Eid (Stanford, California)
ABSTRACT Techniques for enhanced isotachophoresis assays using additives with spatial gradients include forming a concentration gradient of an additive along a channel from an input port to an output port. The channel is used for isotachophoresis with ions of a leading electrolyte having a first mobility greater than a mobility of an analyte, and ions of a trailing electrolyte having a second mobility less than the mobility of the analyte. The additive is different from both the leading electrolyte and the trailing electrolyte; and the additive has a third mobility that assures the analyte will encounter the additive. The method further comprises introducing a mixture of the trailing electrolyte and a sample including the analyte. The method further comprises applying an electric field to the channel; and, measuring the analyte.
FILED Monday, October 03, 2011
APPL NO 13/252138
ART UNIT 1759 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 27/44795 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09151733 Sundaresan
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Army Research Office (CCDC ARO)
APPLICANT(S) Mannur J. Sundaresan (Greensboro, North Carolina)
ASSIGNEE(S) North Carolina A and T State University (Greensboro, North Carolina)
INVENTOR(S) Mannur J. Sundaresan (Greensboro, North Carolina)
ABSTRACT A sensor array for non-destructively monitoring a structure to detect a critical structural event. The sensor array includes at least one discrete AE sensor node for producing an electrical signal in response to a structural event and at least one shear wave sensor assembly. The shear wave sensor assembly includes at least one shear wave sensor. A gate module is connected to the at least one discrete AE sensor node and to the at least one shear wave sensor assembly, whereby the gate module is adapted to pass through the electrical signal from the at least one discrete AE sensor node in response to a pre-determined signal from the at least one shear wave sensor assembly. The sensor array may further include a signal processing module for receiving and processing the discrete AE sensor output signal. In addition, a data collection system may be located downstream of the signal processing module.
FILED Wednesday, March 07, 2012
APPL NO 13/414092
ART UNIT 2855 — Printing/Measuring and Testing
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 29/14 (20130101) Original (OR) Class
G01N 29/2475 (20130101)
G01N 2291/0231 (20130101)
G01N 2291/0421 (20130101)
G01N 2291/0422 (20130101)
G01N 2291/2694 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09151787 Mazzaro
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
APPLICANT(S) U.S. Army Research Laboratory (Adelphi, Maryland)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Army (Washington, District of Columbia)
INVENTOR(S) Gregory J. Mazzaro (Columbia, Maryland)
ABSTRACT Methods and apparatus for measuring permittivity having a meander-line ring resonator, which may be disposed on a substrate proximate to and separated from an input coupler and an output coupler thereon, the resonator ring further including a continuous conductive material having at least two turns to form a single congruent pattern, symmetrical along at least one axis.
FILED Thursday, November 01, 2012
APPL NO 13/666404
ART UNIT 2867 — Printing/Measuring and Testing
CURRENT CPC
Measuring Electric Variables; Measuring Magnetic Variables
G01R 27/04 (20130101) Original (OR) Class
G01R 27/2623 (20130101)

Waveguides; Resonators, Lines, or Other Devices of the Waveguide Type
H01P 7/00 (20130101)
H01P 7/082 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09152040 Brueck et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
APPLICANT(S) Steven R. J. Brueck (Albuquerque, New Mexico);  Alexander K. Raub (Albuquerque, New Mexico)
ASSIGNEE(S) STC.UNM (Albuquerque, New Mexico)
INVENTOR(S) Steven R. J. Brueck (Albuquerque, New Mexico);  Alexander K. Raub (Albuquerque, New Mexico)
ABSTRACT In accordance with some aspects of the present disclosure, a maskless interferomeric lithography system for fabricating a three-dimensional (3D) photonic crystal using a multiple two-beam-exposures is disclosed. The system can comprise an illumination system comprising an optical arrangement operable to receive radiation from a radiation source and provide three or more tilted two-beam interference pattern exposures to be combined into a three-dimensional pattern; and a substrate operable to be supported by a substrate table, wherein the substrate comprises a photoresist formed on a top surface of the substrate and operable to receive the three-dimensional pattern and wherein means are provided to adjust the position of the substrate in all six mechanical degrees of freedom.
FILED Friday, February 03, 2012
APPL NO 13/365964
ART UNIT 2881 — Optics
CURRENT CPC
Manufacture, Shaping, or Supplementary Processes
C03B 37/01 (20130101)

Photomechanical Production of Textured or Patterned Surfaces, e.g for Printing, for Processing of Semiconductor Devices; Materials Therefor; Originals Therefor; Apparatus Specially Adapted Therefor;
G03F 7/0005 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09152147 Khazan et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Materiel Command (AFMC)
Air Force Office of Scientific Research (AFOSR)
Office of the Under Secretary of Defense for Research and Engineering (OUSD R&E)
MIT Lincoln Laboratory (MITLL)
Federally Funded Research and Development Center (FFRDC)
Operated by Massachusetts Institute of Technology (MIT) at Lexington, MA
APPLICANT(S) Roger Khazan (Arlington, Massachusetts);  Adam Shawn Petcher (Billerica, Massachusetts);  Daniil M. Utin (Newton, Massachusetts)
ASSIGNEE(S) MASSACHUSETTS INSTITUTE OF TECHNOLOGY (Cambridge, Massachusetts)
INVENTOR(S) Roger Khazan (Arlington, Massachusetts);  Adam Shawn Petcher (Billerica, Massachusetts);  Daniil M. Utin (Newton, Massachusetts)
ABSTRACT A method for transportation of material includes operating a material transportation vehicle according to a material transportation plan. The plan includes a representation of one or more regions within a geographical area, each of the regions being associated with a group of one or more communication stations and a representation of a route of travel within the geographical area. The route of travel traverses a first region of the one or more regions within the geographical area. The operating includes causing the vehicle to travel along the route of travel including causing the vehicle to enter the first region, accepting control information originating from a first communication station of the communication stations associated with the first region, the first communication station being authorized to control a material transportation resource of the vehicle in the first region, and causing an exchange of the material according to the accepted control information.
FILED Tuesday, February 04, 2014
APPL NO 14/172306
ART UNIT 2435 — Cryptography and Security
CURRENT CPC
Systems for Controlling or Regulating Non-electric Variables
G05D 1/0011 (20130101) Original (OR) Class
G05D 1/0022 (20130101)

Data Processing Systems or Methods, Specially Adapted for Administrative, Commercial, Financial, Managerial, Supervisory or Forecasting Purposes; Systems or Methods Specially Adapted for Administrative, Commercial, Financial, Managerial, Supervisory or Forecasting Purposes, Not Otherwise Provided for
G06Q 10/047 (20130101)

Transmission of Digital Information, e.g Telegraphic Communication
H04L 63/062 (20130101)
H04L 63/107 (20130101)
H04L 2463/062 (20130101)

Wireless Communication Networks
H04W 4/021 (20130101)
H04W 56/0045 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09152148 Thielman
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) The United States of America (Washington, District of Columbia)
ASSIGNEE(S) The United States of America as Represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Gerhard W. Thielman (Fredericksburg, Virginia)
ABSTRACT A spherical integrated remote-control locomotive excursor (SIRCLE) is provided for remote reconnaissance. The SIRCLE includes a spherical shell, a chassis within the shell and a set of wheels between the shell and chassis. The spherical shell has inner and outer surfaces. The chassis contains a platform, an electric motor and a power supply. The set of wheels are driven by the motor and supported by the chassis. The wheels engage the inner surface and turn in response to the motor. The shell rolls by turning the wheels to propel the SIRCLE.
FILED Monday, April 28, 2014
APPL NO 14/263529
ART UNIT 3663 — Computerized Vehicle Controls and Navigation, Radio Wave, Optical and Acoustic Wave Communication, Robotics, and Nuclear Systems
CURRENT CPC
Motor Vehicles; Trailers
B62D 5/04 (20130101)

Systems for Controlling or Regulating Non-electric Variables
G05D 1/0011 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09152182 McMahon et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) Shean Thomas McMahon (Seal Beach, California);  Robert Anthony Kunc (Rancho Palos Verdes, California);  Kang Lee (Woodland Hills, California);  Vladimir Esterkin (Redondo Beach, California);  Ranjit Pradhan (Torrance, California);  Xiwen Wang (Hacienda Heights, California);  Frank T. Willis, Jr. (Rio Rancho, New Mexico);  Andrew Kostrzewski (Garden Grove, California);  Sookwang Ro (Glendale, California);  Thomas Forrester (Hacienda Heights, California);  Tomasz Jannson (Torrence, California);  Michael Alan Thompson (Redondo Beach, California)
ASSIGNEE(S) Physical Optics Corporation (Torrance, California)
INVENTOR(S) Shean Thomas McMahon (Seal Beach, California);  Robert Anthony Kunc (Rancho Palos Verdes, California);  Kang Lee (Woodland Hills, California);  Vladimir Esterkin (Redondo Beach, California);  Ranjit Pradhan (Torrance, California);  Xiwen Wang (Hacienda Heights, California);  Frank T. Willis, Jr. (Rio Rancho, New Mexico);  Andrew Kostrzewski (Garden Grove, California);  Sookwang Ro (Glendale, California);  Thomas Forrester (Hacienda Heights, California);  Tomasz Jannson (Torrence, California);  Michael Alan Thompson (Redondo Beach, California)
ABSTRACT Embodiments of the invention provide a removable memory unit (RMU) that facilitates concatenation of said memory modules irrespective of their individual physical interfaces, enables encryption/decryption keys (including cryptographic ignition keys (CIKs)) to reside onboard the RMU, provides for physical separation of RED and BLACK data in cross-domain environments and implements zeroization functionality onboard the RMU. Further embodiments provide a swappable IO backplane and adapter plates for incorporation into a wide variety of platforms.
FILED Thursday, April 05, 2012
APPL NO 13/440897
ART UNIT 2131 — Computerized Vehicle Controls and Navigation, Radio Wave, Optical and Acoustic Wave Communication, Robotics, and Nuclear Systems
CURRENT CPC
Electric Digital Data Processing
G06F 1/1658 (20130101) Original (OR) Class
G06F 13/409 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09152569 Li et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) Jian Li (Austin, Texas);  Ramakrishnan Rajamony (Austin, Texas);  William E. Speight (Austin, Texas);  Xiaoxia Wu (State College, Pennsylvania);  Lixin Zhang (Austin, Texas)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) Jian Li (Austin, Texas);  Ramakrishnan Rajamony (Austin, Texas);  William E. Speight (Austin, Texas);  Xiaoxia Wu (State College, Pennsylvania);  Lixin Zhang (Austin, Texas)
ABSTRACT In one embodiment, a cache memory includes a cache array including a plurality of entries for caching cache lines of data, where the plurality of entries are distributed between a first region implemented in a first memory technology and a second region implemented in a second memory technology. The cache memory further includes a cache directory of the contents of the cache array and a cache controller that controls operation of the cache memory.
FILED Tuesday, November 04, 2008
APPL NO 12/264682
ART UNIT 2137 — Memory Access and Control
CURRENT CPC
Electric Digital Data Processing
G06F 12/123 (20130101)
G06F 12/0811 (20130101)
G06F 12/0846 (20130101)
G06F 12/0848 (20130101)
G06F 12/0897 (20130101) Original (OR) Class
G06F 2212/225 (20130101)
G06F 2212/271 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09152827 Linderman et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
APPLICANT(S) The United States of America as represented by the Secretary of the Air Force (Washington, District of Columbia)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Air Force (Washington, District of Columbia)
INVENTOR(S) Richard Linderman (Rome, New York);  Qing Wu (Manlius, New York);  Garrett Rose (Clinton, New York);  Hai Li (Pittsburg, Pennsylvania);  Yiran Chen (Pittsburg, Pennsylvania);  Miao Hu (Pittsburg, Pennsylvania)
ABSTRACT An apparatus that performs the mathematical matrix-vector multiplication approximation operations using crossbar arrays of resistive memory devices (e.g. memristor, resistive random-access memory, spintronics, etc.). A crossbar array formed by resistive memory devices serves as a memory array that stores the coefficients of a matrix. Combined with input and output analog circuits, the crossbar array system realizes the method of performing matrix-vector multiplication approximation operations with significant performance, area and energy advantages over existing methods and designs. This invention also includes an extended method that realizes the auto-associative neural network recall function using the resistive memory crossbar architecture.
FILED Tuesday, August 13, 2013
APPL NO 13/965459
ART UNIT 2193 — Interprocess Communication and Software Development
CURRENT CPC
Analogue Computers
G06G 7/16 (20130101) Original (OR) Class

Computer Systems Based on Specific Computational Models
G06N 3/0445 (20130101)
G06N 3/0635 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09152870 Sawhney et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Research Laboratory (AFRL)
APPLICANT(S) SRI International (Menlo Park, California)
ASSIGNEE(S) SRI INTERNATIONAL (Menlo Park, California)
INVENTOR(S) Harpreet Singh Sawhney (Princeton Junction, New Jersey);  Jayakrishan Eledath (Robbinsville, New Jersey);  Saad Ali (East Windsor, New Jersey);  Bogdan C. Matei (Princeton Junction, New Jersey);  Steven S. Weiner (Merion Station, Pennsylvania);  Xutao Lv (East Windsor, New Jersey)
ABSTRACT A computer vision service includes technologies to, among other things, analyze computer vision or learning tasks requested by computer applications, select computer vision or learning algorithms to execute the requested tasks based on one or more performance capabilities of the computer vision or learning algorithms, perform the computer vision or learning tasks for the computer applications using the selected algorithms, and expose the results of performing the computer vision or learning tasks for use by the computer applications.
FILED Friday, March 14, 2014
APPL NO 14/212237
ART UNIT 2665 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 9/00979 (20130101) Original (OR) Class
G06K 9/6253 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09152880 Moyer
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) The United States of America, as represented by the Secretary of the Army (Washington, District of Columbia)
ASSIGNEE(S) THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARTY OF THE ARMY (Washington, District of Columbia)
INVENTOR(S) Steven K. Moyer (Centreville, Virginia)
ABSTRACT Methods for determining the probability of a human observer correctly performing a visual discrimination task of a target with a dynamic image stream, movie, are based on the V50 criterion, or the number of resolvable cycles needed by the human observer for a fifty percent probability of discrimination task completion, for performing the same visual discrimination task of the same targets in static scenes given an infinite amount of time. Once the V50 value is determined for the target set using static images, this value is used with the resolvable cycles V of the target set from the movie in an empirical Target Transfer Probability Function TTPF defined by P(t)=(V(t)/V50(t))1.5/(1+(V(t)/V50(t))1.5). The TTPF calculates the probability of correctly performing the visual discrimination task of a target at a given instance in time within the movie. These P values are then modified by a time limited search equation.
FILED Friday, May 30, 2014
APPL NO 14/291055
ART UNIT 2665 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 9/46 (20130101)
G06K 9/52 (20130101) Original (OR) Class
G06K 9/6267 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09152916 Esser et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) Steven K. Esser (San Jose, California);  Dharmendra S. Modha (San Jose, California)
ABSTRACT Embodiments of the invention provide a neural core circuit comprising a synaptic interconnect network including plural electronic synapses for interconnecting one or more source electronic neurons with one or more target electronic neurons. The interconnect network further includes multiple axon paths and multiple dendrite paths. Each synapse is at a cross-point junction of the interconnect network between a dendrite path and an axon path. The core circuit further comprises a routing module maintaining routing information. The routing module routes output from a source electronic neuron to one or more selected axon paths. Each synapse provides a configurable level of signal conduction from an axon path of a source electronic neuron to a dendrite path of a target electronic neuron.
FILED Friday, September 19, 2014
APPL NO 14/491816
ART UNIT 2129 — AI & Simulation/Modeling
CURRENT CPC
Computer Systems Based on Specific Computational Models
G06N 3/04 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09153314 Dally
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of Energy (DOE)
APPLICANT(S) NVIDIA Corporation (Santa Clara, California)
ASSIGNEE(S) NVIDIA Corporation (Santa Clara, California)
INVENTOR(S) William J. Dally (Los Altos Hills, California)
ABSTRACT A system is provided for transmitting signals. The system includes a ground-referenced single-ended signaling (GRS) driver circuit that is configured to pre-charge a first capacitor to store a first charge between a first output node and a first reference node based on a first input data signal during a first pre-charge phase and drive an output signal relative to a ground network based on the first charge during a first drive phase. A control circuit is configured to generate a first set of control signals based on the first input data signal and a first clock signal, where the first set of control signals causes the first GRS driver circuit to operate in either the first pre-charge phase or in the first drive phase.
FILED Thursday, May 09, 2013
APPL NO 13/890899
ART UNIT 2827 — Semiconductors/Memory
CURRENT CPC
Static Stores
G11C 7/1057 (20130101)
G11C 7/1069 (20130101)
G11C 11/4096 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09153431 Lee et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) STC.UNM (Albuquerque, New Mexico)
ASSIGNEE(S) STC.UNM (Albuquerque, New Mexico)
INVENTOR(S) Seung-Chang Lee (Albuquerque, New Mexico);  Steven R. J. Brueck (Albuquerque, New Mexico)
ABSTRACT A method of epitaxially growing nitrogen-based compound semiconductor thin films on a semiconductor substrate, which is periodically patterned with grooves. The method can provide an epitaxial growth of a first crystalline phase epitaxial film on the substrate, and block the growth of an initial crystalline phase with barrier materials prepared at the sides of the grooves. Semiconductor devices employing the epitaxial films are also disclosed.
FILED Tuesday, November 06, 2012
APPL NO 13/670391
ART UNIT 2826 — Semiconductors/Memory
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 21/02433 (20130101) Original (OR) Class
H01L 21/02609 (20130101)
H01L 29/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09153539 Dally et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of Energy (DOE)
APPLICANT(S) NVIDIA Corporation (Santa Clara, California)
ASSIGNEE(S) NVIDIA Corporation (Santa Clara, California)
INVENTOR(S) William J. Dally (Los Altos Hills, California);  Jonah M. Alben (San Jose, California);  John W. Poulton (Chapel Hill, North Carolina);  Thomas Hastings Greer, III (Chapel Hill, North Carolina)
ABSTRACT A system of interconnected chips comprising a multi-chip module (MCM) includes a first processor chip, a graphics processing cluster (GPC) chip, and an MCM package configured to include the first processor chip, the GPC chip, and an interconnect circuit. The first processor chip is configured to include a first ground-referenced single-ended signaling interface circuit. A first set of electrical traces fabricated within the MCM package and configured to couple the first single-ended signaling interface circuit to the interconnect circuit. The GPC chip is configured to include a second single-ended signaling interface circuit and to execute shader programs. A second set of electrical traces fabricated within the MCM package and configured to couple the second single-ended signaling interface circuit to the interconnect circuit. In one embodiment, each single-ended signaling interface advantageously implements ground-referenced single-ended signaling.
FILED Thursday, August 22, 2013
APPL NO 13/973947
ART UNIT 2827 — Semiconductors/Memory
CURRENT CPC
Electric Digital Data Processing
G06F 13/00 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 23/535 (20130101) Original (OR) Class
H01L 2224/16145 (20130101)
H01L 2224/16225 (20130101)
H01L 2924/00 (20130101)
H01L 2924/13091 (20130101)
H01L 2924/13091 (20130101)
H01L 2924/15192 (20130101)
H01L 2924/15311 (20130101)

Pulse Technique
H03K 19/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09153785 Yu et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) Luping Yu (Chicago, Illinois);  Hae Jung Son (Chicago, Illinois)
ASSIGNEE(S) The University of Chicago (Chicago, Illinois)
INVENTOR(S) Luping Yu (Chicago, Illinois);  Hae Jung Son (Chicago, Illinois)
ABSTRACT Novel semiconducting photovoltaic polymers with conjugated units that provide improved solar conversion efficiency that can be used in electro-optical and electric devices. The polymers exhibit increased solar conversion efficiency in solar devices.
FILED Friday, April 13, 2012
APPL NO 14/111473
ART UNIT 1766 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Macromolecular Compounds Obtained Otherwise Than by Reactions Only Involving Unsaturated Carbon-to-carbon Bonds
C08G 61/123 (20130101)
C08G 61/126 (20130101)
C08G 2261/91 (20130101)
C08G 2261/146 (20130101)
C08G 2261/1412 (20130101)
C08G 2261/1426 (20130101)
C08G 2261/3243 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 51/0036 (20130101)
H01L 51/0043 (20130101)
H01L 51/0047 (20130101) Original (OR) Class
H01L 51/4253 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 10/549 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09154058 Baughman et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
Department of the Navy (DON)
Office of Naval Research (ONR)
Multidisciplinary University Research Initiative (MURI)
Non-Profit Organization (NPO)
Robert A. Welch Foundation
National Science Foundation (NSF)
APPLICANT(S) Ray H. Baughman (Dallas, Texas);  Ali E. Aliev (Dallas, Texas);  Jiyoung Oh (Richardson, Texas);  Mikhail Kozlov (Dallas, Texas);  Shaoli Fang (Richardson, Texas);  Raquel Ovalle-Robles (Sachse, Texas);  Anvar A. Zakhidov (McKinney, Texas)
ASSIGNEE(S) Board of Regents, The University of Texas System (Austin, Texas)
INVENTOR(S) Ray H. Baughman (Dallas, Texas);  Ali E. Aliev (Dallas, Texas);  Jiyoung Oh (Richardson, Texas);  Mikhail Kozlov (Dallas, Texas);  Shaoli Fang (Richardson, Texas);  Raquel Ovalle-Robles (Sachse, Texas);  Anvar A. Zakhidov (McKinney, Texas)
ABSTRACT Nanofiber actuators and strain amplifiers having a material that generates a force or generates a displacement when directly or indirectly electrically driven. This material is an aerogel or a related low density or high density network comprising conducting fibers that are electrically interconnected and can substantially actuate without the required presence of either a liquid or solid electrolyte. Reversible or permanently frozen actuation is used to modify the properties of the actuator material for applications.
FILED Monday, August 17, 2009
APPL NO 13/125993
ART UNIT 2855 — Printing/Measuring and Testing
CURRENT CPC
Electric Machines Not Otherwise Provided for
H02N 1/006 (20130101)
H02N 11/006 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09154228 Faruque et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Research Laboratory (AFRL)
APPLICANT(S) University of North Dakota (Grand Forks, North Dakota)
ASSIGNEE(S) University of North Dakota (Grand Forks, North Dakota)
INVENTOR(S) Shams Faruque (Grand Forks, North Dakota);  Saleh Faruque (Grand Forks, North Dakota);  William Semke (Larimore, North Dakota)
ABSTRACT A free space communications apparatus includes a first receiving element configured to receive a communication signal and an ambient noise signal and to generate a first current as a function of any and all received signals, a second receiving element electrically coupled with the first receiving element to receive the ambient noise signal and to generate a second current as a function of any and all received signals, and an output signal produced as a function of the communication signal received by the first receiving element. The first and second receiving elements are electrically connected in a circuit that cancels at least a portion of the first current as a function of the second current to produce the output signal.
FILED Monday, October 15, 2012
APPL NO 13/652256
ART UNIT 2878 — Optics
CURRENT CPC
Transmission
H04B 10/1123 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09154235 Scherer et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) CALIFORNIA INSTITUTE OF TECHNOLOGY (Pasadena, California)
ASSIGNEE(S) CALIFORNIA INSTITUTE OF TECHNOLOGY (Pasadena, California)
INVENTOR(S) Axel Scherer (Barnard, Vermont);  Aditya Rajagopal (Irvine, California);  Seheon Kim (San Jose, California);  Andrew P. Homyk (South Pasadena, California)
ABSTRACT The present disclosure describes an optically powered transducer with a photovoltaic collector. An optical fiber power delivery method and system and a free space power delivery method are also provided. A fabrication process for making an optically powered transducer is further described, together with an implantable transducer system based on optical power delivery.
FILED Tuesday, June 17, 2014
APPL NO 14/306813
ART UNIT 2636 — Optical Communications
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0017 (20130101)
A61B 5/6867 (20130101)
A61B 2560/0219 (20130101)

Measurement of Intensity, Velocity, Spectral Content, Polarisation, Phase or Pulse Characteristics of Infra-Red, Visible or Ultra-violet Light; Colorimetry; Radiation Pyrometry
G01J 3/02 (20130101)
G01J 3/0283 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 31/054 (20141201)
H01L 31/0475 (20141201)
H01L 31/03529 (20130101)

Generation of Electric Power by Conversion of Infra-red Radiation, Visible Light or Ultraviolet Light, e.g Using Photovoltaic [PV] Modules
H02S 40/38 (20141201)

Amplifiers
H03F 3/082 (20130101)
H03F 3/45183 (20130101)
H03F 2203/45702 (20130101)

Transmission
H04B 10/807 (20130101) Original (OR) Class

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 10/52 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09154400 Godfrey et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) Aaron F. Godfrey (Eagan, Minnesota);  Christopher B. Johns (Edina, Minnesota)
ASSIGNEE(S) Cray Inc. (Seattle, Washington)
INVENTOR(S) Aaron F. Godfrey (Eagan, Minnesota);  Christopher B. Johns (Edina, Minnesota)
ABSTRACT A system for allowing dynamic changing of routing information of a network interconnect while avoiding deadlocks and preserving packet ordering. A network resiliency system detects when an error in the network interconnect occurs and dynamically generates new routing information for the routers that factors in the detected error. The network resiliency system then generates new routing information that factors in the failure. The network resiliency system then directs the network interconnect to enter a quiescent state in which no packets are transiting through the network interconnect. After the network interconnect enters the quiescent state, the network resiliency system directs the loading of the new routing information into the routing tables of the network interconnect and then directs the network interconnect to start injecting request packets into the network interconnect.
FILED Tuesday, May 10, 2011
APPL NO 13/104799
ART UNIT 2446 — Computer Networks
CURRENT CPC
Transmission of Digital Information, e.g Telegraphic Communication
H04L 45/02 (20130101) Original (OR) Class
H04L 45/28 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09154704 Antesberger
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) The United States of America, as represented by the Secretary of the Army (Washington, District of Columbia)
ASSIGNEE(S) THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (Washington, District of Columbia)
INVENTOR(S) Anthony Wayne Antesberger (Woodbridge, Virginia)
ABSTRACT A radial based approach to electro-optic imagers, rather than the conventional rectilinear approach, would have basic overall system design advantages. Those system design advantages would apply to the components and the entire system implementation and include approaches to objective optical design, focal plane array FPA with fill factor, FPA layout and associated read-out integrated circuit ROIC, support electronics architecture and associated memory requirements, image processing IP algorithms, display layout and format, and eyepiece optics. A radial based approach to EO imagers would yield a device/system with attributes requiring less complicated optical components, with potentially fewer elements, for both the objective and eyepiece lenses. In addition, alternative objective optics could be more easily employed, such as holographic or wave front coded, due to reduced complexity of implementing correction algorithms as a result of referencing the system around its optical axis. The radial readout EO system would have pixel ‘one’ at the center and be ‘read out and displayed’ like the rings of a tree rather than words on a page.
FILED Tuesday, December 09, 2014
APPL NO 14/564273
ART UNIT 2662 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Pictorial Communication, e.g Television
H04N 5/335 (20130101)
H04N 5/369 (20130101)
H04N 5/378 (20130101)
H04N 5/2327 (20130101)
H04N 5/23212 (20130101)
H04N 5/23293 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09154711 Denham
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) Raytheon Company (Waltham, Massachusetts)
ASSIGNEE(S) RAYTHEON COMPANY (Waltham, Massachusetts)
INVENTOR(S) Martin S. Denham (Bend, Oregon)
ABSTRACT Systems and methods for configuring an infrared thermal imaging system using a video interface of an electronic device, such as a microcontroller, for example, for sending commands and control information. In one example a an infrared thermal imaging system includes a focal plane array (FPA) of infrared detectors, the FPA being configured to generate an output signal in response to infrared radiation impinging thereupon, read out integrated circuitry (ROIC) operatively coupled to the FPA, and a microcontroller having at least one video display interface operatively coupled to the ROIC, the microcontroller being configured to send data to the ROIC via the at least one video display interface, the data including command data.
FILED Thursday, November 29, 2012
APPL NO 13/688353
ART UNIT 2481 — Recording and Compression
CURRENT CPC
Pictorial Communication, e.g Television
H04N 5/33 (20130101) Original (OR) Class
H04N 5/365 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09155131 Sumakeris et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Materiel Command (AFMC)
Air Force Research Laboratory (AFRL)
APPLICANT(S) Joseph John Sumakeris (Apex, North Carolina);  Michael James Paisley (Garner, North Carolina)
ASSIGNEE(S) Cree, Inc. (Durham, North Carolina)
INVENTOR(S) Joseph John Sumakeris (Apex, North Carolina);  Michael James Paisley (Garner, North Carolina)
ABSTRACT A heating device for controllably heating an article defines a processing chamber to hold the article and includes a housing and an EMF generator. The housing includes a susceptor portion surrounding at least a portion of the processing chamber, and a conductor portion interposed between the susceptor portion and the processing chamber. The EMF generator is operable to induce eddy currents within the susceptor portion such that substantially no eddy currents are induced in the conductor portion. The conductor portion is operative to conduct heat from the susceptor portion to the processing chamber. The heating device may further include a platter and an opening defined in the conductor portion, wherein the opening is interposed between the susceptor portion and the platter.
FILED Thursday, May 15, 2008
APPL NO 12/121072
ART UNIT 1716 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Coating Metallic Material; Coating Material With Metallic Material; Surface Treatment of Metallic Material by Diffusion into the Surface, by Chemical Conversion or Substitution; Coating by Vacuum Evaporation, by Sputtering, by Ion Implantation or by Chemical Vapour Deposition, in General
C23C 16/46 (20130101)
C23C 16/4581 (20130101)

Single-crystal-growth; Unidirectional Solidification of Eutectic Material or Unidirectional Demixing of Eutectoid Material; Refining by Zone-melting of Material; Production of a Homogeneous Polycrystalline Material With Defined Structure; Single Crystals or Homogeneous Polycrystalline Material With Defined Structure; After-treatment of Single Crystals or a Homogeneous Polycrystalline Material With Defined Structure; Apparatus Therefor
C30B 25/10 (20130101)

Electric Heating; Electric Lighting Not Otherwise Provided for
H05B 6/108 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09155190 Haq et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Army Research Office (CCDC ARO)
APPLICANT(S) Jesmin Haq (Tempe, Arizona);  Scott Ageno (Phoenix, Arizona);  Douglas E. Loy (Chandler, Arizona);  Shawn O'Rourke (Tempe, Arizona);  Robert Naujokaitis (Chandler, Arizona)
ASSIGNEE(S) AZ Board of Regents, a body corporate of the State of AZ Acting for and on behalf of AZ State University (Scottsdale, Arizona)
INVENTOR(S) Jesmin Haq (Tempe, Arizona);  Scott Ageno (Phoenix, Arizona);  Douglas E. Loy (Chandler, Arizona);  Shawn O'Rourke (Tempe, Arizona);  Robert Naujokaitis (Chandler, Arizona)
ABSTRACT Some embodiments include a method of preparing a flexible substrate assembly. Other embodiments of related methods and structures are also disclosed.
FILED Friday, June 07, 2013
APPL NO 13/913141
ART UNIT 2847 — Electrical Circuits and Systems
CURRENT CPC
Printed Circuits; Casings or Constructional Details of Electric Apparatus; Manufacture of Assemblages of Electrical Components
H05K 1/181 (20130101)
H05K 1/0271 (20130101) Original (OR) Class
H05K 1/0277 (20130101)
H05K 1/0393 (20130101)
H05K 3/00 (20130101)
H05K 3/007 (20130101)
H05K 3/281 (20130101)
H05K 2203/016 (20130101)
H05K 2203/0152 (20130101)
H05K 2203/0191 (20130101)
H05K 2203/1383 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 156/10 (20150115)
Y10T 428/14 (20150115)
Y10T 428/26 (20150115)
Y10T 428/1476 (20150115)
Y10T 428/2848 (20150115)
Y10T 428/23914 (20150401)
Y10T 428/24355 (20150115)
Y10T 428/24942 (20150115)
Y10T 428/31515 (20150401)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Energy (DOE) 

US 09150476 Shekhawat et al.
FUNDED BY
Department of Energy (DOE)
Office of Fossil Energy and Carbon Management (FECM)
National Energy Technology Laboratory (NETL)
APPLICANT(S) Dushyant Shekhawat (Morgantown, West Virginia);  David A. Berry (Morgantown, West Virginia);  Daniel J. Haynes (Morgantown, West Virginia);  Victor Abdelsayed (Morgantown, West Virginia);  Mark W. Smith (Morgantown, West Virginia);  James J. Spivey (Baton Rouge, Louisiana)
ASSIGNEE(S) U.S. Department of Energy (Washington, District of Columbia)
INVENTOR(S) Dushyant Shekhawat (Morgantown, West Virginia);  David A. Berry (Morgantown, West Virginia);  Daniel J. Haynes (Morgantown, West Virginia);  Victor Abdelsayed (Morgantown, West Virginia);  Mark W. Smith (Morgantown, West Virginia);  James J. Spivey (Baton Rouge, Louisiana)
ABSTRACT A method of hydrogenation utilizing a reactant gas mixture comprising a carbon oxide and a hydrogen agent, and a hydrogenation catalyst comprising a mixed-metal oxide containing metal sites supported and/or incorporated into the lattice. The mixed-metal oxide comprises a perovskite, a pyrochlore, a fluorite, a brownmillerite, or mixtures thereof doped at the A-site or the B-site. The metal site may comprise a deposited metal, where the deposited metal is a transition metal, an alkali metal, an alkaline earth metal, or mixtures thereof. Contact between the carbon oxide, hydrogen agent, and hydrogenation catalyst under appropriate conditions of temperature, pressure and gas flow rate generate a hydrogenation reaction and produce a hydrogenated product made up of carbon from the carbon oxide and some portion of the hydrogen agent. The carbon oxide may be CO, CO2, or mixtures thereof and the hydrogen agent may be H2. In a particular embodiment, the hydrogenated product comprises an alcohol, an olefin, an aldehyde, a ketone, an ester, an oxo-product, or mixtures thereof.
FILED Friday, August 02, 2013
APPL NO 13/957539
ART UNIT 1671 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Acyclic or Carbocyclic Compounds
C07C 27/00 (20130101)
C07C 27/06 (20130101)
C07C 27/22 (20130101)
C07C 29/16 (20130101)
C07C 29/153 (20130101)
C07C 29/154 (20130101)
C07C 29/156 (20130101)
C07C 29/157 (20130101)
C07C 29/158 (20130101) Original (OR) Class
C07C 31/02 (20130101)
C07C 31/04 (20130101)
C07C 31/08 (20130101)
C07C 45/00 (20130101)
C07C 45/49 (20130101)
C07C 45/50 (20130101)
C07C 47/00 (20130101)
C07C 49/00 (20130101)
C07C 67/00 (20130101)
C07C 67/36 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150800 Liu et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) Southern Company (Birmingham, Alabama)
ASSIGNEE(S) SOUTHERN COMPANY (Birmingham, Alabama)
INVENTOR(S) Guohai Liu (Birmingham, Alabama);  Pannalal Vimalchand (Birmingham, Alabama);  WanWang Peng (Birmingham, Alabama)
ABSTRACT A second stage gasification unit in a staged gasification integrated process flow scheme and operating methods are disclosed to gasify a wide range of low reactivity fuels. The inclusion of second stage gasification unit operating at high temperatures closer to ash fusion temperatures in the bed provides sufficient flexibility in unit configurations, operating conditions and methods to achieve an overall carbon conversion of over 95% for low reactivity materials such as bituminous and anthracite coals, petroleum residues and coke. The second stage gasification unit includes a stationary fluidized bed gasifier operating with a sufficiently turbulent bed of predefined inert bed material with lean char carbon content. The second stage gasifier fluidized bed is operated at relatively high temperatures up to 1400° C. Steam and oxidant mixture can be injected to further increase the freeboard region operating temperature in the range of approximately from 50 to 100° C. above the bed temperature.
FILED Tuesday, December 10, 2013
APPL NO 14/102327
ART UNIT 1736 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Production of Producer Gas, Water-gas, Synthesis Gas From Solid Carbonaceous Material, or Mixtures Containing These Gases; Carburetting Air or Other Gases
C10J 3/482 (20130101) Original (OR) Class
C10J 3/721 (20130101)
C10J 2300/093 (20130101)
C10J 2300/0956 (20130101)
C10J 2300/0976 (20130101)
C10J 2300/0993 (20130101)
C10J 2300/1807 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 20/18 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150887 Miller et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) Elliot Norman Miller (Gainesville, Florida);  Laura R. Jarboe (Ames, Iowa);  Lorraine P. Yomano (Gainesville, Florida);  Sean W. York (Gainesville, Florida);  Keelnatham Shanmugam (Gainesville, Florida);  Lonnie O'Neal Ingram (Gainesville, Florida)
ASSIGNEE(S) UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (Gainsville, Florida)
INVENTOR(S) Elliot Norman Miller (Gainesville, Florida);  Laura R. Jarboe (Ames, Iowa);  Lorraine P. Yomano (Gainesville, Florida);  Sean W. York (Gainesville, Florida);  Keelnatham Shanmugam (Gainesville, Florida);  Lonnie O'Neal Ingram (Gainesville, Florida)
ABSTRACT The invention relates to bacterium that have increased resistance to furfural and methods of preparation. The invention also relates to methods of producing ethanol using the bacterium and corresponding kits.
FILED Monday, January 04, 2010
APPL NO 13/147155
ART UNIT 1656 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/0008 (20130101)

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 7/065 (20130101) Original (OR) Class

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 50/16 (20130101)
Y02E 50/17 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150889 Liao et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) James C. Liao (Los Angeles, California);  Kwang Myung Cho (Los Angeles, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) James C. Liao (Los Angeles, California);  Kwang Myung Cho (Los Angeles, California)
ABSTRACT The disclosure provides a process that converts CO2 to higher alcohols (e.g. isobutanol) using electricity as the energy source. This process stores electricity (e.g. from solar energy, nuclear energy, and the like) in liquid fuels that can be used as high octane number gasoline substitutes. Instead of deriving reducing power from photosynthesis, this process derives reducing power from electrically generated mediators, either H2 or formate. H2 can be derived from electrolysis of water. Formate can be generated by electrochemical reduction of CO2. After delivering the reducing power in the cell, formate becomes CO2 and recycles back. Therefore, the biological CO2 fixation process can occur in the dark.
FILED Saturday, January 15, 2011
APPL NO 13/522288
ART UNIT 1652 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/0006 (20130101)
C12N 9/88 (20130101)

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 7/04 (20130101)
C12P 7/16 (20130101) Original (OR) Class
C12P 7/22 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 50/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150945 Bei
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Oak Ridge National Laboratory (ORNL)
Federally Funded Research and Development Center (FFRDC)
Operated by UT-Battelle, LLC (UTB) at Oak Ridge, TN
APPLICANT(S) Hongbin Bei (Knoxville, Tennessee)
ASSIGNEE(S) UT-BATTELLE, LLC (Oak Ridge, Tennessee)
INVENTOR(S) Hongbin Bei (Knoxville, Tennessee)
ABSTRACT A multi-component high-entropy alloy includes a composition selected from the following group: VNbTaTiMoWRe, VNbTaTiMoW, VNbTaTiMoRe, VNbTaTiWRe, VNbTaMoWRe, VNbTiMoWRe, VTaTiMoWRe, NbTaTiMoWRe, VNbTaTiMo, VNbTaTiW, VNbTaMoW, VNbTiMoW, VTaTiMoW, NbTaTiMoW, VNbTaTiRe, VNbTaMoRe, VNbTiMoRe, VTaTiMoRe, NbTaTiMoRe, VNbTaWRe, VNbTiWRe, VTaTiWRe, NbTaTiWRe, VNbMoWRe, VTaMoWRe, NbTaMoWRe, VTiMoWRe, NbTiMoWRe, TaTiMoWRe, wherein relative amounts of each element vary by no more than ±15 atomic %.
FILED Thursday, October 27, 2011
APPL NO 13/283078
ART UNIT 1735 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Alloys
C22C 1/02 (20130101)
C22C 9/06 (20130101)
C22C 19/05 (20130101)
C22C 19/07 (20130101)
C22C 27/02 (20130101)
C22C 27/06 (20130101)
C22C 30/00 (20130101) Original (OR) Class
C22C 30/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150968 Adzic et al.
FUNDED BY
Department of Energy (DOE)
Brookhaven Science Associates, LLC (BSA)
Office of Science (DOE-SC)
Brookhaven National Laboratory (BNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Brookhaven Science Associates, LLC (BSA) at Upton, NY
APPLICANT(S) Brookhaven Science Associates, LLC (Upton, New York)
ASSIGNEE(S) Brookhaven Science Associates, LLC (Upton, New York)
INVENTOR(S) Radoslav R. Adzic (East Setauket, New York);  Alexander Harris (East Setauket, New York)
ABSTRACT High-surface-area carbon nanostructures coated with a smooth and conformal submonolayer-to-multilayer thin metal films and their method of manufacture are described. The manufacturing process may involve initial oxidation of the carbon nanostructures followed by immersion in a solution with the desired pH to create negative surface dipoles. The nanostructures are subsequently immersed in an alkaline solution containing non-noble metal ions which adsorb at surface reaction sites. The metal ions are then reduced via chemical or electrical means and the nanostructures are exposed to a solution containing a salt of one or more noble metals which replace adsorbed non-noble surface metal atoms by galvanic displacement. Subsequent film growth may be performed via the initial quasi-underpotential deposition of a non-noble metal followed by immersion in a solution comprising a more noble metal. The resulting coated nanostructures may be used, for example, as high-performance electrodes in supercapacitors, batteries, or other electric storage devices.
FILED Monday, February 25, 2013
APPL NO 13/775674
ART UNIT 1732 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 21/185 (20130101)
B01J 23/42 (20130101)
B01J 23/44 (20130101)
B01J 23/56 (20130101)
B01J 23/60 (20130101)
B01J 23/892 (20130101)
B01J 23/8926 (20130101)
B01J 35/0006 (20130101)
B01J 35/008 (20130101)
B01J 35/0033 (20130101)
B01J 37/348 (20130101)

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 30/00 (20130101)
B82Y 40/00 (20130101)

Non-metallic Elements; Compounds Thereof;
C01B 31/0293 (20130101)

Coating Metallic Material; Coating Material With Metallic Material; Surface Treatment of Metallic Material by Diffusion into the Surface, by Chemical Conversion or Substitution; Coating by Vacuum Evaporation, by Sputtering, by Ion Implantation or by Chemical Vapour Deposition, in General
C23C 28/02 (20130101) Original (OR) Class
C23C 28/34 (20130101)
C23C 28/42 (20130101)
C23C 28/321 (20130101)
C23C 28/322 (20130101)
C23C 28/345 (20130101)
C23C 28/347 (20130101)

Capacitors; Capacitors, Rectifiers, Detectors, Switching Devices or Light-sensitive Devices, of the Electrolytic Type
H01G 11/24 (20130101)
H01G 11/36 (20130101)

Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/92 (20130101)
H01M 4/926 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 60/13 (20130101)
Y02E 60/50 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150975 Berger et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Argonne National Laboratory (ANL)
Federally Funded Research and Development Center (FFRDC)
Operated by UChicago Argonne, LLC (UCHICAGO) at Argonne, IL
APPLICANT(S) John F. Berger (Wilmington, North Carolina);  Mark A. Williamson (Naperville, Illinois);  Stanley G. Wiedmeyer (Glen Ellyn, Illinois);  James L. Willit (Batavia, Illinois);  Laurel A. Barnes (Chicago, Illinois);  Robert J. Blaskovitz (Lockport, Illinois)
ASSIGNEE(S) GE-HITACHI NUCLEAR ENERGY AMERICAS LLC (Wilmington, North Carolina)
INVENTOR(S) John F. Berger (Wilmington, North Carolina);  Mark A. Williamson (Naperville, Illinois);  Stanley G. Wiedmeyer (Glen Ellyn, Illinois);  James L. Willit (Batavia, Illinois);  Laurel A. Barnes (Chicago, Illinois);  Robert J. Blaskovitz (Lockport, Illinois)
ABSTRACT An electrorefiner system according to a non-limiting embodiment of the present invention may include a vessel configured to maintain a molten salt electrolyte and configured to receive a plurality of alternately arranged cathode and anode assemblies. The anode assemblies are configured to hold an impure nuclear feed material. Upon application of the power system, the impure nuclear feed material is anodically dissolved and a purified metal is deposited on the cathode rods of the cathode assemblies. A scraper is configured to dislodge the purified metal deposited on the cathode rods. A conveyor system is disposed at a bottom of the vessel and configured to remove the dislodged purified metal from the vessel.
FILED Thursday, December 22, 2011
APPL NO 13/335082
ART UNIT 1754 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Processes for the Electrolytic Production, Recovery or Refining of Metals; Apparatus Therefor
C25C 3/34 (20130101)
C25C 7/005 (20130101)
C25C 7/08 (20130101) Original (OR) Class
C25C 7/025 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09151099 Allison
FUNDED BY
Department of Energy (DOE)
Office of Environmental Management (DOE-EM)
Savannah River National Laboratory (SRNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Savannah River Nuclear Solutions, LLC (SRNS) at Aiken, SC
APPLICANT(S) SAVANNAH RIVER NUCLEAR SOLUTIONS, LLC (Aiken, South Carolina)
ASSIGNEE(S) Savannah River Nuclear Solutions, LLC (Aiken, South Carolina)
INVENTOR(S) Thomas L Allison (Martinez, Georgia)
ABSTRACT A door opening spring assistance apparatus is set forth that will automatically apply a door opening assistance force using a combination of rods and coil springs. The release of the rods by the coil springs reduces the force required to set the door in motion.
FILED Thursday, November 01, 2012
APPL NO 13/666144
ART UNIT 3634 — Static Structures, Supports and Furniture
CURRENT CPC
Devices for Moving Wings into Open or Closed Position; Checks for Wings; Wing Fittings Not Otherwise Provided For, Concerned With the Functioning of the Wing
E05F 1/105 (20130101) Original (OR) Class
E05F 5/08 (20130101)

Indexing Scheme Relating to Hinges or Other Suspension Devices for Doors, Windows or Wings and Devices for Moving Wings into Open or Closed Position, Checks for Wings and Wing Fittings Not Otherwise Provided For, Concerned With the Functioning of the Wing
E05Y 2201/426 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09151543 Iyengar et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
APPLICANT(S) Madhusudan K. Iyengar (Woodstock, New York);  Pritish R. Parida (Fishkill, New York);  Mark D. Schultz (Ossining, New York)
ASSIGNEE(S) INTERNATIONAL BUSINESS MACHINES CORPORATION (Armonk, New York)
INVENTOR(S) Madhusudan K. Iyengar (Woodstock, New York);  Pritish R. Parida (Fishkill, New York);  Mark D. Schultz (Ossining, New York)
ABSTRACT A data center cooling system is operated in a first mode; it has an indoor portion wherein heat is absorbed from components in the data center, and an outdoor heat exchanger portion wherein outside air is used to cool a first heat transfer fluid (e.g., water) present in at least the outdoor heat exchanger portion of the cooling system during the first mode. The first heat transfer fluid is a relatively high performance heat transfer fluid (as compared to the second fluid), and has a first heat transfer fluid freezing point. A determination is made that an appropriate time has been reached to switch from the first mode to a second mode. Based on this determination, the outdoor heat exchanger portion of the data cooling system is switched to a second heat transfer fluid, which is a relatively low performance heat transfer fluid, as compared to the first heat transfer fluid. It has a second heat transfer fluid freezing point lower than the first heat transfer fluid freezing point, and the second heat transfer fluid freezing point is sufficiently low to operate without freezing when the outdoor air temperature drops below a first predetermined relationship with the first heat transfer fluid freezing point.
FILED Friday, July 15, 2011
APPL NO 13/184239
ART UNIT 3744 — Material and Article Handling
CURRENT CPC
Heat-exchange Apparatus, Not Provided for in Another Subclass, in Which the Heat-exchange Media Do Not Come into Direct Contact
F28D 15/00 (20130101) Original (OR) Class

Printed Circuits; Casings or Constructional Details of Electric Apparatus; Manufacture of Assemblages of Electrical Components
H05K 7/2079 (20130101)
H05K 7/20836 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09151813 Hu et al.
FUNDED BY
Department of Energy (DOE)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Environmental Health Sciences (NIEHS)
APPLICANT(S) Jian Zhi Hu (Richland, Washington);  Mary Y. Hu (Richland, Washington);  Mark R. Townsend (Kennewick, Washington);  Johannes A. Lercher (Ottobrunn, Germany);  Charles H. F. Peden (West Richland, Washington)
ASSIGNEE(S) BATTELLE MEMORIAL INSTITUTE (Richland, Washington)
INVENTOR(S) Jian Zhi Hu (Richland, Washington);  Mary Y. Hu (Richland, Washington);  Mark R. Townsend (Kennewick, Washington);  Johannes A. Lercher (Ottobrunn, Germany);  Charles H. F. Peden (West Richland, Washington)
ABSTRACT Re-usable ceramic magic angle spinning (MAS) NMR rotors constructed of high-mechanic strength ceramics are detailed that include a sample compartment that maintains high pressures up to at least about 200 atmospheres (atm) and high temperatures up to about least about 300° C. during operation. The rotor designs minimize pressure losses stemming from penetration over an extended period of time. The present invention makes possible a variety of in-situ high pressure, high temperature MAS NMR experiments not previously achieved in the prior art.
FILED Wednesday, August 07, 2013
APPL NO 13/961012
ART UNIT 1797 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Thread Cutting; Working of Screws, Bolt Heads, or Nuts, in Conjunction Therewith
B23G 1/02 (20130101)

Measuring Electric Variables; Measuring Magnetic Variables
G01R 3/00 (20130101)
G01R 33/305 (20130101) Original (OR) Class
G01R 33/307 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 29/49996 (20150115)
Y10T 409/300112 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09151852 Marleau
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Sandia National Laboratories (SNL)
Federally Funded Research and Development Center (FFRDC)
Operated by National Technology and Engineering Solutions of Sandia, LLC (NTESS) at Albuquerque, NM
APPLICANT(S) Sandia Corporation (Albuquerque, New Mexico)
ASSIGNEE(S) Sandia Corporation (Albuquerque, New Mexico)
INVENTOR(S) Peter Marleau (Dublin, California)
ABSTRACT Various technologies pertaining to identifying a material in a sample and imaging the sample are described herein. The material is identified by computing energy-dependent attenuation of neutrons that is caused by presence of the sample in travel paths of the neutrons. A mono-energetic neutron generator emits the neutron, which is downscattered in energy by a first detector unit. The neutron exits the first detector unit and is detected by a second detector unit subsequent to passing through the sample. Energy-dependent attenuation of neutrons passing through the sample is computed based upon a computed energy of the neutron, wherein such energy can be computed based upon 1) known positions of the neutron generator, the first detector unit, and the second detector unit; or 2) computed time of flight of neutrons between the first detector unit and the second detector unit.
FILED Wednesday, June 04, 2014
APPL NO 14/296332
ART UNIT 2884 — Optics
CURRENT CPC
Measurement of Nuclear or X-radiation
G01T 3/005 (20130101)
G01T 3/065 (20130101) Original (OR) Class

Geophysics; Gravitational Measurements; Detecting Masses or Objects; Tags
G01V 5/0008 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09151853 Dahal et al.
FUNDED BY
Department of Energy (DOE)
Office of Nuclear Energy (DOE-NE)
Idaho National Laboratory (INL)
Federally Funded Research and Development Center (FFRDC)
Operated by Battelle Energy Alliance, LLC (BEA) at Idaho Falls, ID
APPLICANT(S) RENSSELAER POLYTECHNIC INSTITUTE (Troy, New York)
ASSIGNEE(S) RENSSELAER POLYTECHNIC INSTITUTE (Troy, New York)
INVENTOR(S) Rajendra P. Dahal (Troy, New York);  Jacky Kuan-Chih Huang (Troy, New York);  James J. Q. Lu (Watervliet, New York);  Yaron Danon (Selkirk, New York);  Ishwara B. Bhat (Clifton Park, New York)
ABSTRACT Neutron-detecting structures and methods of fabrication are provided which include: a substrate with a plurality of cavities extending into the substrate from a surface; a p-n junction within the substrate and extending, at least in part, in spaced opposing relation to inner cavity walls of the substrate defining the plurality of cavities; and a neutron-responsive material disposed within the plurality of cavities. The neutron-responsive material is responsive to neutrons absorbed for releasing ionization radiation products, and the p-n junction within the substrate spaced in opposing relation to and extending, at least in part, along the inner cavity walls of the substrate reduces leakage current of the neutron-detecting structure.
FILED Thursday, November 07, 2013
APPL NO 14/074131
ART UNIT 2893 — Semiconductors/Memory
CURRENT CPC
Measurement of Nuclear or X-radiation
G01T 3/00 (20130101)
G01T 3/08 (20130101) Original (OR) Class

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 27/1428 (20130101)
H01L 31/115 (20130101)
H01L 31/02161 (20130101)
H01L 31/03529 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09152881 Brumby et al.
FUNDED BY
Department of Energy (DOE)
Los Alamos National Security, LLC (LANS)
National Nuclear Security Administration (NNSA)
Los Alamos National Laboratory (LANL)
Federally Funded Research and Development Center (FFRDC)
Operated by Triad National Security, LLC (TRIAD) at Los Alamos, NM
APPLICANT(S) Los Alamos National Security, LLC (Los Alamos, New Mexico)
ASSIGNEE(S) Los Alamos National Security, LLC (Los Alamos, New Mexico)
INVENTOR(S) Steven P. Brumby (Santa Fe, New Mexico);  Luis Bettencourt (Los Alamos, New Mexico);  Garrett T. Kenyon (Santa Fe, New Mexico);  Rick Chartrand (Los Alamos, New Mexico);  Brendt Wohlberg (Los Alamos, New Mexico)
ABSTRACT Approaches for deciding what individuals in a population of visual system “neurons” are looking for using sparse overcomplete feature dictionaries are provided. A sparse overcomplete feature dictionary may be learned for an image dataset and a local sparse representation of the image dataset may be built using the learned feature dictionary. A local maximum pooling operation may be applied on the local sparse representation to produce a translation-tolerant representation of the image dataset. An object may then be classified and/or clustered within the translation-tolerant representation of the image dataset using a supervised classification algorithm and/or an unsupervised clustering algorithm.
FILED Friday, September 13, 2013
APPL NO 14/026295
ART UNIT 2665 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 9/6221 (20130101) Original (OR) Class
G06K 9/6244 (20130101)
G06K 2009/4695 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09152888 Kenyon et al.
FUNDED BY
Department of Energy (DOE)
Los Alamos National Security, LLC (LANS)
National Nuclear Security Administration (NNSA)
Los Alamos National Laboratory (LANL)
Federally Funded Research and Development Center (FFRDC)
Operated by Triad National Security, LLC (TRIAD) at Los Alamos, NM
APPLICANT(S) Los Alamos National Security, LLC (Los Alamos, New Mexico)
ASSIGNEE(S) Los Alamos National Security, LLC (Los Alamos, New Mexico)
INVENTOR(S) Garrett T. Kenyon (Santa Fe, New Mexico);  Steven P. Brumby (Santa Fe, New Mexico);  John S. George (White Rock, New Mexico);  Dylan M. Paiton (Rio Rancho, New Mexico);  Peter F. Schultz (Los Alamos, New Mexico)
ABSTRACT A contour/shape detection model may use relatively simple and efficient kernels to detect target edges in an object within an image or video. A co-occurrence probability may be calculated for two or more edge features in an image or video using an object definition. Edge features may be differentiated between in response to measured contextual support, and prominent edge features may be extracted based on the measured contextual support. The object may then be identified based on the extracted prominent edge features.
FILED Friday, September 13, 2013
APPL NO 14/026730
ART UNIT 2665 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 9/80 (20130101) Original (OR) Class
G06K 9/468 (20130101)
G06K 9/4604 (20130101)
G06K 9/4609 (20130101)
G06K 9/6211 (20130101)
G06K 9/6212 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09153314 Dally
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of Energy (DOE)
APPLICANT(S) NVIDIA Corporation (Santa Clara, California)
ASSIGNEE(S) NVIDIA Corporation (Santa Clara, California)
INVENTOR(S) William J. Dally (Los Altos Hills, California)
ABSTRACT A system is provided for transmitting signals. The system includes a ground-referenced single-ended signaling (GRS) driver circuit that is configured to pre-charge a first capacitor to store a first charge between a first output node and a first reference node based on a first input data signal during a first pre-charge phase and drive an output signal relative to a ground network based on the first charge during a first drive phase. A control circuit is configured to generate a first set of control signals based on the first input data signal and a first clock signal, where the first set of control signals causes the first GRS driver circuit to operate in either the first pre-charge phase or in the first drive phase.
FILED Thursday, May 09, 2013
APPL NO 13/890899
ART UNIT 2827 — Semiconductors/Memory
CURRENT CPC
Static Stores
G11C 7/1057 (20130101)
G11C 7/1069 (20130101)
G11C 11/4096 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09153353 Liu et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Lawrence Berkeley National Laboratory (LBNL)
Federally Funded Research and Development Center (FFRDC)
Operated by University of California (UC BERKELEY) at Berkeley, CA
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Gao Liu (Piedmont, California);  Vincent S. Battaglia (San Anselmo, California);  Sang-Jae Park (Walnut Creek, California)
ABSTRACT A family of carboxylic acid groups containing fluorene/fluorenon copolymers is disclosed as binders of silicon particles in the fabrication of negative electrodes for use with lithium ion batteries. Triethyleneoxide side chains provide improved adhesion to materials such as, graphite, silicon, silicon alloy, tin, tin alloy. These binders enable the use of silicon as an electrode material as they significantly improve the cycle-ability of silicon by preventing electrode degradation over time. In particular, these polymers, which become conductive on first charge, bind to the silicon particles of the electrode, are flexible so as to better accommodate the expansion and contraction of the electrode during charge/discharge, and being conductive promote the flow battery current.
FILED Friday, March 15, 2013
APPL NO 13/842161
ART UNIT 1761 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 30/00 (20130101)

Macromolecular Compounds Obtained Otherwise Than by Reactions Only Involving Unsaturated Carbon-to-carbon Bonds
C08G 61/02 (20130101)
C08G 2261/312 (20130101)
C08G 2261/411 (20130101)
C08G 2261/516 (20130101)
C08G 2261/1412 (20130101)
C08G 2261/3142 (20130101)

Working-up; General Processes of Compounding; After-treatment Not Covered by Subclasses C08B, C08C, C08F, C08G or C08H
C08J 5/005 (20130101)
C08J 2365/00 (20130101)

Use of Inorganic or Non-macromolecular Organic Substances as Compounding Ingredients
C08K 3/08 (20130101)
C08K 3/08 (20130101)

Compositions of Macromolecular Compounds
C08L 65/00 (20130101)

Cables; Conductors; Insulators; Selection of Materials for Their Conductive, Insulating or Dielectric Properties
H01B 1/12 (20130101) Original (OR) Class
H01B 1/22 (20130101)
H01B 1/24 (20130101)

Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/134 (20130101)
H01M 4/364 (20130101)
H01M 4/386 (20130101)
H01M 4/387 (20130101)
H01M 4/587 (20130101)
H01M 4/622 (20130101)
H01M 4/624 (20130101)
H01M 4/1395 (20130101)
H01M 10/0525 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 60/122 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09153380 Taylor et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Argonne National Laboratory (ANL)
Federally Funded Research and Development Center (FFRDC)
Operated by UChicago Argonne, LLC (UCHICAGO) at Argonne, IL
APPLICANT(S) DELPHI TECHNOLOGIES, INC. (Troy, Michigan)
ASSIGNEE(S) Delphi Technologies, Inc. (Troy, Michigan)
INVENTOR(S) Ralph S. Taylor (Noblesville, Indiana);  John D. Myers (Kokomo, Indiana);  William J. Baney (Roanoke, Virginia)
ABSTRACT A ceramic short circuit resistant capacitor that is bendable and/or shapeable to provide a multiple layer capacitor that is extremely compact and amenable to desirable geometries. The capacitor that exhibits a benign failure mode in which a multitude of discrete failure events result in a gradual loss of capacitance. Each event is a localized event in which localized heating causes an adjacent portion of one or both of the electrodes to vaporize, physically cleaning away electrode material from the failure site. A first metal electrode, a second metal electrode, and a ceramic dielectric layer between the electrodes are thin enough to be formed in a serpentine-arrangement with gaps between the first electrode and the second electrode that allow venting of vaporized electrode material in the event of a benign failure.
FILED Tuesday, January 29, 2013
APPL NO 13/752441
ART UNIT 2848 — Electrical Circuits and Systems
CURRENT CPC
Capacitors; Capacitors, Rectifiers, Detectors, Switching Devices or Light-sensitive Devices, of the Electrolytic Type
H01G 2/18 (20130101) Original (OR) Class
H01G 4/015 (20130101)
H01G 4/308 (20130101)
H01G 4/1218 (20130101)
H01G 13/00 (20130101)

Climate Change Mitigation Technologies Related to Transportation
Y02T 10/7022 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 29/43 (20150115)
Y10T 29/435 (20150115)
Y10T 29/49124 (20150115)
Y10T 29/49155 (20150115)
Y10T 156/1168 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09153404 Chen
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Lawrence Livermore National Laboratory (LLNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Lawrence Livermore National Security LLC (LLNS) at Livermore, CA
APPLICANT(S) Lawrence Livermore National Security, LLC (Livermore, California)
ASSIGNEE(S) Lawrence Livermore National Security, LLC (Livermore, California)
INVENTOR(S) Yu-Jiuan Chen (Fremont, California)
ABSTRACT Devices and methods are provided to allow rapid deflection of a charged particle beam. The disclosed devices can, for example, be used as part of a hadron therapy system to allow scanning of a target area within a patient's body. The disclosed charged particle beam deflectors include a dielectric wall accelerator (DWA) with a hollow center and a dielectric wall that is substantially parallel to a z-axis that runs through the hollow center. The dielectric wall includes one or more deformed high gradient insulators (HGIs) that are configured to produce an electric field with an component in a direction perpendicular to the z-axis. A control component is also provided to establish the electric field component in the direction perpendicular to the z-axis and to control deflection of a charged particle beam in the direction perpendicular to the z-axis as the charged particle beam travels through the hollow center of the DWA.
FILED Tuesday, December 04, 2012
APPL NO 13/705084
ART UNIT 2881 — Optics
CURRENT CPC
Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 5/1043 (20130101)
A61N 5/1077 (20130101)
A61N 2005/1087 (20130101)

Techniques for Handling Particles or Ionising Radiation Not Otherwise Provided For; Irradiation Devices; Gamma Ray or X-ray Microscopes
G21K 1/087 (20130101)

Electric Discharge Tubes or Discharge Lamps
H01J 3/26 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09153425 Van Berkel
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Oak Ridge National Laboratory (ORNL)
Federally Funded Research and Development Center (FFRDC)
Operated by UT-Battelle, LLC (UTB) at Oak Ridge, TN
APPLICANT(S) Gary J. Van Berkel (Clinton, Tennessee)
ASSIGNEE(S) UT-BATTELLE, LLC (Oak Ridge, Tennessee)
INVENTOR(S) Gary J. Van Berkel (Clinton, Tennessee)
ABSTRACT A system and method for analyzing a chemical composition of a specimen are described. The system can include at least one pin; a sampling device configured to contact a liquid with a specimen on the at least one pin to form a testing solution; and a stepper mechanism configured to move the at least one pin and the sampling device relative to one another. The system can also include an analytical instrument for determining a chemical composition of the specimen from the testing solution. In particular, the systems and methods described herein enable chemical analysis of specimens, such as tissue, to be evaluated in a manner that the spatial-resolution is limited by the size of the pins used to obtain tissue samples, not the size of the sampling device used to solubilize the samples coupled to the pins.
FILED Wednesday, September 01, 2010
APPL NO 12/873412
ART UNIT 1639 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Electric Discharge Tubes or Discharge Lamps
H01J 49/0431 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09153453 Bouet et al.
FUNDED BY
Department of Energy (DOE)
Brookhaven Science Associates, LLC (BSA)
Office of Science (DOE-SC)
Argonne National Laboratory (ANL)
Federally Funded Research and Development Center (FFRDC)
Operated by UChicago Argonne, LLC (UCHICAGO) at Argonne, IL
Brookhaven National Laboratory (BNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Brookhaven Science Associates, LLC (BSA) at Upton, NY
APPLICANT(S) Nathalie C. D. Bouet (Wading River, New York);  Raymond P. Conley (Manorville, New York);  Ralu Divan (Darien, Illinois);  Albert Macrander (Naperville, Illinois)
ASSIGNEE(S) Brookhaven Science Associates, LLC (Upton, New York);  UChicago Argonne, LLC (Chicago, Illinois)
INVENTOR(S) Nathalie C. D. Bouet (Wading River, New York);  Raymond P. Conley (Manorville, New York);  Ralu Divan (Darien, Illinois);  Albert Macrander (Naperville, Illinois)
ABSTRACT A process is disclosed for sectioning by etching of monolayers and multilayers using an RIE technique with fluorine-based chemistry. In one embodiment, the process uses Reactive Ion Etching (RIE) alone or in combination with Inductively Coupled Plasma (ICP) using fluorine-based chemistry alone and using sufficient power to provide high ion energy to increase the etching rate and to obtain deeper anisotropic etching. In a second embodiment, a process is provided for sectioning of WSi2/Si multilayers using RIE in combination with ICP using a combination of fluorine-based and chlorine-based chemistries and using RF power and ICP power. According to the second embodiment, a high level of vertical anisotropy is achieved by a ratio of three gases; namely, CHF3, Cl2, and O2 with RF and ICP. Additionally, in conjunction with the second embodiment, a passivation layer can be formed on the surface of the multilayer which aids in anisotropic profile generation.
FILED Friday, February 10, 2012
APPL NO 13/371124
ART UNIT 2816 — Semiconductors/Memory
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 10/00 (20130101)

Non-mechanical Removal of Metallic Material From Surface; Inhibiting Corrosion of Metallic Material or Incrustation in General; Multi-step Processes for Surface Treatment of Metallic Material Involving at Least One Process Provided for in Class C23 and at Least One Process Covered by Subclass C21D or C22F or Class C25
C23F 4/00 (20130101)

Techniques for Handling Particles or Ionising Radiation Not Otherwise Provided For; Irradiation Devices; Gamma Ray or X-ray Microscopes
G21K 1/062 (20130101)
G21K 2201/067 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 21/3065 (20130101) Original (OR) Class
H01L 21/32137 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09153539 Dally et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of Energy (DOE)
APPLICANT(S) NVIDIA Corporation (Santa Clara, California)
ASSIGNEE(S) NVIDIA Corporation (Santa Clara, California)
INVENTOR(S) William J. Dally (Los Altos Hills, California);  Jonah M. Alben (San Jose, California);  John W. Poulton (Chapel Hill, North Carolina);  Thomas Hastings Greer, III (Chapel Hill, North Carolina)
ABSTRACT A system of interconnected chips comprising a multi-chip module (MCM) includes a first processor chip, a graphics processing cluster (GPC) chip, and an MCM package configured to include the first processor chip, the GPC chip, and an interconnect circuit. The first processor chip is configured to include a first ground-referenced single-ended signaling interface circuit. A first set of electrical traces fabricated within the MCM package and configured to couple the first single-ended signaling interface circuit to the interconnect circuit. The GPC chip is configured to include a second single-ended signaling interface circuit and to execute shader programs. A second set of electrical traces fabricated within the MCM package and configured to couple the second single-ended signaling interface circuit to the interconnect circuit. In one embodiment, each single-ended signaling interface advantageously implements ground-referenced single-ended signaling.
FILED Thursday, August 22, 2013
APPL NO 13/973947
ART UNIT 2827 — Semiconductors/Memory
CURRENT CPC
Electric Digital Data Processing
G06F 13/00 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 23/535 (20130101) Original (OR) Class
H01L 2224/16145 (20130101)
H01L 2224/16225 (20130101)
H01L 2924/00 (20130101)
H01L 2924/13091 (20130101)
H01L 2924/13091 (20130101)
H01L 2924/15192 (20130101)
H01L 2924/15311 (20130101)

Pulse Technique
H03K 19/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09153720 Frost et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) John S. Frost (Oak Park, California);  Randolph J. Brandt (Palmdale, California);  Peter Hebert (Glendale, California);  Omar Al Taher (Los Angeles, California)
ASSIGNEE(S) THE BOEING COMPANY (Chicago, Illinois)
INVENTOR(S) John S. Frost (Oak Park, California);  Randolph J. Brandt (Palmdale, California);  Peter Hebert (Glendale, California);  Omar Al Taher (Los Angeles, California)
ABSTRACT An interconnect includes a first set of connector pads, a second set of connector pads, and a continuous central portion. A first plurality of legs extends at a first angle from the continuous central portion. Each leg of the first plurality of legs is connected to a connector pad of a first set of connector pads. A second plurality of legs extends at a second angle from the continuous central portion. Each leg of the second plurality of legs is connected to a connector pad of the second set of connector pads. Gaps are defined between legs. The gaps enable movement of the first set of connector pads relative to the second set of connector pads.
FILED Thursday, February 10, 2011
APPL NO 13/025013
ART UNIT 1757 — Semiconductors/Memory
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 31/0508 (20130101) Original (OR) Class

Electrically-conductive Connections; Structural Associations of a Plurality of Mutually-insulated Electrical Connecting Elements; Coupling Devices; Current Collectors
H01R 11/01 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09153731 Kahen
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
APPLICANT(S) The Research Foundation for the State University of New York (Amherst, New York)
ASSIGNEE(S) The Research Foundation for the State University of New York (Amherst, New York)
INVENTOR(S) Keith Kahen (Rochester, New York)
ABSTRACT A tight confinement nanocrystal comprises a homogeneous center region having a first composition and a smoothly varying region having a second composition wherein a confining potential barrier monotonically increases and then monotonically decreases as the smoothly varying region extends from the surface of the homogeneous center region to an outer surface of the nanocrystal. A method of producing the nanocrystal comprises forming a first solution by combining a solvent and at most two nanocrystal precursors; heating the first solution to a nucleation temperature; adding to the first solution, a second solution having a solvent, at least one additional and different precursor to form the homogeneous center region and at most an initial portion of the smoothly varying region; and lowering the solution temperature to a growth temperature to complete growth of the smoothly varying region.
FILED Thursday, August 07, 2014
APPL NO 14/454293
ART UNIT 1761 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Treatment of Inorganic Materials, Other Than Fibrous Fillers, to Enhance Their Pigmenting or Filling Properties; Preparation of Carbon Black;
C09C 1/00 (20130101)

Materials for Miscellaneous Applications, Not Provided for Elsewhere
C09K 11/00 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 33/002 (20130101) Original (OR) Class
H01L 33/005 (20130101)
H01L 33/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09153803 Valentin Chung et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency - Energy (ARPA-E)
APPLICANT(S) Brice Hoani Valentin Chung (Cambridge, Massachusetts);  Paul J. Burke (Framingham, Massachusetts);  Donald R. Sadoway (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts);  Total Marketing Services (Puteaux, France)
INVENTOR(S) Brice Hoani Valentin Chung (Cambridge, Massachusetts);  Paul J. Burke (Framingham, Massachusetts);  Donald R. Sadoway (Cambridge, Massachusetts)
ABSTRACT A cell for high temperature electrochemical reactions is provided. The cell includes a container, at least a portion of the container acting as a first electrode. An extension tube has a first end and a second end, the extension tube coupled to the container at the second end forming a conduit from the container to said first end. A second electrode is positioned in the container and extends out of the container via the conduit. A seal is positioned proximate the first end of the extension tube, for sealing the cell.
FILED Friday, July 13, 2012
APPL NO 13/548347
ART UNIT 1754 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Processes for the Electrolytic Production, Recovery or Refining of Metals; Apparatus Therefor
C25C 7/005 (20130101)

Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 2/06 (20130101)
H01M 2/08 (20130101)
H01M 2/30 (20130101)
H01M 2/0252 (20130101)
H01M 2/0447 (20130101) Original (OR) Class
H01M 10/34 (20130101)
H01M 10/38 (20130101)
H01M 10/39 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 29/49117 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09153831 Chen et al.
FUNDED BY
Department of Energy (DOE)
National Aeronautics and Space Administration (NASA)
NASA Shared Services Center (NSSC)
APPLICANT(S) Fanglin Chen (Irmo, South Carolina);  Fei Zhao (Columbia, South Carolina);  Qiang Liu (Columbia, South Carolina)
ASSIGNEE(S) University of South Carolina (Columbia, South Carolina)
INVENTOR(S) Fanglin Chen (Irmo, South Carolina);  Fei Zhao (Columbia, South Carolina);  Qiang Liu (Columbia, South Carolina)
ABSTRACT In certain embodiments of the present disclosure, a solid oxide fuel cell is described. The solid oxide fuel cell includes a hierarchically porous cathode support having an impregnated cobaltite cathode deposited thereon, an electrolyte, and an anode support. The anode support includes hydrocarbon oxidation catalyst deposited thereon, wherein the cathode support, electrolyte, and anode support are joined together and wherein the solid oxide fuel cell operates a temperature of 600° C. or less.
FILED Wednesday, October 06, 2010
APPL NO 12/898794
ART UNIT 1726 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/905 (20130101)
H01M 4/925 (20130101)
H01M 4/8605 (20130101)
H01M 4/8621 (20130101)
H01M 4/8885 (20130101)
H01M 4/9016 (20130101)
H01M 4/9033 (20130101)
H01M 4/9066 (20130101)
H01M 8/1004 (20130101)
H01M 8/1213 (20130101) Original (OR) Class
H01M 8/1226 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 60/521 (20130101)
Y02E 60/525 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 156/10 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09153833 Chiang et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
APPLICANT(S) 24M Technologies, Inc. (Cambridge, Massachusetts)
ASSIGNEE(S) 24M Technologies, Inc. (Cambridge, Massachusetts)
INVENTOR(S) Yet-Ming Chiang (Weston, Massachusetts);  W. Craig Carter (Jamaica Plain, Massachusetts);  Mihai Duduta (Somerville, Massachusetts);  Pimpa Limthongkul (Boston, Massachusetts)
ABSTRACT Redox flow devices are described including a positive electrode current collector, a negative electrode current collector, and an ion-permeable membrane separating said positive and negative current collectors, positioned and arranged to define a positive electroactive zone and a negative electroactive zone; wherein at least one of said positive and negative electroactive zone comprises a flowable semi-solid composition comprising ion storage compound particles capable of taking up or releasing said ions during operation of the cell, and wherein the ion storage compound particles have a polydisperse size distribution in which the finest particles present in at least 5 vol % of the total volume, is at least a factor of 5 smaller than the largest particles present in at least 5 vol % of the total volume.
FILED Tuesday, May 13, 2014
APPL NO 14/276723
ART UNIT 1726 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Propulsion of Electrically-propelled Vehicles; Supplying Electric Power for Auxiliary Equipment of Electrically-propelled Vehicles; Electrodynamic Brake Systems for Vehicles in General; Magnetic Suspension or Levitation for Vehicles; Monitoring Operating Variables of Electrically-propelled Vehicles; Electric Safety Devices for Electrically-propelled Vehicles
B60L 11/1879 (20130101)

Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 8/20 (20130101)
H01M 8/188 (20130101) Original (OR) Class
H01M 8/0206 (20130101)
H01M 8/0215 (20130101)
H01M 8/0221 (20130101)
H01M 8/0228 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 60/528 (20130101)

Climate Change Mitigation Technologies Related to Transportation
Y02T 10/705 (20130101)
Y02T 10/7005 (20130101)
Y02T 10/7011 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

National Science Foundation (NSF) 

US 09149224 Newman et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
National Aeronautics and Space Administration (NASA)
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computer and Network Systems (CNS)
APPLICANT(S) Dava J. Newman (Cambridge, Massachusetts);  Ashley M. Wessendorf (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Dava J. Newman (Cambridge, Massachusetts);  Ashley M. Wessendorf (Cambridge, Massachusetts)
ABSTRACT Described herein are systems and techniques for a motion capture system and a three-dimensional (3D) tracking system used to record body position and/or movements/motions and using the data to measure skin strain (a strain field) all along the body while a joint is in motion (dynamic) as well as in a fixed position (static). The data and technique can be used to quantify strains, calculate 3D contours, and derive patterns believed to reveal skin's properties during natural motions.
FILED Monday, October 17, 2011
APPL NO 13/274992
ART UNIT 3736 — Sheet Container Making, Package Making, Receptacles, Shoes, Apparel, and Tool Driving or Impacting
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0064 (20130101)
A61B 5/0077 (20130101)
A61B 5/442 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149309 Paczkowski et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) Patrick Paczkowski (New Haven, Connecticut);  Julie Dorsey (Madison, Connecticut);  Min Hyuk Kim (Daejeon Chungnam, South Korea);  Holly Rushmeier (Old Saybrook, Connecticut)
ASSIGNEE(S) Yale University (New Haven, Connecticut)
INVENTOR(S) Patrick Paczkowski (New Haven, Connecticut);  Julie Dorsey (Madison, Connecticut);  Min Hyuk Kim (Daejeon Chungnam, South Korea);  Holly Rushmeier (Old Saybrook, Connecticut)
ABSTRACT A method, a system, and a computer program product for graphically representing physical objects in a contextual setting are disclosed. A first data for a predetermined location, at least one distance measurement between at least two location points at the predetermined location, and at least one image of at least one portion of the predetermined location can be received. Based on the receiving and information obtained from at least one publicly available resource, a spatial representation of the predetermined location configured to include at least one existing feature can be generated. Spatial representation of the predetermined location includes a detailed representation of the at least one portion of the predetermined location having the at least one existing feature.
FILED Wednesday, July 18, 2012
APPL NO 13/551879
ART UNIT 2668 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 17/80 (20130101) Original (OR) Class
A61B 17/8033 (20130101)

Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 9/00671 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149563 Wei et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) Mei Wei (Coventry, Connecticut);  Haibo Qu (Secane, Pennsylvania)
ASSIGNEE(S) THE UNIVERSITY OF CONNECTICUT (Farmington, Connecticut)
INVENTOR(S) Mei Wei (Coventry, Connecticut);  Haibo Qu (Secane, Pennsylvania)
ABSTRACT Ceramic/structural protein composite scaffolds and their preparation in a simple one-step process are shown.
FILED Thursday, November 06, 2008
APPL NO 12/265956
ART UNIT 1611 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 24/0047 (20130101)
A61L 24/102 (20130101)
A61L 27/12 (20130101)
A61L 27/46 (20130101)
A61L 27/46 (20130101)
A61L 27/52 (20130101) Original (OR) Class
A61L 27/56 (20130101)
A61L 2300/112 (20130101)
A61L 2430/02 (20130101)

Compositions of Macromolecular Compounds
C08L 89/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150598 Schmidt et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) Jacob J. Schmidt (Sherman Oaks, California);  Shiva Portonovo (West Hollywood, California);  Jason L. Poulos (Los Angeles, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California);  Librede, Inc. (Sherman Oaks, California)
INVENTOR(S) Jacob J. Schmidt (Sherman Oaks, California);  Shiva Portonovo (West Hollywood, California);  Jason L. Poulos (Los Angeles, California)
ABSTRACT Disclosed herein are devices and methods related to the production and measurements of amphiphilic molecule bilayers, which are useful in high throughput electrophysiological screening and ion channel measurement in bilayers. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
FILED Friday, October 05, 2012
APPL NO 13/646305
ART UNIT 2867 — Printing/Measuring and Testing
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/127 (20130101)

Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 9/22 (20130101) Original (OR) Class

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 27/00 (20130101)
G01N 33/48728 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150788 Luk et al.
FUNDED BY
Environmental Protection Agency (EPA)
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Civil, Mechanical and Manufacturing Innovation (CMMI)
APPLICANT(S) Yan-Yeung Luk (Manlius, New York);  Karen A. Simon (Syracuse, New York);  Dacheng Ren (Syracuse, New York)
ASSIGNEE(S) Syracuse University (Syracuse, New York)
INVENTOR(S) Yan-Yeung Luk (Manlius, New York);  Karen A. Simon (Syracuse, New York);  Dacheng Ren (Syracuse, New York)
ABSTRACT The present invention relates to a non-amphiphile-based water-in-water emulsion composition. The non-amphiphile-based water-in-water emulsion composition includes a water-soluble polymer, a non-amphiphilic lyotropic mesogen encapsulated by the water-soluble polymer; and water. In one embodiment, the non-amphiphilic lyotropic mesogen includes, without limitation, a lyotropic chromonic liquid crystal, and more specifically disodium cromoglycate (DSCG). In another embodiment, the water-soluble polymer can include, without limitation, a polyacrylamide, a polyol, a polyvinylpyrrolidone, a polysaccharide, or a water-soluble fluoride-bearing polymer. The present invention also relates to a porous hydrogel made with the use of the non-amphiphile-based water-in-water emulsion. The present invention further relates to using the emulsion and hydrogel for various applications.
FILED Thursday, September 18, 2008
APPL NO 12/233337
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 25/04 (20130101)
A01N 25/04 (20130101)
A01N 37/46 (20130101)
A01N 43/08 (20130101)

Heterocyclic Compounds
C07D 307/58 (20130101)

Materials for Miscellaneous Applications, Not Provided for Elsewhere
C09K 19/02 (20130101)
C09K 19/06 (20130101)
C09K 19/60 (20130101)
C09K 19/544 (20130101) Original (OR) Class

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 11/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150876 Jackson et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Biological Sciences (BIO)
Division of Biological Infrastructure (DBI)
Department of Agriculture (USDA)
APPLICANT(S) E I DU PONT DE NEMOURS AND COMPANY (Wilmington, Delaware);  COLD SPRING HARBOR LABORATORY (Cold Spring Harbor, New York)
ASSIGNEE(S) E I DU PONT DE NEMOURS AND COMPANY (Wilmington, Delaware);  COLD SPRING HARBOR LABORATORY (Cold Spring Harbor, New York)
INVENTOR(S) David Peter Jackson (Brooklyn, New York);  Namiko Satoh Nagasawa (Huntington, New York);  Hajime Sakai (Newark, Delaware);  Nobuhiro Nagasawa (Akita, Japan)
ABSTRACT The invention relates to the isolation and characterization of a maize gene, RAMOSA3 (RA3), responsible for meristem development and inflorescence development including branching. The gene, gene product, and regulatory regions may be used to manipulate branching, meristem growth, inflorescence development and arrangement, and ultimately to improve yield of plants. The invention includes the gene and protein product as well as the use of the same for temporal and spatial expression in transgenic plants to alter plant morphology and affect yield in plants. The invention also includes the gene and protein product for SISTER OF RAMOSA3 (SRA).
FILED Tuesday, March 05, 2013
APPL NO 13/785221
ART UNIT 1663 — Plants
CURRENT CPC
Peptides
C07K 14/415 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/827 (20130101)
C12N 15/8261 (20130101)
C12N 15/8262 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09151607 Davies et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) Angela Devon Davies (Charlotte, North Carolina);  Brigid Ann Mullany (Charlotte, North Carolina);  Edward Phillip Morse (Concord, North Carolina);  Matthew Alan Davies (Charlotte, North Carolina)
ASSIGNEE(S) UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE (Charlotte, North Carolina)
INVENTOR(S) Angela Devon Davies (Charlotte, North Carolina);  Brigid Ann Mullany (Charlotte, North Carolina);  Edward Phillip Morse (Concord, North Carolina);  Matthew Alan Davies (Charlotte, North Carolina)
ABSTRACT A system for determining the position and location of a module comprising: a module which includes an optical generator which generates an optical beam; a diffractive element placed in the path of the optical beam which generates an optical pattern; a reference length artifact placed in a location with close proximity to the optical pattern; and a plurality of digital cameras connected to a computer with photogrammetry software and a minimization algorithm installed on the computer; where the digital cameras are set up in different locations to take one or more digital images of the optical pattern, with at least one digital image including the reference length artifact; and where the digital images are downloaded onto the computer and processed by the photogrammetry software to generate optical coordinate data followed by the insertion of the optical coordinate data into the minimization algorithm to generate the position and location of the module.
FILED Tuesday, May 31, 2011
APPL NO 13/118969
ART UNIT 2487 — Recording and Compression
CURRENT CPC
Measuring Distances, Levels or Bearings; Surveying; Navigation; Gyroscopic Instruments; Photogrammetry or Videogrammetry
G01C 11/02 (20130101) Original (OR) Class

Radio Direction-finding; Radio Navigation; Determining Distance or Velocity by Use of Radio Waves; Locating or Presence-detecting by Use of the Reflection or Reradiation of Radio Waves; Analogous Arrangements Using Other Waves
G01S 7/497 (20130101)
G01S 17/89 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09151705 Di Carlo et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Space and Naval Warfare Systems Center (SPAWAR)
National Science Foundation (NSF)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
ASSIGNEE(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
INVENTOR(S) Dino Di Carlo (Los Angeles, California);  Daniel R. Gossett (Los Angeles, California);  Henry T. K. Tse (San Francisco, California);  Aram Chung (Los Angeles, California)
ABSTRACT A system for deforming and analyzing a plurality of particles carried in a sample volume includes a substrate defining an inlet, configured to receive the sample volume, and an outlet; and a fluidic pathway fluidly coupled to the inlet and the outlet. The fluidic pathway includes a delivery region configured to receive the plurality of particles from the inlet and focus the plurality of particles from a random distribution to a focused state, a deformation region defining an intersection located downstream of the delivery region and coupled to the outlet, and wherein the deformation region is configured to receive the plurality of particles from the delivery region and to transmit each particle in the plurality of particles into the intersection from a single direction, a first branch fluidly coupled to the deformation region and configured to transmit a first flow into the intersection, and a second branch fluidly coupled to the deformation region and configured to transmit a second flow, substantially opposing the first flow, into the intersection, wherein the first flow and the second flow are configured to induce extension of one or more particles in the plurality of particles.
FILED Friday, October 18, 2013
APPL NO 14/058028
ART UNIT 1797 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 15/1434 (20130101) Original (OR) Class
G01N 33/50 (20130101)
G01N 33/5091 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09151713 Fan et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET)
APPLICANT(S) Xudong Fan (Saline, Michigan);  Yuze Sun (Rockville, Maryland);  Wonsuk Lee (Ann Arbor, Michigan)
ASSIGNEE(S) The Regents Of The University Of Michigan (Ann Arbor, Michigan)
INVENTOR(S) Xudong Fan (Saline, Michigan);  Yuze Sun (Rockville, Maryland);  Wonsuk Lee (Ann Arbor, Michigan)
ABSTRACT The present disclosure provides a method of detecting a target analyte, by binding the target analyte and a probe with at least one fluorophore to form a fluid composition. The fluid composition is excited within a laser cavity. The method comprises measuring a laser emission from the fluid composition based on an interaction between the target analyte and the probe. In certain aspects, the method provides hybridizing the target analyte and the probe, prior to the exciting. In certain variations, the methods comprise detecting a target analyte by measuring a laser emission from the fluid composition based on an interaction between the target analyte, where the interaction is probe energy transfer, intercalation, hybridization of the target analyte and the probe, or combinations thereof. The energy transfer can include fluorescence resonance energy transfer (FRET), FRET with a molecular-beacon, or cavity-assisted radiative energy transfer, by way of non-limiting example.
FILED Tuesday, January 10, 2012
APPL NO 13/979099
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/645 (20130101)
G01N 21/6402 (20130101)
G01N 21/6428 (20130101) Original (OR) Class
G01N 33/582 (20130101)
G01N 2021/6441 (20130101)
G01N 2021/6484 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09151759 Matsui et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) Research Foundation of the City University of New York (New York, New York)
ASSIGNEE(S) Research Foundation of the City University of New York (New York, New York)
INVENTOR(S) Hiroshi Matsui (New York, New York);  Roberto de la Rica (New York, New York);  Menglu Shi (New York, New York)
ABSTRACT The subject matter disclosed in this specification pertains to a method for detecting cells with elastic cell membranes. A plurality of cells are fixed to an impedimetric transducer and osmotic stress is applied. Those cells with elastic membranes, including cancer cells, undergo a volume change which is detected by the impedimetric transducer.
FILED Monday, May 06, 2013
APPL NO 13/887587
ART UNIT 2856 — Printing/Measuring and Testing
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/8216 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/574 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09152540 Xie et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) OREGON STATE BOARD OF HIGHER EDUCATION ON BEHALF OF PORTLAND STATE UNIVERSITY (Portland, Oregon)
ASSIGNEE(S) Oregon State Board of Higher Education on Behalf of Portland State University (Portland, Oregon)
INVENTOR(S) Fei Xie (Portland, Oregon);  Kai Cong (Portland, Oregon);  Li Lei (Portland, Oregon)
ABSTRACT Embodiments of the present disclosure may be configured to permit development and validation of a device driver or a device application program by using improved virtual devices. Such improved virtual devices may facilitate driver development without use of physical devices or hardware prototypes. In various embodiments, advanced validation of a device-driver combination may be permitted that would be difficult to achieve even with a physical device. Certain embodiments also may detect inconsistencies between virtual and physical devices, which may be used to improve drivers and device application programs and increase compatibility of such drivers and device application programs with physical devices.
FILED Friday, January 11, 2013
APPL NO 14/353353
ART UNIT 2128 — AI & Simulation/Modeling
CURRENT CPC
Electric Digital Data Processing
G06F 9/455 (20130101)
G06F 11/3668 (20130101) Original (OR) Class
G06F 11/3672 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09152688 Tirthapura et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) International Business Machines Corporation (Armonk, New York);  Iowa State University Research Foundation, Inc. (Ames, Iowa)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York);  Iowa State University Research Foundation, Inc. (Ames, Iowa)
INVENTOR(S) Srikanta N Tirthapura (Ames, Iowa);  David P Woodruff (Mountain View, California)
ABSTRACT A method for estimating aggregates over a stream of axis-aligned rectangles, includes: decomposing the stream along one-dimensional intervals, wherein vertices for the rectangle are located in a predetermined grid; assigning each grid row to buckets, wherein the one-dimensional intervals are placed into buckets according to the corresponding rows in which the one-dimensional intervals are positioned; and estimating a sum of a number of grid points touched by at least one of the rectangles in each row of the grid to approximate a volume of the axis-aligned rectangles by: using pairwise-independent hash functions in a multi-dimensional algorithm to determine buckets that include a first interval corresponding to a given rectangle, wherein the interval has hash function results that meet a predetermined threshold; and inserting a second interval for the rectangle corresponding to the first interval into a one-dimensional algorithm for the corresponding bucket meeting the predetermined threshold.
FILED Friday, March 08, 2013
APPL NO 13/791472
ART UNIT 2168 — Data Bases & File Management
CURRENT CPC
Electric Digital Data Processing
G06F 17/30333 (20130101)
G06F 17/30592 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09152716 Triandopoulos et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computer and Network Systems (CNS)
Office of Cyberinfrastructure (OCI)
APPLICANT(S) EMC Corporation (Hopkinton, Massachusetts)
ASSIGNEE(S) EMC Corporation (Hopkinton, Massachusetts)
INVENTOR(S) Nikolaos Triandopoulos (Arlington, Massachusetts);  Michael T. Goodrich (Irvine, California);  Duy Nguyen (Redwood City, California);  Olga Ohrimenko (Providence, Rhode Island);  Charalampos Papamanthou (Berkeley, California);  Roberto Tamassia (Providence, Rhode Island);  Cristina Videira Lopes (Irvine, California)
ABSTRACT An improved search engine technique allows a user to ensure that an untrusted search engine provides complete and correct search results without requiring large proofs for large data collections. Thus techniques are presented for a trusted crawler to index a distributed collection of documents and create an authenticated search structure that allows an untrusted search server to return reliably complete and correct search results.
FILED Monday, December 31, 2012
APPL NO 13/731885
ART UNIT 2156 — Data Bases & File Management
CURRENT CPC
Electric Digital Data Processing
G06F 17/30864 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09153437 Rolandi et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) Marco Rolandi (Seattle, Washington);  Hideki Sato (Hino, Japan);  Stephanie Vasko (Seattle, Washington);  Michael Brasino (Issaquah, Washington);  Adnan Kapetanovic (Tukwila, Washington);  Vamsi Talla (Seattle, Washington)
ASSIGNEE(S) University of Washington through its Center for Commercialization (Seattle, Washington)
INVENTOR(S) Marco Rolandi (Seattle, Washington);  Hideki Sato (Hino, Japan);  Stephanie Vasko (Seattle, Washington);  Michael Brasino (Issaquah, Washington);  Adnan Kapetanovic (Tukwila, Washington);  Vamsi Talla (Seattle, Washington)
ABSTRACT Methods for forming inorganic nanostructures are provided. The methods create the inorganic nanostructures by positioning a writing electrode (e.g., a conductive “stamp”) spaced nanometers above a substrate such that a precursor is intermediate the two. Applying an electric field, a voltage bias, an ionic current, or an electronic current between the writing electrode and the substrate converts the precursor into an inorganic solid material (e.g., a semiconductor such as silicon or germanium) in the area of the writing electrode.
FILED Friday, March 30, 2012
APPL NO 14/009000
ART UNIT 2894 — Semiconductors/Memory
CURRENT CPC
Processes or Apparatus Specially Adapted for the Manufacture or Treatment of Microstructural Devices or Systems
B81C 1/00492 (20130101)
B81C 2201/0154 (20130101)

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 10/00 (20130101)
B82Y 40/00 (20130101)

Photomechanical Production of Textured or Patterned Surfaces, e.g for Printing, for Processing of Semiconductor Devices; Materials Therefor; Originals Therefor; Apparatus Specially Adapted Therefor;
G03F 7/0002 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 21/02532 (20130101)
H01L 21/02636 (20130101) Original (OR) Class
H01L 21/02656 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09153785 Yu et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) Luping Yu (Chicago, Illinois);  Hae Jung Son (Chicago, Illinois)
ASSIGNEE(S) The University of Chicago (Chicago, Illinois)
INVENTOR(S) Luping Yu (Chicago, Illinois);  Hae Jung Son (Chicago, Illinois)
ABSTRACT Novel semiconducting photovoltaic polymers with conjugated units that provide improved solar conversion efficiency that can be used in electro-optical and electric devices. The polymers exhibit increased solar conversion efficiency in solar devices.
FILED Friday, April 13, 2012
APPL NO 14/111473
ART UNIT 1766 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Macromolecular Compounds Obtained Otherwise Than by Reactions Only Involving Unsaturated Carbon-to-carbon Bonds
C08G 61/123 (20130101)
C08G 61/126 (20130101)
C08G 2261/91 (20130101)
C08G 2261/146 (20130101)
C08G 2261/1412 (20130101)
C08G 2261/1426 (20130101)
C08G 2261/3243 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 51/0036 (20130101)
H01L 51/0043 (20130101)
H01L 51/0047 (20130101) Original (OR) Class
H01L 51/4253 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 10/549 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09154058 Baughman et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
Department of the Navy (DON)
Office of Naval Research (ONR)
Multidisciplinary University Research Initiative (MURI)
Non-Profit Organization (NPO)
Robert A. Welch Foundation
National Science Foundation (NSF)
APPLICANT(S) Ray H. Baughman (Dallas, Texas);  Ali E. Aliev (Dallas, Texas);  Jiyoung Oh (Richardson, Texas);  Mikhail Kozlov (Dallas, Texas);  Shaoli Fang (Richardson, Texas);  Raquel Ovalle-Robles (Sachse, Texas);  Anvar A. Zakhidov (McKinney, Texas)
ASSIGNEE(S) Board of Regents, The University of Texas System (Austin, Texas)
INVENTOR(S) Ray H. Baughman (Dallas, Texas);  Ali E. Aliev (Dallas, Texas);  Jiyoung Oh (Richardson, Texas);  Mikhail Kozlov (Dallas, Texas);  Shaoli Fang (Richardson, Texas);  Raquel Ovalle-Robles (Sachse, Texas);  Anvar A. Zakhidov (McKinney, Texas)
ABSTRACT Nanofiber actuators and strain amplifiers having a material that generates a force or generates a displacement when directly or indirectly electrically driven. This material is an aerogel or a related low density or high density network comprising conducting fibers that are electrically interconnected and can substantially actuate without the required presence of either a liquid or solid electrolyte. Reversible or permanently frozen actuation is used to modify the properties of the actuator material for applications.
FILED Monday, August 17, 2009
APPL NO 13/125993
ART UNIT 2855 — Printing/Measuring and Testing
CURRENT CPC
Electric Machines Not Otherwise Provided for
H02N 1/006 (20130101)
H02N 11/006 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

National Aeronautics and Space Administration (NASA) 

US 09149224 Newman et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
National Aeronautics and Space Administration (NASA)
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computer and Network Systems (CNS)
APPLICANT(S) Dava J. Newman (Cambridge, Massachusetts);  Ashley M. Wessendorf (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Dava J. Newman (Cambridge, Massachusetts);  Ashley M. Wessendorf (Cambridge, Massachusetts)
ABSTRACT Described herein are systems and techniques for a motion capture system and a three-dimensional (3D) tracking system used to record body position and/or movements/motions and using the data to measure skin strain (a strain field) all along the body while a joint is in motion (dynamic) as well as in a fixed position (static). The data and technique can be used to quantify strains, calculate 3D contours, and derive patterns believed to reveal skin's properties during natural motions.
FILED Monday, October 17, 2011
APPL NO 13/274992
ART UNIT 3736 — Sheet Container Making, Package Making, Receptacles, Shoes, Apparel, and Tool Driving or Impacting
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0064 (20130101)
A61B 5/0077 (20130101)
A61B 5/442 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09149933 Ihrke et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S) GM GLOBAL TECHNOLOGY OPERATIONS LLC (Detroit, Michigan);  The United States of America as Represented by the Administrator of the National Aeronautics and Space Administration (Washington, District of Columbia)
ASSIGNEE(S) GM Global Technology Operations LLC (Detroit, Michigan);  The United States of America as represented by the Administrator of the National Aeronautics and Space Administration (Washington, District of Columbia)
INVENTOR(S) Chris A. Ihrke (Hartland, Michigan);  Bryan J. Bergelin (Houston, Texas);  Lyndon Bridgwater (Houston, Texas)
ABSTRACT A grasp assist device includes a glove with first and second tendon-driven fingers, a tendon, and a sleeve with a shared tendon actuator assembly. Tendon ends are connected to the respective first and second fingers. The actuator assembly includes a drive assembly having a drive axis and a tendon hook. The tendon hook, which defines an arcuate surface slot, is linearly translatable along the drive axis via the drive assembly, e.g., a servo motor thereof. The flexible tendon is routed through the surface slot such that the surface slot divides the flexible tendon into two portions each terminating in a respective one of the first and second ends. The drive assembly may include a ball screw and nut. An end cap of the actuator assembly may define two channels through which the respective tendon portions pass. The servo motor may be positioned off-axis with respect to the drive axis.
FILED Friday, February 07, 2014
APPL NO 14/175094
ART UNIT 3664 — Computerized Vehicle Controls and Navigation, Radio Wave, Optical and Acoustic Wave Communication, Robotics, and Nuclear Systems
CURRENT CPC
Manipulators; Chambers Provided With Manipulation Devices
B25J 9/104 (20130101)
B25J 15/0009 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150459 Cardenas
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S) Henry E Cardenas (Ruston, Louisiana)
ASSIGNEE(S) Louisiana Tech University Foundation, Inc. (Ruston, Louisiana)
INVENTOR(S) Henry E Cardenas (Ruston, Louisiana)
ABSTRACT A method and apparatus for strengthening cementitious concrete by placing a nanoparticle carrier liquid in contact with a first surface of a concrete section and inducing a current across the concrete section at sufficient magnitude and for sufficient time that nanoparticles in the nanoparticle carrier liquid migrate through a significant depth of the concrete section.
FILED Wednesday, April 11, 2007
APPL NO 11/734155
ART UNIT 1759 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Lime, Magnesia; Slag; Cements; Compositions Thereof, e.g Mortars, Concrete or Like Building Materials; Artificial Stone; Ceramics; Refractories; Treatment of Natural Stone
C04B 41/4564 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09151639 Youngquist et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S) The United States of America as Represented by the Administrator of the National Aeronautics and Space Administration (Washington, District of Columbia)
ASSIGNEE(S) The United States of America as Represented by the Administrator of the National Aeronautics and Space Adminstration (Washington, District of Columbia)
INVENTOR(S) Robert C. Youngquist (Cocoa, Florida);  Stanley O. Starr (Satellite Beach, Florida)
ABSTRACT A two-dimensional inductive position sensing system uses four drive inductors arranged at the vertices of a parallelogram and a sensing inductor positioned within the parallelogram. The sensing inductor is movable within the parallelogram and relative to the drive inductors. A first oscillating current at a first frequency is supplied to a first pair of the drive inductors located at ends of a first diagonal of the parallelogram. A second oscillating current at a second frequency is supplied to a second pair of the drive inductors located at ends of a second diagonal of the parallelogram. As a result, the sensing inductor generates a first output voltage at the first frequency and a second output voltage at the second frequency. A processor determines a position of the sensing inductor relative to the drive inductors using the first output voltage and the second output voltage.
FILED Monday, February 10, 2014
APPL NO 14/176824
ART UNIT 2858 — Printing/Measuring and Testing
CURRENT CPC
Measuring Length, Thickness or Similar Linear Dimensions; Measuring Angles; Measuring Areas; Measuring Irregularities of Surfaces or Contours
G01B 7/003 (20130101)

Measuring Not Specially Adapted for a Specific Variable; Arrangements for Measuring Two or More Variables Not Covered in a Single Other Subclass; Tariff Metering Apparatus; Measuring or Testing Not Otherwise Provided for
G01D 5/2073 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09153831 Chen et al.
FUNDED BY
Department of Energy (DOE)
National Aeronautics and Space Administration (NASA)
NASA Shared Services Center (NSSC)
APPLICANT(S) Fanglin Chen (Irmo, South Carolina);  Fei Zhao (Columbia, South Carolina);  Qiang Liu (Columbia, South Carolina)
ASSIGNEE(S) University of South Carolina (Columbia, South Carolina)
INVENTOR(S) Fanglin Chen (Irmo, South Carolina);  Fei Zhao (Columbia, South Carolina);  Qiang Liu (Columbia, South Carolina)
ABSTRACT In certain embodiments of the present disclosure, a solid oxide fuel cell is described. The solid oxide fuel cell includes a hierarchically porous cathode support having an impregnated cobaltite cathode deposited thereon, an electrolyte, and an anode support. The anode support includes hydrocarbon oxidation catalyst deposited thereon, wherein the cathode support, electrolyte, and anode support are joined together and wherein the solid oxide fuel cell operates a temperature of 600° C. or less.
FILED Wednesday, October 06, 2010
APPL NO 12/898794
ART UNIT 1726 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/905 (20130101)
H01M 4/925 (20130101)
H01M 4/8605 (20130101)
H01M 4/8621 (20130101)
H01M 4/8885 (20130101)
H01M 4/9016 (20130101)
H01M 4/9033 (20130101)
H01M 4/9066 (20130101)
H01M 8/1004 (20130101)
H01M 8/1213 (20130101) Original (OR) Class
H01M 8/1226 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 60/521 (20130101)
Y02E 60/525 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 156/10 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 

Small Business Administration (SBA) 

US 09149222 Zets et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Gary Zets (Maitland, Florida);  Bruce Mortimer (Maitland, Florida)
ASSIGNEE(S) Engineering Acoustics, Inc (Casselberry, Florida)
INVENTOR(S) Gary Zets (Maitland, Florida);  Bruce Mortimer (Maitland, Florida)
ABSTRACT A system and method for providing therapy and assessment utilizing vibrotactile feedback is disclosed. Such treatment is useful for the assessment and treatment of disequilibrium, movement and balance disorders. The system and method measures a subject's performance of predetermined tasks with respect to expected parameters using sensors such as force plates, inertial sensors, and three dimensional cameras. Predetermined motions are motions such as stand, sit-to-stand, reach, bend, functional gait, functional gait plus headshake, and other functional tasks. Vibrotactile stimulation may be applied during the subject's performance as disruptive input. Variance and rate of change of variance between measured and expected parameters is used as a tool for assessment of said subject, and is also used for providing real-time vibrotactile training to said subject. The invention is useful in the treatment of Traumatic Brain Injury (TBI), neurologic disorders causing disequilibrium and balance disorders, and the like.
FILED Friday, November 18, 2011
APPL NO 13/300428
ART UNIT 3736 — Sheet Container Making, Package Making, Receptacles, Shoes, Apparel, and Tool Driving or Impacting
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/16 (20130101) Original (OR) Class
A61B 5/1114 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150616 McCoy et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute on Deafness and Other Communication Disorders (NIDCD)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) 13 Therapeutics, Inc. (Portland, Oregon)
ASSIGNEE(S) 13THERAPEUTICS, INC. (Portland, Oregon)
INVENTOR(S) Sharon L. McCoy (Portland, Oregon);  Steven H. Hefeneider (Portland, Oregon)
ABSTRACT Peptides for the treatment of inflammation, and therapeutic uses and methods of using the same are disclosed. Peptides including a transducing sequence are effective for inhibiting cytokine activity and TNF-α secretion through interaction with toll-like receptors. Experiments are described illustrating the efficacy of the compounds in treating otitis media.
FILED Tuesday, January 29, 2013
APPL NO 13/753106
ART UNIT 1676 — Printing/Measuring and Testing
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)

Peptides
C07K 7/06 (20130101)
C07K 7/08 (20130101) Original (OR) Class
C07K 14/005 (20130101)
C07K 14/07 (20130101)
C07K 14/47 (20130101)
C07K 2319/10 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 2710/24122 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150617 McCoy et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute on Deafness and Other Communication Disorders (NIDCD)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) 13 Therapeutics, Inc. (Portland, Oregon)
ASSIGNEE(S) 13THERAPEUTICS, INC. (Portland, Oregon)
INVENTOR(S) Sharon L. McCoy (Portland, Oregon);  Steven H. Hefeneider (Portland, Oregon)
ABSTRACT Peptides for the treatment of inflammation, and therapeutic uses and methods of using the same are disclosed. Peptides including a transducing sequence are effective for inhibiting cytokine activity and TNF-α secretion through interaction with toll-like receptors. Experiments are described illustrating the efficacy of the compounds in treating otitis media
FILED Tuesday, January 29, 2013
APPL NO 13/753141
ART UNIT 1676 — Printing/Measuring and Testing
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)

Peptides
C07K 7/06 (20130101)
C07K 7/08 (20130101) Original (OR) Class
C07K 14/005 (20130101)
C07K 14/07 (20130101)
C07K 14/47 (20130101)
C07K 2319/10 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 2710/24122 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Agriculture (USDA) 

US 09150869 Jeffries et al.
FUNDED BY
Department of Agriculture (USDA)
National Institute of Food and Agriculture (NIFA)
APPLICANT(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
ASSIGNEE(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin);  The United States of America as Represented by the Secretary of Agriculture (Washington, District of Columbia)
INVENTOR(S) Thomas William Jeffries (Madison, Wisconsin);  JuYun Bae (Madison, Wisconsin);  Bernice Chin-Yun Lin (Cupertino, California);  Jennifer Rebecca Headman Van Vleet (Visalia, California)
ABSTRACT Disclosed are nucleic acid constructs comprising coding sequences operably linked to a promoter not natively associated with the coding sequence. The coding sequences encode Pichia stipitis proteins that allow recombinant strains of Saccharomyces cerevisiae expressing the protein to grow on xylose, and allow or increase uptake of xylose by Pichia stipitis or Saccharomyces cerevisiae expressing the coding sequences. Expression of the coding sequences enhances uptake of xylose and/or glucose, allowing increased ethanol or xylitol production.
FILED Monday, January 26, 2015
APPL NO 14/560749
ART UNIT 1652 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Peptides
C07K 14/39 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/81 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09150876 Jackson et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Biological Sciences (BIO)
Division of Biological Infrastructure (DBI)
Department of Agriculture (USDA)
APPLICANT(S) E I DU PONT DE NEMOURS AND COMPANY (Wilmington, Delaware);  COLD SPRING HARBOR LABORATORY (Cold Spring Harbor, New York)
ASSIGNEE(S) E I DU PONT DE NEMOURS AND COMPANY (Wilmington, Delaware);  COLD SPRING HARBOR LABORATORY (Cold Spring Harbor, New York)
INVENTOR(S) David Peter Jackson (Brooklyn, New York);  Namiko Satoh Nagasawa (Huntington, New York);  Hajime Sakai (Newark, Delaware);  Nobuhiro Nagasawa (Akita, Japan)
ABSTRACT The invention relates to the isolation and characterization of a maize gene, RAMOSA3 (RA3), responsible for meristem development and inflorescence development including branching. The gene, gene product, and regulatory regions may be used to manipulate branching, meristem growth, inflorescence development and arrangement, and ultimately to improve yield of plants. The invention includes the gene and protein product as well as the use of the same for temporal and spatial expression in transgenic plants to alter plant morphology and affect yield in plants. The invention also includes the gene and protein product for SISTER OF RAMOSA3 (SRA).
FILED Tuesday, March 05, 2013
APPL NO 13/785221
ART UNIT 1663 — Plants
CURRENT CPC
Peptides
C07K 14/415 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/827 (20130101)
C12N 15/8261 (20130101)
C12N 15/8262 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Commerce (DOC) 

US 09150666 Bowen
FUNDED BY
Department of Commerce (DOC)
National Institute of Standards and Technology (NIST)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Dental and Craniofacial Research (NIDCR)
U.S. Public Health Service (USPHS)
APPLICANT(S) Rafael L. Bowen (Gaithersburg, Maryland)
ASSIGNEE(S) ADA Foundation (Chicago, Illinois)
INVENTOR(S) Rafael L. Bowen (Gaithersburg, Maryland)
ABSTRACT Disclosed are compositions that comprise vinylarylalkylene ethers of cyclodextrins optionally containing ether-linked adhesion-promoting groups, in combination with copolymerizable monomer or monomers. The copolymerizable monomer or monomers may include vinylarylalkylene ethers of oligohydroxy compounds (for example, sorbitol divinylbenzyl ether and others). The composition further may include stabilizers (for example, 1,3,5-trimethyl-2,4,6-tris(3,5-di-(tert)-butyl-4-hydroxybenzyl)benzene and others), and polymerization initiators (for example, phenylbis[2,4,6-trimethylbenzoyl]phosphine oxide and others) and reinforcing materials (for example, imogolite). Methods of preparing the compositions as well as the components of compositions and methods for their use in dental and other applications are also disclosed.
FILED Tuesday, January 27, 2009
APPL NO 12/360421
ART UNIT 1762 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 6/08 (20130101)

Polysaccharides; Derivatives Thereof
C08B 11/18 (20130101)
C08B 37/0009 (20130101)
C08B 37/0012 (20130101) Original (OR) Class

Macromolecular Compounds Obtained by Reactions Only Involving Carbon-to-carbon Unsaturated Bonds
C08F 224/00 (20130101)

Compositions of Macromolecular Compounds
C08L 5/16 (20130101)

Adhesives; Non-mechanical Aspects of Adhesive Processes in General; Adhesive Processes Not Provided for Elsewhere; Use of Materials as Adhesives
C09J 4/00 (20130101)
C09J 101/30 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Homeland Security (DHS) 

US 09149473 Ecker et al.
FUNDED BY
Department of Homeland Security (DHS)
Homeland Security Advanced Research Projects Agency (HSARPA)
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
APPLICANT(S) David J. Ecker (Encinitas, California);  Mark W. Eshoo (Solana Beach, California)
ASSIGNEE(S) IBIS BIOSCIENCES, INC. (Carlsbad, California)
INVENTOR(S) David J. Ecker (Encinitas, California);  Mark W. Eshoo (Solana Beach, California)
ABSTRACT The methods disclosed herein relate to methods and compositions for amplifying nucleic acid sequences, more specifically, from nucleic acid sequences of pathogens by targeted whole genome amplification.
FILED Friday, September 14, 2007
APPL NO 12/441329
ART UNIT 1637 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/4741 (20130101) Original (OR) Class

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 19/34 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/68 (20130101)
C12Q 1/686 (20130101)
C12Q 1/686 (20130101)
C12Q 1/689 (20130101)
C12Q 1/6806 (20130101)
C12Q 1/6806 (20130101)
C12Q 1/6848 (20130101)
C12Q 1/6848 (20130101)
C12Q 2531/119 (20130101)
C12Q 2531/119 (20130101)
C12Q 2537/143 (20130101)
C12Q 2537/143 (20130101)
C12Q 2537/143 (20130101)
C12Q 2563/167 (20130101)
C12Q 2565/513 (20130101)
C12Q 2565/627 (20130101)
C12Q 2565/627 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Veterans Affairs (DVA) 

US 09149370 Herr et al.
FUNDED BY
Department of Veterans Affairs (DVA)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Hugh M. Herr (Somerville, Massachusetts);  Ernesto C. Martinez-Villalpando (Cambridge, Massachusetts);  Jeff Anthony Weber (San Francisco, California)
ABSTRACT A knee prosthesis comprises an agonist-antagonist arrangement of two series-elastic actuators in parallel, including a knee joint, flexion and extension actuators connected to the joint in parallel with a leg member, and a controller for independently energizing the actuators to control the movement of the knee joint and leg. The flexion actuator comprises the series combination of a flexion motor and a flexion elastic element and the extension actuator comprises the series combination of an extension motor and an extension elastic element. Sensors provide feedback to the controller. The flexion actuator and the extension actuator may be unidirectional, with the flexion and extension elastic elements being series springs. The extension actuator may alternatively be bidirectional, with the extension elastic element being a set of pre-compressed series springs. Alternatively, the flexion elastic element may be a non-linear softening spring and the extension elastic element may be a non-linear hardening spring.
FILED Monday, August 05, 2013
APPL NO 13/959495
ART UNIT 3774 — Medical & Surgical Instruments, Treatment Devices, Surgery and Surgical Supplies
CURRENT CPC
Filters Implantable into Blood Vessels; Prostheses; Devices Providing Patency To, or Preventing Collapsing Of, Tubular Structures of the Body, e.g Stents; Orthopaedic, Nursing or Contraceptive Devices; Fomentation; Treatment or Protection of Eyes or Ears; Bandages, Dressings or Absorbent Pads; First-aid Kits
A61F 2/64 (20130101) Original (OR) Class
A61F 2/68 (20130101)
A61F 2/72 (20130101)
A61F 2/6607 (20130101)
A61F 2002/701 (20130101)
A61F 2002/704 (20130101)
A61F 2002/741 (20130101)
A61F 2002/763 (20130101)
A61F 2002/5003 (20130101)
A61F 2002/5075 (20130101)
A61F 2002/6657 (20130101)
A61F 2002/7625 (20130101)
A61F 2002/7635 (20130101)
A61F 2002/7645 (20130101)

Motor Vehicles; Trailers
B62D 57/032 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of the Treasury (TREASURY) 

US 09150915 Esfandyarpour et al.
FUNDED BY
Department of Health and Human Services (HHS)
Department of the Treasury (TREASURY)
Internal Revenue Service (IRS)
APPLICANT(S) Genapsys, Inc. (Redwood City, California)
ASSIGNEE(S) GENAPSYS, INC. (Redwood City, California)
INVENTOR(S) Hesaam Esfandyarpour (Redwood City, California);  Mark Oldham (Emerald Hills, California)
ABSTRACT A method comprises magnetically holding a bead carrying biological material (e.g., nucleic acid, which may be in the form of DNA fragments or amplified DNA) in a specific location of a substrate, and applying an electric field local to the bead to isolate the biological material or products or byproducts of reactions of the biological material. For example, the bead is isolated from other beads having associated biological material. The electric field in various embodiments concentrates reagents for an amplification or sequencing reaction, and/or concentrates and isolates detectable reaction by-products. For example, by isolating nucleic acids around individual beads, the electric field can allow for clonal amplification, as an alternative to emulsion PCR. In other embodiments, the electric field isolates a nanosensor proximate to the bead, to facilitate detection of at least one of local pH change, local conductivity change, local charge concentration change and local heat. The beads may be trapped in the form of an array of localized magnetic field regions.
FILED Tuesday, January 13, 2015
APPL NO 14/596111
ART UNIT 1639 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6869 (20130101) Original (OR) Class

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 27/4145 (20130101)
G01N 27/4146 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 29/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Environmental Protection Agency (EPA) 

US 09150788 Luk et al.
FUNDED BY
Environmental Protection Agency (EPA)
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Civil, Mechanical and Manufacturing Innovation (CMMI)
APPLICANT(S) Yan-Yeung Luk (Manlius, New York);  Karen A. Simon (Syracuse, New York);  Dacheng Ren (Syracuse, New York)
ASSIGNEE(S) Syracuse University (Syracuse, New York)
INVENTOR(S) Yan-Yeung Luk (Manlius, New York);  Karen A. Simon (Syracuse, New York);  Dacheng Ren (Syracuse, New York)
ABSTRACT The present invention relates to a non-amphiphile-based water-in-water emulsion composition. The non-amphiphile-based water-in-water emulsion composition includes a water-soluble polymer, a non-amphiphilic lyotropic mesogen encapsulated by the water-soluble polymer; and water. In one embodiment, the non-amphiphilic lyotropic mesogen includes, without limitation, a lyotropic chromonic liquid crystal, and more specifically disodium cromoglycate (DSCG). In another embodiment, the water-soluble polymer can include, without limitation, a polyacrylamide, a polyol, a polyvinylpyrrolidone, a polysaccharide, or a water-soluble fluoride-bearing polymer. The present invention also relates to a porous hydrogel made with the use of the non-amphiphile-based water-in-water emulsion. The present invention further relates to using the emulsion and hydrogel for various applications.
FILED Thursday, September 18, 2008
APPL NO 12/233337
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 25/04 (20130101)
A01N 25/04 (20130101)
A01N 37/46 (20130101)
A01N 43/08 (20130101)

Heterocyclic Compounds
C07D 307/58 (20130101)

Materials for Miscellaneous Applications, Not Provided for Elsewhere
C09K 19/02 (20130101)
C09K 19/06 (20130101)
C09K 19/60 (20130101)
C09K 19/544 (20130101) Original (OR) Class

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 11/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

General Services Administration (GSA) 

US 09152392 Petro et al.
FUNDED BY
General Services Administration (GSA)
APPLICANT(S) Piksel, Inc. (Wilmington, Delaware)
ASSIGNEE(S) Piksel, Inc. (Wilmington, Delaware)
INVENTOR(S) Michael Anthony Petro (Rockaway, New Jersey);  Keith David Schnable (Redmond, Washington);  David Persing (Issaquah, Washington);  Maxim Gubin (Forest Hills, New York);  Leonid Geller (Secaucus, New Jersey);  Joseph Jacques-André Chamberland (Toronto, Canada);  David Martin Anderson (Lynnwood, Washington)
ABSTRACT Methods and systems for a disabled user compliant video player for an end-to-end streaming web video solution affording accessibility for disabled users, including blind users and those with partial or poor vision, colorblind users, deaf users and those limited to only keyboard/voice input. Another embodiment of the present invention is directed to systems and methods for real-time creation and modification of specialized media players, to be used as stand-alone applications or as embedded data display applications.
FILED Friday, October 11, 2013
APPL NO 14/052670
ART UNIT 2199 — Interprocess Communication and Software Development
CURRENT CPC
Electric Digital Data Processing
G06F 3/0482 (20130101)
G06F 3/04842 (20130101)
G06F 8/20 (20130101)
G06F 8/34 (20130101) Original (OR) Class
G06F 8/38 (20130101)
G06F 8/41 (20130101)
G06F 8/60 (20130101)
G06F 8/65 (20130101)

Educational or Demonstration Appliances; Appliances for Teaching, or Communicating With, the Blind, Deaf or Mute; Models; Planetaria; Globes; Maps; Diagrams
G09B 21/005 (20130101)

Transmission of Digital Information, e.g Telegraphic Communication
H04L 65/4084 (20130101)

Pictorial Communication, e.g Television
H04N 21/4884 (20130101)
H04N 21/8193 (20130101)
H04N 21/8543 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

National Security Agency (NSA) 

US 09154159 Liu
FUNDED BY
National Security Agency (NSA)
APPLICANT(S) INTERNATIONAL BUSINESS MACHINES CORPORATION (Armonk, New York)
ASSIGNEE(S) INTERNATIONAL BUSINESS MACHINES CORPORATION (Armonk, New York)
INVENTOR(S) Yong Liu (Rye, New York)
ABSTRACT A deserializer includes an input interface configured to receive an N-bit serialized stream at a source clock frequency; a modified-tree deserializing architecture that receives the first N−1 bits of the serialized stream from the input interface and generates N−1 parallel outputs corresponding to the first N−1 bits; and a last-bit flip-flop that directly samples the input interface to obtain an Nth bit, such that all N bits are available within one source clock cycle after the Nth bit arrives at the input interface.
FILED Tuesday, December 31, 2013
APPL NO 14/144743
ART UNIT 2845 — Electrical Circuits and Systems
CURRENT CPC
Pulse Technique
H03K 3/0372 (20130101)

Coding; Decoding; Code Conversion in General
H03M 9/00 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

Non-Profit Organization (NPO) 

US 09154058 Baughman et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
Department of the Navy (DON)
Office of Naval Research (ONR)
Multidisciplinary University Research Initiative (MURI)
Non-Profit Organization (NPO)
Robert A. Welch Foundation
National Science Foundation (NSF)
APPLICANT(S) Ray H. Baughman (Dallas, Texas);  Ali E. Aliev (Dallas, Texas);  Jiyoung Oh (Richardson, Texas);  Mikhail Kozlov (Dallas, Texas);  Shaoli Fang (Richardson, Texas);  Raquel Ovalle-Robles (Sachse, Texas);  Anvar A. Zakhidov (McKinney, Texas)
ASSIGNEE(S) Board of Regents, The University of Texas System (Austin, Texas)
INVENTOR(S) Ray H. Baughman (Dallas, Texas);  Ali E. Aliev (Dallas, Texas);  Jiyoung Oh (Richardson, Texas);  Mikhail Kozlov (Dallas, Texas);  Shaoli Fang (Richardson, Texas);  Raquel Ovalle-Robles (Sachse, Texas);  Anvar A. Zakhidov (McKinney, Texas)
ABSTRACT Nanofiber actuators and strain amplifiers having a material that generates a force or generates a displacement when directly or indirectly electrically driven. This material is an aerogel or a related low density or high density network comprising conducting fibers that are electrically interconnected and can substantially actuate without the required presence of either a liquid or solid electrolyte. Reversible or permanently frozen actuation is used to modify the properties of the actuator material for applications.
FILED Monday, August 17, 2009
APPL NO 13/125993
ART UNIT 2855 — Printing/Measuring and Testing
CURRENT CPC
Electric Machines Not Otherwise Provided for
H02N 1/006 (20130101)
H02N 11/006 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

U.S. State Government 

US 09150884 Nielsen et al.
FUNDED BY
U.S. State Government
State of Arizona
APPLICANT(S) David Ross Nielsen (Tempe, Arizona);  Rebekah McKenna (Mesa, Arizona)
ASSIGNEE(S) Arizona Board of Regents, a Body Corporate of the State of Arizona, Acting for and on Behalf of Arizona State University (Scottsdale, Arizona)
INVENTOR(S) David Ross Nielsen (Tempe, Arizona);  Rebekah McKenna (Mesa, Arizona)
ABSTRACT A method for the in vivo production of styrene from renewable substrates using a recombinant microorganism is disclosed. Additionally, a method for the in vivo production of styrene oxide from renewable substrates using a recombinant microorganism is also disclosed. In both cases, the host cell expresses at least one gene encoding a polypeptide that possesses phenylalanine ammonia lyase activity in addition to at least one gene encoding a polypeptide that possesses trans-cinnamic acid decarboxylase activity. In the case of styrene oxide, the host cell must additionally express at least one gene encoding a polypeptide that possesses styrene monooxygenase activity.
FILED Thursday, March 08, 2012
APPL NO 14/003713
ART UNIT 1656 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/0071 (20130101)
C12N 9/88 (20130101)

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 1/04 (20130101)
C12P 5/005 (20130101) Original (OR) Class
C12P 17/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Government Rights Acknowledged 

US 09150305 Mancher et al.
FUNDED BY
APPLICANT(S) Joshua Mancher (Stamford, Connecticut);  Lewis L. Kristie (Milford, Connecticut);  Marcus D. Cappelli (Shelton, Connecticut)
ASSIGNEE(S) SIKORSKY AIRCRAFT CORPORATION (Stratford, Connecticut)
INVENTOR(S) Joshua Mancher (Stamford, Connecticut);  Lewis L. Kristie (Milford, Connecticut);  Marcus D. Cappelli (Shelton, Connecticut)
ABSTRACT A replacement vibration absorbing device for replacing a wear wrap on a flexbeam includes a sleeve having a plurality of layers of vibration absorbing material, wherein an edge of the sleeve is cut so that the sleeve may be installed around a generally central portion of a flexbeam.
FILED Wednesday, February 29, 2012
APPL NO 13/408248
ART UNIT 1781 — Miscellaneous Articles, Stock Material
CURRENT CPC
Aeroplanes; Helicopters
B64C 27/001 (20130101) Original (OR) Class
B64C 27/33 (20130101)
B64C 27/51 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 29/49826 (20150115)
Y10T 428/31909 (20150401)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09151755 Walker et al.
FUNDED BY
APPLICANT(S) David H. Walker (Galveston, Texas);  Sunil Thomas (Dickinson, Texas)
ASSIGNEE(S) The Boards of Regents, of the University of Texas System (Austin, Texas)
INVENTOR(S) David H. Walker (Galveston, Texas);  Sunil Thomas (Dickinson, Texas)
ABSTRACT The present invention provides an isolated and purified heat shock protein 60 (Hsp60) peptide having the amino acid sequence of SEQ ID NO:2. The instant invention is also directed to a vaccine against Ehrlichia comprising a peptide homologous to the amino acid sequence of SEQ ID NO:2. The instant invention is also directed to an antibody directed against a peptide homologous to the amino acid sequence of SEQ ID NO:2. The instant invention is also directed to a method of determining whether a subject is infected with Ehrlichia, comprising the steps of: contacting a sample from a subject with the antibody described herein; and detecting a resulting antibody reaction, wherein a positive reaction indicates the subject is infected with Ehrlichia.
FILED Thursday, February 06, 2014
APPL NO 14/174815
ART UNIT 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)
A61K 39/0233 (20130101)
A61K 2039/6081 (20130101)

Peptides
C07K 14/29 (20130101)
C07K 16/1246 (20130101)
C07K 2317/34 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/56911 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09154562 Schulzrinne et al.
FUNDED BY
APPLICANT(S) The Trustees of Columbia University in the City of New York (New York, New York)
ASSIGNEE(S) The Trustees of Columbia University in the City of New York (New York, New York)
INVENTOR(S) Henning G. Schulzrinne (Leonia, New Jersey);  Wonsang Song (New York, New York);  Jong Yul Kim (New York, New York)
ABSTRACT Systems, methods, and media for connecting emergency communications are provided. For example, the methods can include: receiving an emergency communication at a particular public safety answering point from a caller directed to the particular public safety answering point by a location-to-service system; creating a conference on a conference system in response to the particular public safety answering point accepting the emergency communication; selecting a particular call-taker of a plurality of call-takers; sending the particular call-taker an invitation to accept the emergency communication; in response to receiving an indication that the particular call-taker has accepted the emergency communication, connecting the selected call-taker to the conference; connecting the caller to the conference; determining the location of the caller; querying the location-to-service system to identify at least one particular emergency responder of a plurality of emergency responders; and connecting at least one of the at least one particular emergency responder to the conference.
FILED Thursday, September 19, 2013
APPL NO 14/031582
ART UNIT 2656 — Digital Audio Data Processing
CURRENT CPC
Transmission of Digital Information, e.g Telegraphic Communication
H04L 67/18 (20130101) Original (OR) Class

Telephonic Communication
H04M 3/56 (20130101)
H04M 3/5116 (20130101)
H04M 2203/5009 (20130101)
H04M 2242/14 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

How To Use This Page 

THE FEDINVENT PATENT DETAILS PAGE

Each week, FedInvent analyzes newly granted patents and published patent applications whose origins lead back to funding by the US Federal Government. The FedInvent Patent Details page is a companion to the weekly FedInvents Patents Report.

This week's information is published in the FedInvent Patents report for Tuesday, October 06, 2015.

The FedInvent Weekly Patent Details Page contains a subset of patent information to provide a deeper dive into the week’s taxpayer-funded patents to help the reader better understand where a patent fits in the federal innovation ecosphere.

HOW IS THE INFORMATION ORGANIZED?

Patents are organized by the funding agency. Within each group, the patents are organized in numeric order. A patent funded by more than one agency will appear in the section of each of the agencies that funded the research and development that resulted in the invention. This approach gives the reader a complete view of the department or agency activity for the week.

WHAT INFORMATION WILL I FIND?

THE PANEL
There is a panel for each patent that contains the patent number and the title of the patent. When you click the panel, it opens to reveal the following information:

FUNDED BY
The agencies that funded the grants, contracts, or other research agreements that resulted in the patent. FedInvent includes as much information on the source of the funding as possible. The information is presented in a hierarchy going from the Federal Department down to the agencies, subagencies, and offices that funded the work. Here are two examples:

Department of Health and Human Services (HHS)
     National Institutes of Health (NIH)
         National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Department of Defense (DOD)
     Defense Advanced Research Projects Agency (DARPA)
         Army Research Office (ARO)

We do our best to provide detailed information about the funding. In some cases, the patent only reports limited information on the origins of the funding. FedInvents presents what it can confirm. We add the patents without the information required by the Bayh-Dole Act to our list of patents worthy of further investigation.

APPLICANT(S) and ASSIGNEES
FedInvent includes both the Applicants and the Assignees because having both provides more information about where the inventive work was done and by what organizations. Many organizations — universities, corporations, and federal agencies — standardize the Assignee/Owner information by the time a patent is granted. In the case of federal patents, many of the patents use the agency headquarters information for patent assignment.

Showing just the headquarters address would make Washington, DC the epicenter of all taxpayer-funded research and development. Providing both the applicant information and the assignee information provides a more accurate picture of where important taxpayer funded innovation is happening in America. Here are two examples from two different patents:

APPLICANT: U.S. Army Research Laboratory, Adelphi, MD
ASSIGNEE: The United States of America as represented by the Secretary of the Army Washington, DC

APPLICANT: Optech Ventures, LLC (Torrance, California)
ASSIGNEE(S): The Regents of the University of California (Oakland, California); Optech Ventures, LLC (Torrance, California)

INVENTOR(S)
The inventors appear in the same order as they appear on the patent. FedInvents presents the names in first name/last name order because they are easier to read than the last name/first name order of the names on the USPTO patent documents.

ABSTRACT
The abstract as it appears on the patent.

FILED
The date of the patent application including the day of the week.

APPL NO
This is the patent application serial number. If you’d like to learn more about how application serial numbers work you can go to the Lists Page.

ART UNIT
Patent data includes the Art Unit where a patent was examined. (The Art Unit isn’t available for published patent applications.) The Art Unit provides insight into what group of patent examiners prosecuted the patent application and the subject matter that the examiners work on. For example:

3793 — Medical Instruments, Diagnostic Equipment, and Treatment Devices

You can learn more about ART UNITS on the FedInvent Patents Weekly panel called About Tech Center or you can find information on the FedInvent Lists Page.

CURRENT CPC
Current CPC provides a list of the Cooperative Patent Classification symbols assigned to the patent. These are the CPC symbols assigned at the time the patent was granted.

The FedInvent Project is a patent classification maximalist endeavor or put another way, we believe that more you understand about patent classification the more you'll learn about the nature of the invention and the types of work that the federal government is funding.

The symbol presented in BOLD is the symbol identified as the "first" classification which is the most relevant classification on the patent. The date that follows the symbol is the date of the most recent revision to the art classed there.

  • A61B 1/149 (20130101)
  • A61B 1/71 (20130101)
  • A61B 1/105 (20130101)

The CPC symbols match the classifications found on the PDF version of the patent. Over time, the classifications on the full-text version of the patent change to reflect how USPTO organizes patent art to support its examiners. The two sets of CPCs don’t always match.

VIEW PATENT
As of June 2021, we include two ways to view a patent at USPTO. FedInvent provides a link to the Full-Text Version of the patent and a link to the PDF version of the patent.

HOW DO I FIND A SPECIFIC PATENT ON A PAGE?

You can use the Command F or Control F to find a specific patent you are interested in.

HOW DO I GET HERE?

You navigate to the details of a patent by clicking the information icon that follows a patent on the FedInvent Patents Weekly Report.

You can also reach this page using the weekly page link that looks like this:

https://wayfinder.digital/fedinvent/patents-2015/fedinvent-patents-20151006.html

Just update the date portion of the URL. Tuesdays for patents. Thursdays for pre-grant publication of patent applications.

Download a copy of the How To Use This Page

HAVE MORE QUESTIONS?

info@wayfinder.digital